image_name
stringlengths 68
68
| type
stringclasses 2
values | gt_table
stringlengths 116
12.6k
|
|---|---|---|
bb09f0784fc755a9896f064cc7a96b1c4c38226f7d5318cf56ffa2220c919e90.png | simple | <table><tr><td>Drug</td><td><i>n</i></td><td>Median Dosage (mg/kg/day)</td><td>Median Length of Treatment (Days)</td><td>Side Effects (<i>n</i>)</td></tr><tr><td>Rifampicin</td><td>415</td><td>17.5</td><td>240</td><td>Itch, vomit and headache (1); rash (1); hypertransaminasemia (4)</td></tr><tr><td>Pyrazinamide</td><td>411</td><td>27</td><td>95</td><td>Hypertransaminasemia (7); vomit and malaise (1); epigastric pain (1); hyperuricemia (5); drug induced hepatitis (1)</td></tr><tr><td>Isoniazid</td><td>396</td><td>10</td><td>242</td><td>Drug induced hepatitis (1); hypertransaminasemia (4)</td></tr><tr><td>Ethambutol</td><td>245</td><td>17</td><td>86</td><td>Vomit and malaise (1); neutropenia (1); drug induced hepatitis (1); epigastric pain (1)</td></tr><tr><td>Streptomycin</td><td>35</td><td>19</td><td>31</td><td></td></tr><tr><td>Moxifloxacin</td><td>31</td><td>10.3</td><td>161</td><td>Tendinopathy (1); long QT syndrome (1)</td></tr><tr><td>Linezolid</td><td>17</td><td>19.1</td><td>108</td><td></td></tr><tr><td>Amikacin</td><td>12</td><td>16.8</td><td>24,5</td><td></td></tr><tr><td>Cycloserine</td><td>11</td><td>14.1</td><td>220</td><td></td></tr><tr><td>Levofloxacin</td><td>7</td><td>11.6</td><td>202</td><td></td></tr><tr><td>PAS <sup>1</sup></td><td>6</td><td>118</td><td>172.5</td><td></td></tr><tr><td>Ethionamide</td><td>6</td><td>15.4</td><td>91.6</td><td></td></tr><tr><td>Clarithromycin</td><td>5</td><td>15.6</td><td>39.6</td><td></td></tr><tr><td>Kanamicina</td><td>1</td><td>10</td><td>142</td><td></td></tr><tr><td>Ciprofloxacin</td><td>4</td><td>17</td><td>238</td><td>Vomit and weight loss (1)</td></tr></table> |
9c7bb764e03f5ac14e09a1d01a80112f42f0677c6960b8058da23d4d9e1ffd31.png | simple | <table><tr><td>Genes group<sup>a</sup></td><td>Number of genes<sup>b</sup></td></tr><tr><td>Glucose-dependent</td><td>667 (18%)</td></tr><tr><td>Upregulated genes</td><td>349</td></tr><tr><td>Downregulated genes</td><td>318</td></tr><tr><td>CcpA-dependent</td><td>407 (11%)</td></tr><tr><td>Upregulated by CcpA</td><td>197</td></tr><tr><td>Downregulated by CcpA</td><td>210</td></tr><tr><td>Regulated by glucose in a CcpA-dependent manner</td><td>361 (10%)</td></tr><tr><td>Upregulated genes</td><td>170</td></tr><tr><td>Downregulated genes</td><td>191</td></tr><tr><td>Regulated by glucose in a CcpA-independent manner</td><td>303 (8%)</td></tr><tr><td>Upregulated genes</td><td>177</td></tr><tr><td>Downregulated genes</td><td>126</td></tr><tr><td>Regulated by CcpA in absence of glucose</td><td>43 (1%)</td></tr><tr><td>Upregulated by CcpA</td><td>8</td></tr><tr><td>Downregulated by CcpA</td><td>35</td></tr><tr><td>Regulated by CcpA independent of glucose</td><td>3 (0.08%)</td></tr><tr><td>Upregulated by CcpA</td><td>2</td></tr><tr><td>Downregulated by CcpA</td><td>1</td></tr><tr><td>Atypical regulation</td><td>112 (0.3%)</td></tr><tr><td>Upregulated genes</td><td>39</td></tr><tr><td>Downregulated genes</td><td>73</td></tr></table> |
98b5443f36da344ad0fea5f2887105ee6ad740279c61921d8783f885f4355c8a.png | complex | <table><tr><td>No.</td><td>Disease</td><td>Medicine</td><td>Formulation</td><td>Strength</td><td>Target size pack</td></tr><tr><td>1</td><td>Intestinal parasite</td><td>Albendazole</td><td>tablet</td><td>200 mg</td><td>2</td></tr><tr><td>2</td><td>Infectious disease</td><td>Amoxicillin</td><td>capsule</td><td>250 mg</td><td>10</td></tr><tr><td></td><td>Infectious disease</td><td>Amoxicillin</td><td>suspension</td><td>125 mg</td><td>100 ml</td></tr><tr><td>3</td><td></td><td>Aminophyllin</td><td>injection</td><td>25 mg/ml</td><td>1 vial</td></tr><tr><td>4</td><td>Infectious disease</td><td>Amoxicillin_Clavulanic acid</td><td>tablet</td><td>125 mg + 125 mg, tab</td><td>10</td></tr><tr><td></td><td>Infectious disease</td><td>Amoxicillin_Clavulanic acid</td><td>suspension</td><td>125 mg + 31.25 mg</td><td>100 ml</td></tr><tr><td></td><td>Infectious disease</td><td>Amoxicillin_Clavulanic acid</td><td>suspension</td><td>250 mg + 62.50 mg</td><td>100 ml</td></tr><tr><td>5</td><td>Infectious disease</td><td>Azithromycin</td><td>capsule</td><td>250 mg</td><td>6</td></tr><tr><td></td><td>Infectious disease</td><td>Azithromycin</td><td>suspension</td><td>200 mg/5 ml</td><td>100 ml</td></tr><tr><td>6</td><td>Asthma</td><td>Beclomethason</td><td>inhaler</td><td>50 mg/day</td><td>1 inhaler (200 doses)</td></tr><tr><td>7</td><td>Infectious disease</td><td>Benzylpenicillin</td><td>injection</td><td>600 mg = 1 million IU</td><td>1 vial</td></tr><tr><td>8</td><td>Seizure Disorder</td><td>Carbamazepine</td><td>tablet</td><td>100 mg</td><td>20</td></tr><tr><td></td><td>Seizure Disorder</td><td>Carbamazepine</td><td>suspension</td><td>100 mg/5 ml</td><td>100 ml</td></tr><tr><td>9</td><td>Infectious disease</td><td>Cefazolin</td><td>injection</td><td>1 g, vial</td><td>1 vial</td></tr><tr><td>10</td><td>Infectious disease</td><td>Ceftriaxone</td><td>injection</td><td>500 mg vial</td><td>1 vial</td></tr><tr><td>11</td><td>Infectious disease</td><td>Chloramphenicol</td><td>tablet</td><td>250 mg</td><td>10</td></tr><tr><td></td><td>Infectious disease</td><td>Chloramphenicol</td><td>injection</td><td>1 g, vial</td><td>1 vial</td></tr><tr><td>12</td><td>Infectious disease</td><td>Chlorpheniramine</td><td>tablet</td><td>4 mg</td><td>24</td></tr><tr><td>13</td><td>Infectious disease</td><td>Clarithromycin</td><td>suspension</td><td>125 mg/ 5 ml</td><td>100 ml</td></tr><tr><td></td><td>Infectious disease</td><td>Clarithromycin</td><td>tablet</td><td>125 mg</td><td>10</td></tr><tr><td>14</td><td>Infectious disease</td><td>Cotrimoxazole</td><td>tablet</td><td>100 mg + 20 mg (also expressed as 400 mg + 80 mg)</td><td>10</td></tr><tr><td></td><td>Infectious disease</td><td>Cotrimoxazole</td><td>suspension</td><td></td><td>100 ml</td></tr><tr><td>15</td><td>Seizure Disorder</td><td>Diazepam</td><td>tablet</td><td>5 mg</td><td>10</td></tr><tr><td>16</td><td>Anemia</td><td>Ferrous salt</td><td>suspension</td><td>30 mg/5 ml</td><td>100 ml</td></tr><tr><td>17</td><td>Fungal infection</td><td>Fluconazole</td><td>capsule</td><td>150 mg</td><td>6</td></tr><tr><td>18</td><td>Infectious disease</td><td>Gentamycin</td><td>injection</td><td>10 mg/ml</td><td>1 vial</td></tr><tr><td>19</td><td>Pain/inflammation</td><td>Ibuprofen</td><td>tablet</td><td>2 mg</td><td>24</td></tr><tr><td></td><td>Pain/inflammation</td><td>Ibuprofen</td><td>suspension</td><td></td><td>100 ml</td></tr><tr><td>20</td><td>Tuberculosis</td><td>Isoniazide</td><td>tablet</td><td>100 mg</td><td>56</td></tr><tr><td>21</td><td>Pain</td><td>Morphine</td><td>tablet</td><td>10 mg</td><td>56</td></tr><tr><td></td><td>Pain</td><td>Morphine</td><td>oral solution</td><td>10 mg/5 ml</td><td>100 ml</td></tr><tr><td>22</td><td>Dehydration</td><td>ORS</td><td>sachet</td><td>500 ml</td><td>1 sachet</td></tr><tr><td>23</td><td>Pain/inflammation</td><td>Paracetamol</td><td>tablet</td><td>250 mg</td><td>10</td></tr><tr><td></td><td>Pain/inflammation</td><td>Paracetamol</td><td>suppository</td><td>125 mg</td><td>10</td></tr><tr><td></td><td>Pain/inflammation</td><td>Paracetamol</td><td>suppository</td><td>250 mg</td><td>10</td></tr><tr><td></td><td>Pain/inflammation</td><td>Paracetamol</td><td>suspension</td><td>125 mg</td><td>100 ml</td></tr><tr><td>24</td><td>Seizure Disorder</td><td>Phenobarbital</td><td>tablet</td><td>30 mg</td><td>10</td></tr><tr><td></td><td>Seizure Disorder</td><td>Phenobarbital</td><td>injection</td><td>100 mg/ml</td><td>1 vial</td></tr><tr><td>25</td><td>Seizure Disorder</td><td>Phenytoin</td><td>tablet</td><td>50 mg,</td><td>90</td></tr><tr><td></td><td>Seizure Disorder</td><td>Phenytoin</td><td>suspension</td><td>25 mg, 30 mg/5 ml</td><td>500 ml</td></tr><tr><td>26</td><td>Infectious disease</td><td>Procain penicillin</td><td>injection</td><td>1 g, vial</td><td>1 vial</td></tr><tr><td>27</td><td>Asthma</td><td>Salbutamol</td><td>inhaler</td><td>100mcg</td><td>1 inhaler (200 doses)</td></tr><tr><td>28</td><td>Xerophthalmia</td><td>Vitamin A</td><td>capsule</td><td>100.000 IU</td><td>50</td></tr><tr><td>29</td><td>Anemia</td><td>Vitamin B6</td><td>injection</td><td>50 mg/ml</td><td>1 vial</td></tr><tr><td>30</td><td>Dehydration</td><td>Zinc</td><td>tablet</td><td>20 mg</td><td>14</td></tr><tr><td>31</td><td>Spacer</td><td colspan="4">Device</td></tr></table> |
ba6223a6c91e04c7f1658300e2be77451a043f3dbe167d8c5b43f8559b95aae5.png | simple | <table><tr><td>Gene Name</td><td>Forward primer sequence (5′-3′)</td><td>Reverse primer sequence (5′-3′)</td></tr><tr><td><i>β-actin</i></td><td>ACTGGGACGACATGGAGAAGATC</td><td>AAACCTTACCACTCCCGCC</td></tr><tr><td><i>ADRA1B</i></td><td>TCTGGTCGCTGTGCGTGAT</td><td>ATCAAGACCACCAAGACATCCG</td></tr><tr><td><i>ARL3</i></td><td>CATCCCTTGCTCTACATTACTTCC</td><td>AAACGACGGGTGCCACAG</td></tr><tr><td><i>BAP1</i></td><td>ACCCGCACTCCTCCCTTAT</td><td>GAGAACCAAGTGGAGCAGACA</td></tr><tr><td><i>TRPA1</i></td><td>AGTAGCGGCAACATGTCCACC</td><td>CCAAACTAACCCTGAAAGACCG</td></tr></table> |
52403000bce10086232c4951f01e26346320bae007719794c6e3e93a130f5abc.png | simple | <table><tr><td>PPAR</td><td>Human</td><td>Mouse</td><td>Zebrafish</td></tr><tr><td>PPARA</td><td> </td><td> </td><td> </td></tr><tr><td> Genes</td><td>1</td><td>1</td><td>2</td></tr><tr><td> Splice variants</td><td>1</td><td>1</td><td>1 per gene</td></tr><tr><td> Isoforms</td><td>1</td><td>1</td><td>1 per gene</td></tr><tr><td> Size (cds, bp)</td><td>1,407</td><td>1,407</td><td><i>pparaa</i>: 1,413<i>pparab</i>: 1,380</td></tr><tr><td> Protein similarity to zebrafish</td><td>67% for <i>pparaa</i> 74% for <i>pparab</i></td><td>65% for <i>pparaa</i> 71% for <i>pparab</i></td><td> </td></tr><tr><td>PPARD</td><td> </td><td> </td><td> </td></tr><tr><td> Genes</td><td>1</td><td>1</td><td>2</td></tr><tr><td> Splice variants</td><td>1</td><td>1</td><td>1 per gene</td></tr><tr><td> Isoforms</td><td>1</td><td>1</td><td>1 per gene</td></tr><tr><td> Size (cds, bp)</td><td>1,326</td><td>1,323</td><td><i>pparda</i>: 1,491<i>ppardb</i>: 1,554</td></tr><tr><td> Protein similarity to zebrafish</td><td>71% for <i>pparda</i> 73% for <i>ppardb</i></td><td>70% for <i>pparda</i> 73% for <i>ppardb</i></td><td> </td></tr><tr><td>PPARG</td><td> </td><td> </td><td> </td></tr><tr><td> Genes</td><td>1</td><td>1</td><td>1</td></tr><tr><td> Splice variants</td><td>4</td><td>1</td><td>1</td></tr><tr><td> Isoforms</td><td>2</td><td>2</td><td>1</td></tr><tr><td> Size (cds, bp)</td><td>PPARG1 = 1,434PPARG2 = 1,518</td><td>PPARG1 = 1,428PPARG2 = 1,518</td><td><i>pparg</i>: 1,584</td></tr><tr><td> Protein similarity to zebrafish</td><td>67%</td><td>67%</td><td> </td></tr></table> |
325e411c6cb3ef4e4da81ced0baa3bf0cce9f1a33cd02d19da1f51aacc6470f1.png | complex | <table><tr><td></td><td colspan="2">SZ (<i>n</i> = 22)</td><td colspan="2">HC (<i>n</i> <i>=</i> 20)</td><td><i>t</i>/<i>x</i><sup>2</sup></td><td><i>p</i>-Value</td></tr><tr><td>Age, years</td><td colspan="2">33 (9.78)</td><td colspan="2">33.05 (9.31)</td><td>−0.002</td><td>0.99</td></tr><tr><td>Sex, M/F</td><td colspan="2">17/5</td><td colspan="2">14/6</td><td>0.63</td><td>0.54</td></tr><tr><td>Parent SES<sup>a</sup></td><td colspan="2">7.89 (5.85)</td><td colspan="2">5.68 (3.92)</td><td>1.34</td><td>0.19</td></tr><tr><td>Smoking status (smoker/non-smoker)</td><td colspan="2">19/3</td><td colspan="2">10/10</td><td></td><td></td></tr><tr><td>Smoking, packs per day</td><td colspan="2">0.73 (0.54)</td><td colspan="2">0.39 (0.57)</td><td>1.97</td><td>0.06</td></tr><tr><td>Medication naive</td><td colspan="2"><i>n</i> = 9</td><td></td><td></td><td></td><td></td></tr><tr><td>Months off medication</td><td colspan="2">27.75 (49.99)</td><td></td><td></td><td></td><td></td></tr><tr><td>Diagnosis (schizophrenia/schizoaffective)</td><td colspan="2">(19/3)</td><td></td><td></td><td></td><td></td></tr><tr><td>Age of onset, years</td><td colspan="2">21.857 (3.38)</td><td></td><td></td><td></td><td></td></tr><tr><td>RBANS total<sup>b</sup></td><td colspan="2">70.55 (12.67)</td><td colspan="2">93.5 (14.81)</td><td>−2.89</td><td>0.006</td></tr><tr><td></td><td>SZ 0</td><td>SZ 6<sup>c</sup></td><td>HC 0</td><td>HC 6</td><td></td><td></td></tr><tr><td colspan="7">BPRS<sup>d</sup></td></tr><tr><td> Total</td><td>48.59 (10.32)</td><td>29.52 (8.14)</td><td></td><td></td><td>8.88</td><td> < 0.001</td></tr><tr><td> Positive</td><td>8.86 (2.48)</td><td>4.52 (2.58)</td><td></td><td></td><td>7.82</td><td> < 0.001</td></tr><tr><td> Negative</td><td>7.05 (2.38)</td><td>5.14 (2.31)</td><td></td><td></td><td>3.01</td><td>0.007</td></tr><tr><td colspan="7">Task reaction time, s</td></tr><tr><td> Congruent</td><td>0.91 (0.18)</td><td>0.90 (0.19)</td><td>0.80 (0.10)</td><td>0.79 (0.13)</td><td></td><td></td></tr><tr><td> Incongruent</td><td>1.04 (0.18)</td><td>1.03 (0.23)</td><td>1.00 (0.14)</td><td>0.91 (0.10)</td><td></td><td></td></tr><tr><td> Stroop</td><td>0.13 (0.07)</td><td>0.13 (0.07)</td><td>0.19 (0.09)</td><td>0.14 (0.08)</td><td></td><td></td></tr><tr><td colspan="7">Missing trials</td></tr><tr><td> Congruent</td><td>8.45 (11.86)</td><td>6.80 (13.76)</td><td>2.85 (8.38)</td><td>2.75 (5.30)</td><td></td><td></td></tr><tr><td> Incongruent</td><td>4.32 (7.08)</td><td>4.20 (7.85)</td><td>1.05 (2.63)</td><td>1.25 (2.61)</td><td></td><td></td></tr><tr><td colspan="7">Task errors</td></tr><tr><td> Congruent</td><td>10.71 (15.83)</td><td>8.06 (12.49)</td><td>2.75 (4.28)</td><td>4.30 (7.14)</td><td></td><td></td></tr><tr><td> Incongruent</td><td>4.52 (5.23)</td><td>3.28 (3.75)</td><td>4.25 (5.46)</td><td>3.90 (5.09)</td><td></td><td></td></tr></table> |
e5612e9c6f68f49bccbccdda642f11abe33d3502a110c5ddb5d7c0137ad58bba.png | simple | <table><tr><td></td><td>Grade 2 (<i>n</i> = 20)</td><td>Grade 5 (<i>n</i> = 20)</td></tr><tr><td>Null-Prime</td><td>0.51 (0.50)</td><td>0.62 (0.49)</td></tr><tr><td>Prime</td><td>0.52 (0.50)</td><td>0.72 (0.45)</td></tr></table> |
2899d25eae852c8a62005ae7cdfa2a39d4fa7d83162dbdb93799bfd8c04ab012.png | complex | <table><tr><td></td><td colspan="2">Pre-intervention</td><td colspan="2">Post-intervention</td><td></td></tr><tr><td></td><td>Intervention(n = 43)</td><td>Control(n = 30)</td><td>Intervention(n = 37)</td><td>Control(n = 28)</td><td>P-value</td></tr><tr><td colspan="4">Attitudes (agreement with statement)</td><td></td><td></td></tr><tr><td>Teachers do not need to act as role models for being active</td><td>5.0</td><td>11.5</td><td>0.0</td><td>7.5</td><td>0.09</td></tr><tr><td>It is not the role of the teacher to teach movement skills</td><td>14.3</td><td>10.0</td><td>5.7</td><td>19.2</td><td>0.10</td></tr><tr><td>It is not important that children participate in structured active play</td><td>9.8</td><td>13.3</td><td>0.0</td><td>0.0</td><td>-</td></tr><tr><td>Safety concerns limit active play opportunities in the preschool setting</td><td>60.0</td><td>70.0</td><td>38.9</td><td>58.3</td><td>0.14</td></tr><tr><td>It is not the role of the teacher to teach about healthy eating</td><td>14.5</td><td>3.5</td><td>2.8</td><td>15.5</td><td>0.07</td></tr><tr><td>Parents should be able to send any type of food to school with their child.</td><td>7.3</td><td>3.3</td><td>0.0</td><td>3.7</td><td>0.25</td></tr><tr><td>It is alright to sell chocolates and sweets for fundraising</td><td>56.1</td><td>56.5</td><td>59.0</td><td>48.0</td><td>0.39</td></tr><tr><td>Confidence</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>I am confident that I can teach movement skills to children.</td><td>97.6</td><td>90.0</td><td>97.3</td><td>95.7</td><td>0.73</td></tr><tr><td>I am confident in talking to parents about their child's movement skills.</td><td>80.5</td><td>96.7</td><td>97.0</td><td>90.9</td><td>0.33</td></tr><tr><td>I am confident in talking to parents about their child's lunchbox contents</td><td>76.9</td><td>89.7</td><td>89.7</td><td>95.8</td><td>0.40</td></tr><tr><td>Confident talking to parents about their child's television viewing</td><td>47.5</td><td>78.6</td><td>68.8</td><td>75.0</td><td>0.68</td></tr><tr><td>Knowledge of recommended guidelines</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Daily serves of fruit</td><td>100.0</td><td>93.0</td><td>94.5</td><td>96.0</td><td>0.79</td></tr><tr><td>Daily serves of vegetables</td><td>89.7</td><td>96.6</td><td>94.3</td><td>87.5</td><td>0.36</td></tr><tr><td>Recreational screen time (TV/DVDs) (hrs/day)</td><td>84.2</td><td>62.1</td><td>73.5</td><td>87.0</td><td>0.22</td></tr></table> |
3977e5b1af06798363e8c677deed730cd1906f196b94f0e0cf8314e9cb570dad.png | simple | <table><tr><td>Probe Set</td><td>z-score</td><td>DMFS</td><td>Gene Symbol</td><td>Gene Title</td></tr><tr><td>209648_x_at</td><td>4.01</td><td>-</td><td>SOCS5</td><td>suppressor of cytokine signaling 5</td></tr><tr><td>208127_s_at</td><td>3.75</td><td>-</td><td>SOCS5</td><td>suppressor of cytokine signaling 5</td></tr><tr><td>209550_at</td><td>3.18</td><td>-</td><td>NDN</td><td>necdin homolog (mouse)</td></tr><tr><td>201162_at</td><td>3.14</td><td>-</td><td>IGFBP7</td><td>insulin-like growth factor binding protein 7</td></tr><tr><td>213910_at</td><td>2.87</td><td>-</td><td>IGFBP7</td><td>insulin-like growth factor binding protein 7</td></tr><tr><td>212279_at</td><td>2.91</td><td>+</td><td>MAC30</td><td>hypothetical protein MAC30</td></tr><tr><td>213337_s_at</td><td>2.88</td><td>+</td><td>SOCS1</td><td>suppressor of cytokine signaling 1</td></tr></table> |
91924dd56570848f679c975c94c205970ead0dc4210357b3af08c5009195cd5e.png | complex | <table><tr><td rowspan="2" colspan="2"> </td><td colspan="2">Blood culture/IFAT</td><td rowspan="2">Total</td></tr><tr><td>Positive</td><td>Negative</td></tr><tr><td rowspan="2">PCR</td><td>Positive</td><td>25/29</td><td>11/7</td><td>36/36</td></tr><tr><td>Negative</td><td>4/3</td><td>10/11</td><td>14/14</td></tr><tr><td> </td><td>Total</td><td>29/32</td><td>21/18</td><td>50/50</td></tr></table> |
d70c49ec6bdbc35993c1a5ae5a609d42e4809c1b0b3326ed9512a12d5d8bc0b3.png | simple | <table><tr><td></td><td>Control group</td><td>Study group</td><td>Total analysed</td></tr><tr><td>Toes</td><td>156 (50 %)</td><td>156 (50 %)</td><td>312</td></tr><tr><td> Males</td><td>37</td><td>26</td><td>63</td></tr><tr><td> Females</td><td>44</td><td>58</td><td>102</td></tr><tr><td>Average age</td><td>27.19</td><td>25.35</td><td>26.27</td></tr><tr><td> Standard deviation</td><td>9.48</td><td>9.04</td><td>9.26</td></tr><tr><td> Median (range)</td><td>23 (12–50)</td><td>23 (10–50)</td><td>23 (10–50)</td></tr></table> |
ad63902c096ecfb0fc8dd121fa3dd5aa90212d6a3c3a49059e8a358fd3e5a782.png | simple | <table><tr><td>Variable</td><td>Description and unit</td><td>Mean</td><td>Std. Dev.</td></tr><tr><td>Hypertension</td><td>1if has hypertension; 0 otherwise</td><td>0.43</td><td>0.49</td></tr><tr><td>Obesity</td><td>1 if obese; 0 otherwise</td><td>0.31</td><td>0.46</td></tr><tr><td>Age</td><td>In years</td><td>55.46</td><td>16.06</td></tr><tr><td>Marital status</td><td>1 if married; 0 otherwise</td><td>0.56</td><td>0.49</td></tr><tr><td>Education</td><td>1 if some college or higher; 0 otherwise</td><td>0.51</td><td>0.49</td></tr><tr><td>Employment</td><td>1 if employed; 0 otherwise</td><td>0.40</td><td>0. 49</td></tr><tr><td>Income</td><td>Annual income in dollars</td><td>$40,774</td><td>$24,815</td></tr><tr><td>Gender</td><td>1 if male; 0 if female</td><td>0.38</td><td>0.48</td></tr><tr><td>Race</td><td>1 if white; 0 if race other than white</td><td>0.90</td><td>0.29</td></tr><tr><td>Sleep</td><td>Number of sleepless days in previous month</td><td>8.50</td><td>10.56</td></tr><tr><td>Drinks</td><td>1 if drinks alcohol; 0 otherwise</td><td>0.34</td><td>0.47</td></tr><tr><td>Smokes</td><td>1 if smokes; 0 otherwise</td><td>0.21</td><td>0.41</td></tr><tr><td>Exercise</td><td>Number of minutes engaged in exercise for the previous week</td><td>403.57</td><td>674.95</td></tr></table> |
2e4b8bd519effff338f6d686f27331d736a7a8ede4d67acca1bbdd778a218460.png | simple | <table><tr><td>References</td><td>Primary outcomes</td><td>Secondary outcomes</td></tr><tr><td>Fiske (strong)<sup>1</sup>[17]</td><td>There was no difference in sales of healthier food options between intervention and control groups.</td><td></td></tr><tr><td>Kocken (strong) [20]</td><td>Higher sales of healthier food options were observed in intervention groups compared to control groups.</td><td></td></tr></table> |
c5c18a71e43d11fa5600c7acd7db4f1ddb974d3a2098d96fb6367c289e6fd824.png | simple | <table><tr><td>Section of economizer</td><td>Condition design</td></tr><tr><td></td><td>Length was 250 mm</td></tr><tr><td>Evaporator section</td><td>Hot water flow was 80°C</td></tr><tr><td></td><td>Volumetric flow rate was 5 l/min</td></tr><tr><td>Adiabatic section</td><td>Length was 250 mm</td></tr><tr><td></td><td>Length was 250 mm</td></tr><tr><td>Condenser section</td><td>Cool water flow was 25°C</td></tr><tr><td></td><td>Volumetric flow rate was 1 l/min</td></tr></table> |
6bf53173b9992fe30bc678f4cf643926d09bce52abfeb1b083f9bc3f24a50507.png | simple | <table><tr><td>Item</td><td>Dimension</td><td>Missing values (%)</td></tr><tr><td>1. I work hard to keep my HIV a secret<sup>a</sup></td><td>Disclosure concerns</td><td>0.0</td></tr><tr><td>2. Most people believe a person who has HIV is dirty<sup>a</sup></td><td>Public attitudes</td><td>3.4</td></tr><tr><td>3. Having HIV makes me feel unclean<sup>a</sup></td><td>Negative self-image</td><td>8.6</td></tr><tr><td>4. Most people think a person with HIV is disgusting<sup>a</sup></td><td>Public attitudes</td><td>1.7</td></tr><tr><td>5. Having HIV makes me feel I'm a bad person<sup>a</sup></td><td>Negative self-image</td><td>0.0</td></tr><tr><td>6. Most with HIV are rejected when others learn<sup>a</sup></td><td>Public attitudes</td><td>5.2</td></tr><tr><td>7. I am very careful whom I tell that I have HIV<sup>a</sup></td><td>Disclosure concerns</td><td>3.4</td></tr><tr><td>8. Having HIV in my body feels disgusting<sup>a</sup></td><td>Negative self-image</td><td>0.0</td></tr><tr><td>9. I have been hurt by how people reacted to learning I have HIV</td><td>Personalized stigma</td><td>19.0</td></tr><tr><td>10. I worry that people who know I have HIV will tell others</td><td>Disclosure concerns</td><td>13.8</td></tr><tr><td>11. I have stopped socializing with some due to their reactions to my HIV</td><td>Personalized stigma</td><td>19.0</td></tr><tr><td>12. I have lost friends by telling them I have HIV</td><td>Personalized stigma</td><td>24.1</td></tr></table> |
a21a52f93f722a2b72809159ae10450c72e7a2b7809fd762ee21598613ff08df.png | complex | <table><tr><td></td><td colspan="2">Healthy normal control</td><td colspan="2">Obese control</td><td colspan="2">OHS</td><td colspan="2">OSAS</td><td>P</td></tr><tr><td></td><td>Med.</td><td>Perc.25/75</td><td>Med.</td><td>Perc.25/75</td><td>Med.</td><td>Perc.25/75</td><td>Med.</td><td>Perc.25/75</td><td></td></tr><tr><td>Trials administered</td><td>103.5</td><td>81128</td><td>117</td><td>10728</td><td>128</td><td>128128</td><td>128</td><td>102.5128</td><td>0.04</td></tr><tr><td>Total number of correct answers</td><td>76</td><td>6388.25</td><td>78</td><td>62.584.5</td><td>56</td><td>43.578.5</td><td>66</td><td>52.572.5</td><td>0.12</td></tr><tr><td>Total number of incorrect answers</td><td>23.5</td><td>12.7537.25</td><td>32</td><td>24.564</td><td>72</td><td>49.584.5</td><td>62</td><td>2875.5</td><td>0.01</td></tr><tr><td>Total number of persistent errors</td><td>13,5</td><td>4.7519.25</td><td>16</td><td>928.5</td><td>53</td><td>18.565.5</td><td>24</td><td>9.540</td><td>0.03</td></tr><tr><td>Number of completed categories</td><td>6<sup>a,b</sup></td><td>5.56</td><td>6</td><td>26</td><td>1<sup>a</sup></td><td>13</td><td>2<sup>b</sup></td><td>14.5</td><td>0.01</td></tr><tr><td>Percentage of persistent errors</td><td>9.5</td><td>7.7516</td><td>12</td><td>1123</td><td>14</td><td>12.520</td><td>20</td><td>1229</td><td>0.15</td></tr><tr><td>The percentage of conceptual level responses</td><td>73</td><td>65.2580.75</td><td>64</td><td>35.571.5</td><td>27</td><td>1850.5</td><td>28</td><td>21.568.5</td><td>0.01</td></tr><tr><td>Learning to learn scores</td><td>0.26</td><td>-1.622.12</td><td>1.97</td><td>-2.062</td><td>-10.5</td><td>11.5</td><td>-6.85</td><td>-28.30.2</td><td>0.24</td></tr></table> |
04d3fec20d4d20d9ce2fba59093be99545c0de8aebea23cd43de87dc6e1267f2.png | complex | <table><tr><td>Variable</td><td><35</td><td>p-value</td><td>≥35</td><td>p-value</td></tr><tr><td> </td><td>Adjusted odds ratio (95% CI)</td><td> </td><td>Adjusted odds ratio (95% CI)</td><td> </td></tr><tr><td colspan="5">a. Adjusted Confounder Model for not having tested for HIV in the past 2 years, stratified by age</td></tr><tr><td>Asian ethnicity</td><td>2.04 (1.08-3.86)</td><td>0.028</td><td>0.65 (0.28-1.51)</td><td>0.32</td></tr><tr><td>English or French as first language</td><td>1.29 (0.69-2.43)</td><td>0.426</td><td>1.28 (0.62-2.66)</td><td>0.51</td></tr><tr><td>Age (in years) of participate at study enrolment.</td><td>0.97 (0.92-1.02)</td><td>0.245</td><td>1.01 (0.98-1.03)</td><td>0.58</td></tr><tr><td>IDU ever</td><td>0.81 (0.41-1.56)</td><td>0.522</td><td>0.42 (0.20-0.86)</td><td>0.017</td></tr><tr><td>At the present time, do you smoke cigarettes?</td><td>1.31 (0.84-2.03)</td><td>0.234</td><td>1.15 (0.68-1.95)</td><td>0.60</td></tr><tr><td>Not told doctor of male sex partners</td><td>5.83 (3.67-9.24)</td><td><0.001</td><td>3.47 (1.90-6.35)</td><td><0.001</td></tr><tr><td colspan="5">b. Adjusted Confounder Model for not having tested for Hepatitis C Virus in the past 2 years, stratified by age</td></tr><tr><td>Asian ethnicity</td><td>2.30 (1.27-4.19)</td><td>0.006</td><td>1.05 (0.51-2.15)</td><td>0.90</td></tr><tr><td>English or French as first language</td><td>1.25 (0.71-2.22)</td><td>0.435</td><td>1.14 (0.61-2.13)</td><td>0.68</td></tr><tr><td>Age (in years) of participate at study enrolment.</td><td>0.99 (0.95-1.04)</td><td>0.664</td><td>1.02 (1.00-1.04)</td><td>0.063</td></tr><tr><td>Not told doctor of male sex partners</td><td>7.06 (4.30-11.60)</td><td><0.001</td><td>2.43 (1.41-4.18)</td><td>0.001</td></tr><tr><td colspan="5">c. Adjusted Confounder Model for not having tested for syphilis in the past 2 years, stratified by age</td></tr><tr><td>Asian ethnicity</td><td>0.85 (0.45-1.61)</td><td>0.625</td><td>0.67 (0.32-1.40)</td><td>0.29</td></tr><tr><td>English or French as first language</td><td>1.19 (0.66-2.15)</td><td>0.563</td><td>0.81 (0.43-1.52)</td><td>0.51</td></tr><tr><td>Age (in years) of participate at study enrolment.</td><td>0.96 (0.92-1.01)</td><td>0.124</td><td>0.99 (0.97-1.01)</td><td>0.48</td></tr><tr><td>IDU ever</td><td>1.59 (0.86-2.93)</td><td>0.137</td><td>1.77 (1.08-2.90)</td><td>0.023</td></tr><tr><td>At the present time, do you smoke cigarettes?</td><td>0.66 (0.44-1.00)</td><td>0.048</td><td>0.65 (0.43-0.98)</td><td>0.038</td></tr><tr><td>Not told doctor of male sex partners</td><td>0.11 (0.07-0.18)</td><td><0.001</td><td>0.24 (0.14-0.42)</td><td><0.001</td></tr></table> |
066dadc6ba9c3a7b82ff3f33d888610fa58a8a6f17228240457b11e2013baa28.png | complex | <table><tr><td rowspan="2">Variables</td><td rowspan="2">Category</td><td>(1)</td><td>(2)</td><td>(3)</td><td>(4)</td><td>(5)</td></tr><tr><td>rifEI</td><td>rifWI</td><td>rifARCI</td><td>rifSRCI</td><td>rifAC</td></tr><tr><td colspan="7"><i>Demographic characteristics</i></td></tr><tr><td rowspan="2">Gender</td><td>Female (Reference)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Male</td><td>−0.019***</td><td>−0.019***</td><td>−0.011***</td><td>−0.008**</td><td>−0.005***</td></tr><tr><td rowspan="4">Age group</td><td>Quartile 4 (56+) (Reference)</td><td>Reference</td><td></td><td></td><td></td><td></td></tr><tr><td>Quartile 1 (18–33)</td><td>−0.079***</td><td>−0.073***</td><td>−0.049***</td><td>−0.024***</td><td>−0.020***</td></tr><tr><td>Quartile 2 (33–43)</td><td>−0.022***</td><td>−0.018**</td><td>−0.020***</td><td>0.002</td><td>−0.006***</td></tr><tr><td>Quartile 3 (43–56)</td><td>−0.014**</td><td>−0.011</td><td>−0.012***</td><td>0.001</td><td>−0.003**</td></tr><tr><td rowspan="2">Ethnicity</td><td>Ethnic Minority (Reference)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Han</td><td>−0.016**</td><td>−0.016**</td><td>−0.007**</td><td>−0.010***</td><td>−0.004**</td></tr><tr><td rowspan="3">Marital status</td><td>Divorced, separated, or widowed (Reference)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Married</td><td>−0.083***</td><td>−0.084***</td><td>−0.039***</td><td>−0.045***</td><td>−0.021***</td></tr><tr><td>Single</td><td>−0.075***</td><td>−0.075***</td><td>−0.036***</td><td>−0.039***</td><td>−0.019***</td></tr><tr><td>Household size</td><td></td><td>−0.002</td><td>−0.001</td><td>−0.001</td><td>−0.000</td><td>−0.000</td></tr><tr><td><i>Health insurance</i></td><td>Yes = 1; No = 0</td><td>0.024***</td><td>0.024***</td><td>0.012***</td><td>0.012***</td><td>0.006***</td></tr><tr><td colspan="7"><i>Socioeconomic status</i></td></tr><tr><td>Per capita household income</td><td></td><td>−0.054***</td><td>−0.054***</td><td>−0.026***</td><td>−0.029***</td><td>−0.014***</td></tr><tr><td>Work status</td><td>Work = 1; Not working = 0</td><td>0.045***</td><td>0.047***</td><td>0.018***</td><td>0.028***</td><td>0.011***</td></tr><tr><td rowspan="3">Education degree</td><td>Primary education (Reference)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Secondary education</td><td>−0.025***</td><td>−0.027***</td><td>−0.009***</td><td>−0.018***</td><td>−0.006***</td></tr><tr><td>Tertiary education</td><td>0.228***</td><td>0.231***</td><td>0.102***</td><td>0.129***</td><td>0.057***</td></tr><tr><td colspan="7"><i>Lifestyle factors</i></td></tr><tr><td>Smoking history</td><td>Yes = 1; No = 0</td><td>−0.004</td><td>−0.004</td><td>−0.001</td><td>−0.003</td><td>−0.001</td></tr><tr><td>Drinking alcohol</td><td>Yes = 1; No = 0</td><td>0.014**</td><td>0.015**</td><td>0.005*</td><td>0.010***</td><td>0.003**</td></tr><tr><td rowspan="4">BMI</td><td>Normal weight (Reference)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Underweight</td><td>0.095***</td><td>0.095***</td><td>0.046***</td><td>0.049***</td><td>0.024***</td></tr><tr><td>Overweight</td><td>−0.011</td><td>−0.01</td><td>−0.007</td><td>−0.003</td><td>−0.003</td></tr><tr><td>Obese</td><td>0.002</td><td>0.003</td><td>0.000</td><td>0.003</td><td>0.001</td></tr><tr><td colspan="7"><i>Home environment</i></td></tr><tr><td>Tap water</td><td>Yes = 1; No = 0</td><td>−0.035***</td><td>−0.036***</td><td>−0.016***</td><td>−0.020***</td><td>−0.009***</td></tr><tr><td>Flush toilet</td><td>Yes = 1; No = 0</td><td>−0.023***</td><td>−0.025***</td><td>−0.009***</td><td>−0.016***</td><td>−0.006***</td></tr><tr><td rowspan="3">Region</td><td>Eastern (Reference)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Middle</td><td>−0.017***</td><td>−0.020***</td><td>−0.004</td><td>−0.016***</td><td>−0.004***</td></tr><tr><td>Western</td><td>−0.027***</td><td>−0.031***</td><td>−0.005*</td><td>−0.026***</td><td>−0.007***</td></tr><tr><td rowspan="6">Year</td><td>1991 (Reference)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>1993</td><td>0.022***</td><td>0.022***</td><td>0.010***</td><td>0.012***</td><td>0.006***</td></tr><tr><td>1997</td><td>0.064***</td><td>0.065***</td><td>0.029***</td><td>0.036***</td><td>0.016***</td></tr><tr><td>2000</td><td>0.080***</td><td>0.080***</td><td>0.039***</td><td>0.041***</td><td>0.020***</td></tr><tr><td>2004</td><td>0.065***</td><td>0.064***</td><td>0.033***</td><td>0.031***</td><td>0.016***</td></tr><tr><td>2006</td><td>0.044***</td><td>0.043***</td><td>0.024***</td><td>0.020***</td><td>0.011***</td></tr><tr><td>Constant</td><td></td><td>0.505***</td><td>0.501***</td><td>0.246***</td><td>0.255***</td><td>0.126***</td></tr><tr><td>Observations</td><td></td><td>31,958</td><td>31,958</td><td>31,958</td><td>31,958</td><td>31,958</td></tr></table> |
504c5c728e949ca8293489abf3feb2020c4bb5e755aa67d5cb8a4cfb5ca65950.png | complex | <table><tr><td rowspan="2" colspan="2"><i>Variable</i></td><td colspan="2"><i>Cross River</i></td><td colspan="2"><i>Bauchi</i></td></tr><tr><td><i>n/N</i></td><td><i>OR (95% CIca)</i></td><td><i>n/N</i></td><td><i>OR (95% CIca)</i></td></tr><tr><td rowspan="2"><i>Sex of child</i></td><td>Male</td><td>767/2,206</td><td>1.04</td><td>1,191/2,590</td><td>1.02</td></tr><tr><td>Female</td><td>769/2,276</td><td>(0.92–1.18)</td><td>1,112/2,448</td><td>(0.92–1.14)</td></tr><tr><td rowspan="2"><i>Duration of fever</i></td><td>≤ 5 days</td><td>866/2,800</td><td>0.68</td><td>1,537/3,587</td><td>0.67</td></tr><tr><td>>5 days</td><td>662/1,662</td><td>(0.59–0.78)</td><td>704/1,334</td><td>(0.57–0.79)</td></tr><tr><td rowspan="2"><i>Number of children in household</i></td><td>0–2 children</td><td>639/1,887</td><td>0.96</td><td>775/1,701</td><td>1.00</td></tr><tr><td>+3 children</td><td>796/2,292</td><td>(0.83–1.12)</td><td>1,490/3,277</td><td>(0.89–1.13)</td></tr><tr><td rowspan="2"><i>Sex of household head</i></td><td>Male</td><td>1,280/3,673</td><td>1.15</td><td>2,286/4,993</td><td>1.27</td></tr><tr><td>Female</td><td>254/800</td><td>(0.93–1.42)</td><td>10/25</td><td>(0.53–3.01)</td></tr><tr><td rowspan="2"><i>Household food in last week</i></td><td>Enough</td><td>1,260/3,539</td><td>1.39</td><td>2,108/4,551</td><td>1.28</td></tr><tr><td>Not enough</td><td>261/915</td><td>(1.15–1.67)</td><td>183/455</td><td>(1.00–1.64)</td></tr><tr><td rowspan="2"><i>Safety of water source</i></td><td>Safe</td><td>681/1,720</td><td>1.46</td><td>918/1,830</td><td>1.32</td></tr><tr><td>Unsafe</td><td>850/2,744</td><td>(1.13–1.89)</td><td>1,377/3,186</td><td>(1.04–1.68)</td></tr><tr><td rowspan="2"><i>Mother has own income</i></td><td>Yes</td><td>891/2,436</td><td>1.29</td><td>1,476/3,192</td><td>1.09</td></tr><tr><td>No</td><td>550/1,777</td><td>(1.10–1.50)</td><td>788/1,786</td><td>(0.92–1.29)</td></tr><tr><td rowspan="2"><i>Perceived relative financial status</i></td><td>Average or above</td><td>1,026/2,884</td><td>1.18</td><td>1,896/4,159</td><td>0.96</td></tr><tr><td>Below average</td><td>504/1,579</td><td>(1.00–1.38)</td><td>395/848</td><td>(0.78–1.19)</td></tr><tr><td rowspan="2"><i>Education of household head</i></td><td>Junior secondary +</td><td>975/2,588</td><td>1.41</td><td>744/1,234</td><td>2.20</td></tr><tr><td>< junior secondary</td><td>541/1,807</td><td>(1.17–1.70)</td><td>1,533/3,751</td><td>(1.78–2.71)</td></tr><tr><td rowspan="2"><i>Education of the mother</i></td><td>Junior secondary +</td><td>989/2,623</td><td>1.45</td><td>280/423</td><td>–</td></tr><tr><td>< junior secondary</td><td>535/1,816</td><td>(1.21–1.74)</td><td>2,019/4,610</td><td></td></tr><tr><td rowspan="2"><i>Education of the mother</i></td><td>Formal education</td><td>1,426/4,132</td><td>-</td><td>606/979</td><td>2.27</td></tr><tr><td>No formal education</td><td>98/307</td><td></td><td>1,693/4,054</td><td>(1.84–2.78)</td></tr><tr><td rowspan="2"><i>Education of the father</i></td><td>Junior secondary +</td><td>1,086/2,932</td><td>1.37</td><td>729/1,215</td><td>2.16</td></tr><tr><td>< junior secondary</td><td>401/1,332</td><td>(1.13–1.65)</td><td>1,543/3,764</td><td>(1.75–2.66)</td></tr><tr><td rowspan="2"><i>Urban/rural community</i></td><td>Urban</td><td>407/1,259</td><td>0.89</td><td>419/724</td><td>1.77</td></tr><tr><td>Rural</td><td>1,129/3,224</td><td>(0.63–1.25)</td><td>1,884/4,314</td><td>(1.37–2.29)</td></tr><tr><td rowspan="2"><i>Type of road to community</i></td><td>Paved/stoned</td><td>1,051/3,085</td><td>0.92</td><td>859/1,780</td><td>1.16</td></tr><tr><td>Dirt</td><td>447/1,242</td><td>(0.63–1.35)</td><td>1,425/3,193</td><td>(0.86–1.55)</td></tr><tr><td rowspan="2"><i>Health facility in settlement</i></td><td>Yes</td><td>1,269/3,273</td><td>2.31</td><td>1,533/3,171</td><td>1.33</td></tr><tr><td>No</td><td>239/1,109</td><td>(1.57–3.39)</td><td>763/1,847</td><td>(1.01–1.7)</td></tr></table> |
e8f65ade0fe45e659f23134787a7d2d949b0791e133768d6430bcfd469512cca.png | complex | <table><tr><td rowspan="2">Anatomic site</td><td rowspan="2">Time period</td><td colspan="3">Incidence rate (95% CI) by race/ethnicity</td><td colspan="2">Rate ratios (95% CI)</td></tr><tr><td>Non-Hispanic white </td><td>Hispanic</td><td>American Indian</td><td>H versus NHW</td><td>AI versus NHW</td></tr><tr><td colspan="7">Men</td></tr><tr><td rowspan="3">Right side</td><td>1995–1999</td><td>19.2 (17.4–21.2)</td><td>17.5 (14.9–20.4)</td><td>10.0 (5.9–15.6)</td><td>0.92 (0.75–1.10)</td><td>0.52 (0.31–0.82)</td></tr><tr><td>2000–2004</td><td>20.4 (18.7–22.3)</td><td>17.7 (15.4–20.3)</td><td>9.4 (5.9–14.2)</td><td>0.87 (0.73–1.02)</td><td>0.46 (0.29–0.70)</td></tr><tr><td>2005–2009</td><td>17.0 (15.5–18.7)</td><td>14.1 (12.3–16.2)<sup>a</sup></td><td>8.7 (5.6–12.7)</td><td>0.83 (0.70–0.98)</td><td>0.51 (0.33–0.75)</td></tr><tr><td rowspan="3">Left side</td><td>1995–1999</td><td>14.5 (13.0–16.2)</td><td>13.9 (11.6–16.4)</td><td>10.6 (6.3–16.4)</td><td>0.96 (0.78–1.17)</td><td>0.73 (0.43–1.15)</td></tr><tr><td>2000–2004</td><td>12.8 (11.5–14.3)</td><td>15.8 (13.6–18.2)</td><td>9.4 (5.9–14.0)</td><td>1.23 (1.02–1.48)</td><td>0.73 (0.45–1.11)</td></tr><tr><td>2005–2009</td><td>10.8 (9.6–12.1)<sup>a</sup></td><td>12.3 (10.6–14.2)</td><td>9.4 (6.2–13.6)</td><td>1.13 (0.94–1.37)</td><td>0.87 (0.56–1.28)</td></tr><tr><td rowspan="3">Rectum and rectosigmoid junction</td><td>1995–1999</td><td>15.7 (14.1–17.4)</td><td>18.6 (16.0–21.5)</td><td>9.4 (5.8–14.4)</td><td>1.19 (0.98–1.42)</td><td>0.60 (0.36–0.93)</td></tr><tr><td>2000–2004</td><td>15.1 (13.6–16.7)</td><td>20.2 (17.7–22.8)</td><td>14.5 (9.9–20.3)</td><td>1.33 (1.13–1.57)</td><td>0.96 (0.65–1.37)</td></tr><tr><td>2005–2009</td><td>14.5 (13.1–16.1)</td><td>17.8 (15.7–20.0)</td><td>11.9 (8.4–16.4)</td><td>1.22 (1.04–1.43)</td><td>0.82 (0.57–1.14)</td></tr><tr><td colspan="7">Women</td></tr><tr><td rowspan="3">Right side</td><td>1995–1999</td><td>15.2 (13.8–16.7)</td><td>13.0 (11.1–15.2)</td><td>10.1 (6.5–14.8)</td><td>0.86 (0.71–1.03)</td><td>0.66 (0.42–0.99)</td></tr><tr><td>2000–2004</td><td>16.6 (15.2–18.1)</td><td>13.7 (11.8–15.7)</td><td>9.7 (6.5–13.7)</td><td>0.82 (0.70–0.97)</td><td>0.58 (0.39–0.84)</td></tr><tr><td>2005–2009</td><td>14.4 (13.1–15.8)</td><td>14.6 (12.9–16.5)</td><td>12.7 (9.3–16.9)</td><td>1.02 (0.86–1.18)</td><td>0.88 (0.63–1.19)</td></tr><tr><td rowspan="3">Left side</td><td>1995–1999</td><td>10.8 (9.6–12.2)</td><td>9.2 (7.6–11.0)</td><td>6.9 (4.0–11.0)</td><td>0.85 (0.68–1.05)</td><td>0.64 (0.37–1.03)</td></tr><tr><td>2000–2004</td><td>8.6 (7.6–9.8)<sup>a</sup></td><td>9.5 (8.0–11.2)</td><td>7.1 (4.4–10.7)</td><td>1.11 (0.89–1.36)</td><td>0.83 (0.51–1.27)</td></tr><tr><td>2005–2009</td><td>7.4 (6.4–8.4)<sup>a</sup></td><td>8.0 (6.7–9.4)</td><td>5.1 (3.0–8.0)</td><td>1.08 (0.87–1.34)</td><td>0.69 (0.40–1.10)</td></tr><tr><td rowspan="3">Rectum and rectosigmoid junction</td><td>1995–1999</td><td>8.7 (7.6–9.9)</td><td>9.9 (8.2–11.8)</td><td>7.2 (4.1–11.6)</td><td>1.14 (0.91–1.42)</td><td>0.83 (0.47–1.36)</td></tr><tr><td>2000–2004</td><td>9.1 (8.0–10.3)</td><td>9.2 (7.8–10.9)</td><td>5.5 (3.3–8.7)</td><td>1.01 (0.82–1.25)</td><td>0.61 (0.35–0.97)</td></tr><tr><td>2005–2009</td><td>9.5 (8.4–10.7)</td><td>9.6 (8.2–11.1)</td><td>5.2 (3.2–7.9)</td><td>1.00 (0.82–1.21)</td><td>0.54 (0.33–0.84)</td></tr></table> |
107c07bf78403bef6392dea2ed1f8e1a39baeb6b2e5cf345c6f291910c5e42c8.png | complex | <table><tr><td rowspan="2">Characteristics</td><td colspan="3">Lipoatrophy</td><td colspan="3">Fat abnormality</td></tr><tr><td>OR</td><td>95% CI</td><td><i>P</i> value</td><td>OR</td><td>95% CI</td><td><i>P</i> value</td></tr><tr><td>Boys</td><td>4.3</td><td>1.6–11.6</td><td>0.004</td><td>2.7</td><td>1.2–6.3</td><td>0.02</td></tr><tr><td>Age ≥ 10 years</td><td>1.3</td><td>0.6–2.9</td><td>0.54</td><td>1.4</td><td>0.6–3.0</td><td>0.42</td></tr><tr><td>Puberty onset: Yes</td><td>1.2</td><td>0.5–2.7</td><td>0.64</td><td>1.3</td><td>0.6–2.7</td><td>0.52</td></tr><tr><td>Moderate wastingb: Yes</td><td>1.7</td><td>0.7–3.9</td><td>0.20</td><td>1.4</td><td>0.6–3.1</td><td>0.43</td></tr><tr><td>WHO classification Stage<sup>c</sup> 3/4 vs 1/2</td><td>1.7</td><td>0.5–5.0</td><td>0.37</td><td>2.0</td><td>0.7–5.8</td><td>0.23</td></tr><tr><td>Viral load > 40 copies/mL: Yes</td><td>1.1</td><td>0.5–2.6</td><td>0.76</td><td>0.9</td><td>0.4–2.0</td><td>0.82</td></tr><tr><td>CD4 < 500 cells/mm<sup>3</sup>: Yes</td><td>0.5</td><td>0.1–1.7</td><td>0.26</td><td>0.6</td><td>0.2–1.8</td><td>0.34</td></tr><tr><td>Stavudine ever used: Yes</td><td>2.1</td><td>0.9–5.2</td><td>0.09</td><td>2.1</td><td>0.9–5.0</td><td>0.08</td></tr><tr><td>Stavudine exposure 1 year vs No</td><td>1.5</td><td>0.5–4.8</td><td>0.48</td><td>1.7</td><td>0.6–4.9</td><td>0.32</td></tr><tr><td>≥1 year vs No</td><td>3.6</td><td>1.0–12.6</td><td>0.04</td><td>3.1</td><td>0.9–10.8</td><td>0.07</td></tr><tr><td>Zidovudine recent: Yes</td><td>1.0</td><td>0.4–2.4</td><td>0.94</td><td>1.0</td><td>0.4–2.3</td><td>0.93</td></tr><tr><td>Zidovudine exposure < 3 years vs No</td><td>0.5</td><td>0.2–1.8</td><td>0.30</td><td>0.6</td><td>0.2–1.7</td><td>0.30</td></tr><tr><td>≥3 years vs No</td><td>1.3</td><td>0.5–3.3</td><td>0.61</td><td>1.2</td><td>0.5–3.0</td><td>0.63</td></tr><tr><td>Lopinavir/r recent: Yes</td><td>1.3</td><td>0.6–3.1</td><td>0.51</td><td>1.1</td><td>0.5–2.5</td><td>0.86</td></tr><tr><td>Lopinavir/r exposure < 3 years vs No</td><td>0.3</td><td>0.0–2.5</td><td>0.28</td><td>0.3</td><td>0.0–2.0</td><td>0.20</td></tr><tr><td>≥3 years vs No</td><td>2.2</td><td>0.9–5.4</td><td>0.09</td><td>1.8</td><td>0.7–4.3</td><td>0.21</td></tr></table> |
2b703fac727a40d26eec86828ad1f5c7c650a465b20c16ed1172a642efb2bcfa.png | simple | <table><tr><td></td><td>Aboriginal</td><td>Non-Aboriginal</td><td></td></tr><tr><td></td><td>Had surgery n/N (%)</td><td>Had surgery n/N (%)</td><td><i>p</i>-value<sup>b</sup></td></tr><tr><td>All people</td><td>37/120 (30)</td><td>2666/6757 (39)</td><td>-</td></tr><tr><td>Sex</td><td></td><td></td><td>0.972</td></tr><tr><td> Male</td><td>21/72 (29)</td><td>1637/4335 (38)</td><td></td></tr><tr><td> Female</td><td>16/48 (33)</td><td>1029/2422 (42)</td><td></td></tr><tr><td>Age at diagnosis (years)</td><td></td><td></td><td>0.367</td></tr><tr><td> 18–59</td><td>13/40 (33)</td><td>613/1210 (51)</td><td></td></tr><tr><td> 60+</td><td>24/80 (30)</td><td>2053/5547 (37)</td><td></td></tr><tr><td>Spread of disease</td><td></td><td></td><td>0.831</td></tr><tr><td> Localised</td><td>20/64 (31)</td><td>1584/3928 (40)</td><td></td></tr><tr><td> Regional</td><td>17/56 (30)</td><td>1082/2829 (38)</td><td></td></tr><tr><td>Place of residence</td><td></td><td></td><td>0.641</td></tr><tr><td> Major cities</td><td>13/39 (33)</td><td>2044/4760 (43)</td><td></td></tr><tr><td> Inner regional</td><td>13/44 (30)</td><td>480/1498 (32)</td><td></td></tr><tr><td> Rural<sup>c</sup></td><td>11/37 (30)</td><td>142/499 (28)</td><td></td></tr><tr><td>Comorbidities<sup>d</sup></td><td></td><td></td><td>0.018</td></tr><tr><td> No comorbidities</td><td>9/41 (22)</td><td>1390/3196 (43)</td><td></td></tr><tr><td> At least one comorbidity</td><td>28/79 (35)</td><td>1276/3561 (36)</td><td></td></tr><tr><td>Socioeconomic disadvantage</td><td></td><td></td><td>0.245</td></tr><tr><td> Least and second least disadvantaged</td><td>5/15 (33)</td><td>1095/2477 (44)</td><td></td></tr><tr><td> Third least disadvantaged</td><td>3/16 (19)</td><td>464/1168 (40)</td><td></td></tr><tr><td> Second most and most disadvantaged</td><td>29/89 (33)</td><td>1107/3112 (36)</td><td></td></tr></table> |
f495ad6bcd261837643733db09b210b8302080194871ab71acaba0617b5f1f78.png | complex | <table><tr><td>Variable</td><td colspan="3">Training groups</td><td>P value‡</td></tr><tr><td></td><td>Control group<i>n </i>= 60Mean (SD)</td><td>Endurance <i>n </i>= 59Mean (SD)</td><td>Strength <i>n </i>= 60Mean (SD)</td><td></td></tr><tr><td>Demographic</td><td></td><td></td><td></td><td></td></tr><tr><td> Age, years</td><td>46 (5)</td><td>46 (6)</td><td>45 (6)</td><td>0.73</td></tr><tr><td> Height, cm</td><td>164 (5)</td><td>165 (6)</td><td>165 (5)</td><td>0.74</td></tr><tr><td> Weight, kg</td><td>69 (12)</td><td>68 (10)</td><td>67 (11)</td><td>0.64</td></tr><tr><td> Body mass index</td><td>26 (4)</td><td>25 (3)</td><td>25 (3)</td><td>0.40</td></tr><tr><td>Clinical characteristic</td><td></td><td></td><td></td><td></td></tr><tr><td> Duration of neck pain, years</td><td>8 (5)</td><td>9 (6)</td><td>8 (6)</td><td>0.30</td></tr><tr><td> Neck pain, mm (VAS†, scale 0-100)</td><td>58 (20)</td><td>56 (22)</td><td>57 (20)</td><td>0.89</td></tr></table> |
436b5f6229fa146a8bbcec5fd2f739dfe88c159bd24cee86e179e7165f3c9aa4.png | simple | <table><tr><td>Detection range</td><td>Passerinesa</td><td>Wadersb</td><td>Hooded crow (<i>Corvus cornix</i>)</td><td>Gulls</td><td>Mallard (<i>Anas platyrhynchos</i>)</td><td>Raven (<i>Corvus corax</i>)</td><td>Greylag goose (<i>Anser anser</i>)</td><td>White‐tailed eagle (<i>Haliaeetus albicilla</i>)</td></tr><tr><td>RCS (dBm<sup>2</sup>)</td><td>−32.0</td><td>−28.5</td><td>−24.9</td><td>−23.5</td><td>−22.7</td><td>−22.4</td><td>−19.5</td><td>−18.3</td></tr><tr><td>Modeled</td><td>707</td><td>859</td><td>1,051</td><td>1,140</td><td>1,193</td><td>1,214</td><td>1,435</td><td>1,537</td></tr><tr><td>Lower range</td><td>578</td><td>703</td><td>859</td><td>932</td><td>975</td><td>992</td><td>1,173</td><td>1,257</td></tr><tr><td>Upper range</td><td>870</td><td>1,057</td><td>1,293</td><td>1,402</td><td>1,468</td><td>1,494</td><td>1,765</td><td>1,891</td></tr><tr><td>Mean</td><td>959</td><td>2,058</td><td>1,013</td><td>1,653</td><td>1,434</td><td>1,043</td><td>1,932</td><td>1,497</td></tr><tr><td><i>SE</i></td><td>53</td><td>179</td><td>49</td><td>48</td><td>202</td><td>63</td><td>114</td><td>22</td></tr><tr><td>Minimum</td><td>135</td><td>371</td><td>214</td><td>346</td><td>418</td><td>292</td><td>504</td><td>249</td></tr><tr><td>Maximum</td><td>2,866</td><td>4,377</td><td>2,869</td><td>3,564</td><td>3,103</td><td>3,446</td><td>3,722</td><td>3,643</td></tr><tr><td><i>N</i></td><td>76</td><td>33</td><td>74</td><td>220</td><td>11</td><td>58</td><td>38</td><td>725</td></tr></table> |
6c5c266c4fa7cd9dbf25e9905a1044168e71c3642a55de702491a3928f5d30d3.png | simple | <table><tr><td></td><td><i>mean (SD)</i></td></tr><tr><td>Age, y</td><td>31.6 (4.3)</td></tr><tr><td>Age at menarche, y</td><td>13.2 (1.5)</td></tr><tr><td>Pre-pregnancy BMI, kg/m<sup>2</sup></td><td>24.3 (3.7)</td></tr><tr><td></td><td><i>% (n)</i></td></tr><tr><td>Pre-pregnancy BMI group</td><td></td></tr><tr><td> <i>Underweight (BMI < 18.5)</i></td><td>11 (8)</td></tr><tr><td> <i>Normal weight (BMI 18.5 - 24.9)</i></td><td>52 (61)</td></tr><tr><td> <i>Overweight (BMI 25 - 29.9)</i></td><td>30 (36)</td></tr><tr><td> <i>Obese (BMI </i>≥ <i>30)</i></td><td>7 (8)</td></tr><tr><td>Educational level</td><td></td></tr><tr><td> <i>Not completed post high school education</i></td><td>32 (38)</td></tr><tr><td> <i>Completed post high school education</i></td><td>68 (80)</td></tr></table> |
8d32758f2211610bd131a8f02069dbf7a9be911357a1813f73bc7b16f5afd311.png | complex | <table><tr><td>Shot ID</td><td colspan="2">Dimensions</td><td>Treatment</td><td colspan="2">No. of samples analysed</td></tr><tr><td> </td><td><i>d</i> [mm]</td><td>Weight [g]</td><td> </td><td>C</td><td>S</td></tr><tr><td>81A1527</td><td>85.0</td><td>2410.8</td><td>SS</td><td>2</td><td>0</td></tr><tr><td>81A2310</td><td>82.6</td><td>2199.9</td><td>SS</td><td>2</td><td>0</td></tr><tr><td>81A3470</td><td>84.8</td><td>2107.0</td><td>SS</td><td>2</td><td>0</td></tr><tr><td>81A3550</td><td>84.1</td><td>2361.0</td><td>SS</td><td>1</td><td>0</td></tr><tr><td>81A3839</td><td>86.0</td><td>2014.8</td><td>SS</td><td>3</td><td>1</td></tr><tr><td>82A2618</td><td>85.3</td><td>2012.5</td><td>SS</td><td>4</td><td>1</td></tr><tr><td>82A4365<sup>[a]</sup></td><td>99.0</td><td>3500.0</td><td>SS</td><td>1</td><td>0</td></tr><tr><td>82A4233<sup>[a]</sup></td><td>86.0</td><td>2802.6</td><td>SS</td><td>2</td><td>0</td></tr><tr><td>81A3461<sup>[a]</sup></td><td>84.0</td><td>568.3</td><td>SS</td><td>2</td><td>0</td></tr><tr><td>81A6218<sup>[a]</sup></td><td>193.0</td><td>26 000</td><td>SS</td><td>1</td><td>0</td></tr><tr><td>81A6219<sup>[a]</sup></td><td>192.0</td><td>25 750</td><td>SS</td><td>1</td><td>0</td></tr><tr><td>81A6143</td><td>79.9</td><td>1818.1</td><td>HWAS</td><td>1</td><td>1</td></tr><tr><td>83A0161</td><td>83.6</td><td>1743.2</td><td>HW</td><td>1</td><td>1</td></tr><tr><td>83A0189</td><td>70.6</td><td>1263.7</td><td>HWAS</td><td>1</td><td>1</td></tr><tr><td>83A0446</td><td><sup>[b]</sup></td><td>1052.0</td><td>HW</td><td>1</td><td>0</td></tr><tr><td>81A0177</td><td><sup>[b]</sup></td><td><sup>[b]</sup></td><td>HWAS</td><td>1</td><td>0</td></tr><tr><td>81A6102</td><td>83.7</td><td>2045.1</td><td>HW</td><td>0</td><td>1</td></tr></table> |
960ef108f9cda8b49229af8c961135f98cf2fcfff6490db7fd9a1510f429baf7.png | complex | <table><tr><td></td><td colspan="2">A</td><td colspan="2">B</td><td colspan="2">C</td><td colspan="2">D</td><td colspan="2">E</td><td colspan="2">F</td></tr><tr><td>Subject J \Cells</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td><td>WT</td><td>MT</td></tr><tr><td>1-1</td><td>3</td><td>6</td><td>3</td><td>3</td><td>3</td><td>3</td><td>6</td><td>9</td><td>11</td><td>7</td><td>1</td><td>4</td></tr><tr><td>1-2</td><td>2</td><td>3</td><td>0</td><td>9</td><td>1</td><td>5</td><td>1</td><td>8</td><td>4</td><td>7</td><td>2</td><td>6</td></tr><tr><td>1-3</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>2</td><td>0</td><td>2</td><td>1</td><td>1</td></tr><tr><td>1-4</td><td>0</td><td>0</td><td>0</td><td>0</td><td>1</td><td>6</td><td>2</td><td>1</td><td>4</td><td>1</td><td>1</td><td>0</td></tr><tr><td>1-5</td><td>0</td><td>3</td><td>0</td><td>1</td><td>0</td><td>2</td><td>2</td><td>0</td><td>3</td><td>6</td><td>4</td><td>1</td></tr><tr><td>1-6</td><td>1</td><td>1</td><td>1</td><td>3</td><td>0</td><td>3</td><td>1</td><td>4</td><td>1</td><td>7</td><td>2</td><td>3</td></tr><tr><td>2-1</td><td>3</td><td>12</td><td>1</td><td>2</td><td>3</td><td>4</td><td>2</td><td>7</td><td>5</td><td>5</td><td>4</td><td>18</td></tr><tr><td>2-2</td><td>1</td><td>6</td><td>0</td><td>13</td><td>5</td><td>4</td><td>1</td><td>1</td><td>4</td><td>2</td><td>4</td><td>11</td></tr><tr><td>2-3</td><td>2</td><td>3</td><td>2</td><td>2</td><td>3</td><td>8</td><td>1</td><td>6</td><td>4</td><td>9</td><td>3</td><td>13</td></tr><tr><td>2-4</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>1</td><td>1</td><td>1</td><td>0</td></tr><tr><td>2-5</td><td>3</td><td>5</td><td>2</td><td>1</td><td>3</td><td>10</td><td>1</td><td>4</td><td>2</td><td>7</td><td>3</td><td>7</td></tr><tr><td>2-6</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>2</td><td>0</td><td>1</td><td>2</td><td>0</td></tr><tr><td>2-7</td><td>5</td><td>5</td><td>2</td><td>5</td><td>0</td><td>10</td><td>0</td><td>19</td><td>10</td><td>10</td><td>4</td><td>5</td></tr><tr><td>Totals</td><td>23</td><td>46</td><td>11</td><td>39</td><td>19</td><td>55</td><td>17</td><td>63</td><td>49</td><td>65</td><td>32</td><td>69</td></tr></table> |
972d8627912815cf19076f04f2f28beb744fcff4acb5014ad783a8c856c2b446.png | simple | <table><tr><td></td><td></td><td>Status at consent</td><td></td><td></td></tr><tr><td></td><td></td><td>High non-tryer</td><td>High tryer</td><td>Pregnant</td></tr><tr><td></td><td></td><td>%</td><td>%</td><td>%</td></tr><tr><td>Age, years</td><td><18</td><td>0</td><td>0</td><td>1.4</td></tr><tr><td></td><td>18–19</td><td>*</td><td>0</td><td>3.3</td></tr><tr><td></td><td>20–34</td><td>90.9</td><td>83.7</td><td>76.5</td></tr><tr><td></td><td>35+</td><td>*</td><td>16.3</td><td>18.7</td></tr><tr><td></td><td>Mean (standard deviation)</td><td>27.7 (4.0)</td><td>30.7 (4.1)</td><td>29.2 (5.7)</td></tr><tr><td>Race/ethnicity</td><td>Asian, non-Hispanic</td><td>*</td><td>*</td><td>4.2</td></tr><tr><td></td><td>Black, non-Hispanic</td><td>*</td><td>*</td><td>6.4</td></tr><tr><td></td><td>Hispanic</td><td>22.7</td><td>10.2</td><td>20.0</td></tr><tr><td></td><td>Other^</td><td>20.5</td><td>20.4</td><td>8.0</td></tr><tr><td></td><td>White, non-Hispanic</td><td>50.0</td><td>67.3</td><td>61.5</td></tr></table> |
38bf9122af53bf20a006560d02bb03d751006a60d5cd6b97ab0843837932eb66.png | simple | <table><tr><td>Organism</td><td>Degradosome-dependence</td><td>PNPase role</td><td>References</td></tr><tr><td><i>Yersinia pestis</i></td><td>?</td><td>Catalytic activity plays an essential role in cold growth</td><td>Rosenzweig et al., 2005</td></tr><tr><td></td><td>?</td><td>Required for virulence in a catalytic-activity-independent manner</td><td>Rosenzweig et al., 2005</td></tr><tr><td></td><td>?</td><td>S1 domain sufficient for mediating virulence</td><td>Rosenzweig et al., 2005</td></tr><tr><td></td><td>?</td><td>The first 15 aa residues of the S1 domain are dispensable for virulence; however, the first 30 aa residues are required for virulence</td><td>Rosenzweig et al., 2007</td></tr><tr><td></td><td>?</td><td>Amino acid residue F638 within the PNPase S1 domain is required for virulence and cold growth</td><td>Rosenzweig et al., 2007</td></tr><tr><td><i>Yersinia pseudotuberculosis</i></td><td>No</td><td>S1 and KH domains also contribute to cold growth.</td><td>Rosenzweig et al., 2005</td></tr><tr><td></td><td>No</td><td>Degradosome-independent role in cold growth</td><td>Henry et al., 2012</td></tr><tr><td></td><td>Yes</td><td>Degradosome assembly required for virulence</td><td>Yang et al., 2008</td></tr><tr><td></td><td>Yes</td><td>Degradosome-dependent role in oxidative stress response</td><td>Henry et al., 2012</td></tr><tr><td></td><td>No</td><td>PNPase is dispensable for antibiotic/chemical stress responses</td><td>Henry et al., 2012</td></tr></table> |
18fff567e3d450cf677940bacfde405b65c115d0468ee3319fbdbfe2481abc20.png | simple | <table><tr><td>Number</td><td>Outcomes</td></tr><tr><td>1</td><td>Patient-provider communication</td></tr><tr><td>2</td><td>Monitor treatment response</td></tr><tr><td>3</td><td>Detect unrecognised problems</td></tr><tr><td>4</td><td>Changes to patient health behaviour</td></tr><tr><td>5</td><td>Changes to patient management</td></tr><tr><td>6</td><td>Improved patient satisfaction</td></tr><tr><td>7</td><td>Improved health outcomes</td></tr><tr><td>8</td><td>Strong & effective quality improvement</td></tr><tr><td>9</td><td>Increased transparency, accountability, public reporting</td></tr><tr><td>10</td><td>Better system performance (monitoring, planning, financing; evaluating, responding)</td></tr><tr><td>11</td><td>Mediating variables on the effect (both at individual and organisation level)</td></tr><tr><td>12</td><td>Possible subgroup effects</td></tr></table> |
21ae9618cef61888dc41b035e19c6b7f164edf8409f0ba03add911f4413bf7b1.png | complex | <table><tr><td>Stratification criteria</td><td>Description</td></tr><tr><td rowspan="6">Physician Integrated Network (PIN) [30]</td><td>A Manitoba Health primary care renewal initiative that focuses on fee-for-service (FFS) physician groups.</td></tr><tr><td>Its goal is to facilitate systemic improvements in the delivery of primary care.</td></tr><tr><td>Objectives:</td></tr><tr><td>● To improve access to primary care</td></tr><tr><td>● To improve Primary Care Providers’ access to and use of information</td></tr><tr><td>● To improve the work life for all primary care providers</td></tr><tr><td> </td><td>● To demonstrate high quality primary care with a specific focus on Chronic Disease Management</td></tr><tr><td>Uniting Primary Care and Oncology Network (UPCON)[31]</td><td>A collaborative partnership between Winnipeg family practice clinics/primary health care centres and CancerCare Manitoba (CCMB) that is dedicated to promoting and supporting the shared care of the cancer patient.</td></tr></table> |
6eaeb39b9bf455e7f6db849912ef2bf479de22285ece646d283f1dbc1c499a34.png | complex | <table><tr><td>Tissue sample</td><td>Type of core</td><td>No. of cores in TMA blocks</td></tr><tr><td>Control Normal Samples</td><td>Normal</td><td>119</td></tr><tr><td rowspan="2">DCIS</td><td>Normal in DCIS</td><td>12</td></tr><tr><td>DCIS pure lesion</td><td>54</td></tr><tr><td rowspan="3">IDC</td><td>Normal in IDC</td><td>61</td></tr><tr><td>DCIS in IDC</td><td>39</td></tr><tr><td>IDC pure lesion</td><td>120</td></tr></table> |
bc8c9b6a31e0f2ff83578a0fa82aafceccc5047313b80739452feef7e665abda.png | complex | <table><tr><td rowspan="2">Cancer</td><td rowspan="2">Accession number</td><td rowspan="2">Array</td><td colspan="2">Sample size</td><td colspan="2">Log-2 mRNA signal intensity (mean ± SD*)</td><td rowspan="2"><i>P</i></td></tr><tr><td>Control</td><td>Case</td><td>Control</td><td>Case</td></tr><tr><td rowspan="2">Breast cancer</td><td>GSE42568</td><td>HG-U133_Plus_2</td><td>17</td><td>104</td><td>6.36 ± 0.54</td><td>7.57 ± 0.78</td><td><0.001</td></tr><tr><td>GSE15852</td><td>HG-U133A</td><td>43</td><td>43</td><td>9.49 ± 0.18</td><td>9.74 ± 0.21</td><td><0.001</td></tr><tr><td rowspan="2">Lung cancer</td><td>E-MEXP-231</td><td>HG-U133A</td><td>9</td><td>49</td><td>7.83 ± 0.40</td><td>8.62 ± 0.65</td><td>0.001</td></tr><tr><td>GSE19804</td><td>HG-U133_Plus_2</td><td>60</td><td>60</td><td>8.13 ± 0.73</td><td>8.41 ± 0.78</td><td>0.046</td></tr><tr><td rowspan="2">Prostate cancer</td><td>GSE6956</td><td>HG-U133A_2</td><td>20</td><td>69</td><td>9.44 ± 1.11</td><td>10.46 ± 0.36</td><td><0.001</td></tr><tr><td>GSE6919</td><td>HG_U95Av2</td><td>81</td><td>65</td><td>4.62 ± 0.24</td><td>4.67 ± 0.23</td><td>0.040</td></tr><tr><td rowspan="2">Hepatocellular carcinoma</td><td>GSE14323</td><td>HG-U133A_2</td><td>19</td><td>38</td><td>6.95 ± 0.46</td><td>7.82 ± 0.53</td><td><0.001</td></tr><tr><td>GSE6764</td><td>HG-U133_Plus_2</td><td>10</td><td>62</td><td>7.57 ± 0.81</td><td>8.45 ± 0.54</td><td><0.001</td></tr></table> |
1fd07f9865a91ca5d46b878060750d58446db314080c97ceb2bb6165f492f3e3.png | simple | <table><tr><td> </td><td><i>Dry mucus membranes (eyes/mouth)</i></td><td><i>Lighter/uneasy sleep</i></td><td><i>Heavier sleep</i></td><td><i>Sleepiness at daytime</i></td><td><i>Increased fatigue</i></td><td><i>Dizziness</i></td></tr><tr><td>Patient #1</td><td>x</td><td>x</td><td> </td><td> </td><td>x</td><td> </td></tr><tr><td>Patient #2</td><td>x</td><td> </td><td> </td><td>x</td><td> </td><td> </td></tr><tr><td>Patient #3</td><td>x</td><td>x</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Patient #4</td><td>x</td><td> </td><td> </td><td> </td><td> </td><td>x</td></tr><tr><td>Patient #5</td><td>x</td><td> </td><td>x</td><td> </td><td> </td><td> </td></tr></table> |
72e136a0794981acb6d01322ded5f7a5d5e3897398c70f274b269dc42614b169.png | simple | <table><tr><td></td><td>Surgery group</td><td>Packing group</td><td>P</td></tr><tr><td>Re-bleeding</td><td>0</td><td>4</td><td>0.001</td></tr><tr><td>Discomfort after the treatment</td><td>2.4±1.4</td><td>7.6±1.0</td><td>0.001</td></tr><tr><td>Adhesion of nasal cavity</td><td>2</td><td>7</td><td>0.007</td></tr></table> |
c52768e689163dada01245da72d345116567f77ff3cca4449e421979b550d86e.png | complex | <table><tr><td colspan="2">Gene</td><td>Primer sequences</td></tr><tr><td rowspan="3">hsa-miR-155</td><td>RT</td><td>5′-GCGCGTGAGCAGGCTGGAGAAATTAACCACGCGCACCCCT-3′</td></tr><tr><td>Forward</td><td>5′- CTTAATGCTAATCGTGAT -3′</td></tr><tr><td>Reverse</td><td>5′- GAG CAG GCT GGA GAA -3′</td></tr><tr><td rowspan="3">hsa-miR-146a</td><td>RT</td><td>5′-GCGCGTGAGCAGGCTGGAGAAATTAACCACGCGCAACCCA -3′</td></tr><tr><td>Forward</td><td>5′- CTGAGAACTGAATTCCA -3′</td></tr><tr><td>Reverse</td><td>5′- GAG CAG GCT GGA GAA -3′</td></tr><tr><td rowspan="3">U6</td><td>RT</td><td>5′-CGCTTCACGAATTTGCGTGTCAT -3′</td></tr><tr><td>Forward</td><td>5′- CTCGCTTCGGCAGCACATA -3′</td></tr><tr><td>Reverse</td><td>5′- CGCTTCACGAATTTGCGTG -3′</td></tr><tr><td rowspan="2">TGF-β1</td><td>Forward</td><td>5′- CCAACTATTGCTTCAGCTCCA -3′</td></tr><tr><td>Reverse</td><td>5′- GTGTCCAGGCTCCAAATGT -3′</td></tr><tr><td rowspan="2">TNF-α</td><td>Forward</td><td>5′- CCCAGGGACCTCTCTCTAATCA -3′</td></tr><tr><td>Reverse</td><td>5′- AGCTGCCCCTCAGCTTGAG -3′</td></tr><tr><td>GAPDH</td><td>Forward</td><td>5′-CCCCTTCATTGACCTCAACTAC-3′</td></tr><tr><td> </td><td>Reverse</td><td>5′-GATGACAAGCTTCCCGTTCTC-3′</td></tr></table> |
a6f0d33a854b7bef8be5fdbfee9fe42451754a09b6ab2895243a57063e7e31b5.png | simple | <table><tr><td>Division</td><td>Asembo</td><td>Uyoma</td><td>Maranda</td><td>Nyang’oma</td><td>Usigu</td><td>Overall</td></tr><tr><td>Mean [F]±SD</td><td>0.92±0.46</td><td>1.39±0.84</td><td>0.69±0.42</td><td>1.00±0.59</td><td>0.78±0.66</td><td>0.85±0.67</td></tr><tr><td>Highest</td><td>2.27</td><td>5.44</td><td>1.7</td><td>2.23</td><td>2.34</td><td>5.44</td></tr><tr><td>>3.0 ppm</td><td>-</td><td>01(9.1%)</td><td>-</td><td>-</td><td>-</td><td>1(0.8%)</td></tr><tr><td>1.5-2.9 ppm</td><td>3(8.6%)</td><td>2(18.2%)</td><td>2(4.5%)</td><td>2(33.3%)</td><td>5(16.7)</td><td>14(10.9%)</td></tr><tr><td>1.0-1.4 ppm</td><td>9(24.3%)</td><td>2(18.2%)</td><td>6(13.6%)</td><td>0(0.0%)</td><td>4(13.3%)</td><td>216(16.4%)</td></tr><tr><td>0.5-0.9 ppm</td><td>20(57.1%)</td><td>3(27.5%)</td><td>21(47.7%)</td><td>3(50.0%)</td><td>9(30.0%)</td><td>56(43.8%)</td></tr><tr><td>0-0.4 ppm</td><td>5(14.3%)</td><td>3(27.5%)</td><td>15(34.1%)</td><td>1(16.7%)</td><td>12(40.0%)</td><td>36(28.1%)</td></tr><tr><td>Lowest</td><td>0.17</td><td>0.01</td><td>0.02</td><td>0.2</td><td>0.11</td><td>0.01</td></tr><tr><td>% [F] > 1 ppm</td><td>28.6</td><td>45.5</td><td>18.2</td><td>33.3</td><td>30</td><td>28.1</td></tr><tr><td>Sample size (n)</td><td>37</td><td>11</td><td>44</td><td>6</td><td>30</td><td>128</td></tr></table> |
adce0f4866f5d8a33c45a0080d15b0d91f423bfa196adda62b79919ad788b698.png | simple | <table><tr><td> </td><td>O<sub>2</sub><sup>−</sup> (nmol/mL)</td><td>H<sub>2</sub>O<sub>2</sub> (nmol/mL)</td><td>NO<sub>2</sub><sup>−</sup> (nmol/mL)</td><td>TBARS (<i>μ</i>mol/mL)</td></tr><tr><td>Control (<i>X</i> ± SE)</td><td>19.97 ± 0.45</td><td>20.28 ± 0.04</td><td>23.14 ± 1.17</td><td>26.20 ± 0.38</td></tr><tr><td>DL-Hcy TLHC (<i>X</i> ± SE)</td><td>20.19 ± 0.47</td><td>20.23 ± 0.03</td><td>23.52 ± 1.13</td><td>25.88 ± 0.91</td></tr></table> |
93a6af8fdf251e1c46a5118114751393bbb263a2472d47f7caaf2635e5c787c8.png | simple | <table><tr><td>No.</td><td>Ab. <sup>1</sup></td><td>Ag.<sup>2</sup></td><td>Frequency</td><td>Redundancy</td></tr><tr><td>1</td><td>D</td><td>K</td><td>22.0% (13/59)</td><td>1.92 (25/13)</td></tr><tr><td>2</td><td>Y</td><td>E</td><td>18.6% (11/59)</td><td>2.45 (27/11)</td></tr><tr><td>3</td><td>Y</td><td>N</td><td>16.9% (10/59)</td><td>1.80 (18/10)</td></tr><tr><td>4</td><td>S</td><td>E</td><td>16.9% (10/59)</td><td>1.70 (17/10)</td></tr><tr><td>5</td><td>Y</td><td>K</td><td>15.3% ( 9/59)</td><td>1.78 (16/9)</td></tr><tr><td>6</td><td>N</td><td>R</td><td>15.3% ( 9/59)</td><td>1.44 (13/9)</td></tr><tr><td>7</td><td>Y</td><td>R</td><td>15.3% ( 9/59)</td><td>3.56 (32/9)</td></tr><tr><td>8</td><td>D,Y</td><td>K</td><td>15.3% ( 9/59)</td><td>1.78 (16/9)</td></tr><tr><td>9</td><td>S,Y</td><td>Q</td><td>13.6% ( 8/59)</td><td>1.75 (14/8)</td></tr><tr><td>10</td><td>G</td><td>R</td><td>13.6% ( 8/59)</td><td>4.38 (35/8)</td></tr></table> |
e50eabb40c795592be455b2562a010876b2477eadf6833bae68a3215ac18364b.png | simple | <table><tr><td>Gene_symbol</td><td>Description</td><td>Log2 Ratio (A253-5/A253-0)</td><td><i>P</i> value</td></tr><tr><td>MAPK10</td><td>mitogen-activated protein kinase 10</td><td>−1.1440</td><td>0.000264947</td></tr><tr><td>AKT1</td><td>v-akt murine thymoma viral oncogene homolog 1</td><td>1.1076</td><td>0.014492851</td></tr><tr><td>PDGFB</td><td>platelet-derived growth factor beta polypeptide</td><td>1.0834</td><td>6.23066E-05</td></tr><tr><td>BIRC3</td><td>baculoviral IAP repeat containing 3</td><td>1.0176</td><td>0.001517394</td></tr><tr><td>PGF</td><td>placental growth factor</td><td>−1.0496</td><td>0.025969431</td></tr><tr><td>COL4A1</td><td>collagen, type IV, alpha 1</td><td>2.1236</td><td>1.58011E-20</td></tr><tr><td>FN1</td><td>fibronectin 1</td><td>3.6490</td><td>3.35978E-24</td></tr><tr><td>THBS1</td><td>thrombospondin 1</td><td>1.0290</td><td>0.000135356</td></tr><tr><td>FLT1</td><td>fms-related tyrosine kinase 1</td><td>1.2325</td><td>0.025381832</td></tr><tr><td>RASGRF1</td><td>Ras protein-specific guanine nucleotide-releasing factor 1</td><td>1.7221</td><td>1.11117E-05</td></tr><tr><td>CCND2</td><td>cyclin D2</td><td>2.3619</td><td>8.02038E-19</td></tr><tr><td>COL5A2</td><td>collagen, type V, alpha 2</td><td>1.2806</td><td>0.030736616</td></tr><tr><td>TNC</td><td>tenascin C</td><td>1.6496</td><td>9.83873E-07</td></tr><tr><td>PARVA</td><td>parvin, alpha</td><td>1.2195</td><td>9.20291E-07</td></tr></table> |
1c49f4043292bb10ee7ee84f3b413e7084ecad720e5b267409793196151fcf80.png | simple | <table><tr><td>Item</td><td><i>Mean</i></td><td><i>SD</i></td><td>Range</td><td>95% CI</td></tr><tr><td>1. I have a desire to succeed</td><td>4.6</td><td>0.62</td><td>1–5</td><td>4.56; 4.72</td></tr><tr><td>2. I have my own plan for how to stay or become well</td><td>3.9</td><td>0.92</td><td>1–5</td><td>3.80; 4.05</td></tr><tr><td>3. I have goals in life that I want to reach</td><td>4.2</td><td>0.90</td><td>1–5</td><td>4.08; 4.32</td></tr><tr><td>4. I believe that I can meet my current personal goals</td><td>3.7</td><td>0.98</td><td>1–5</td><td>3.59; 3.85</td></tr><tr><td>5. I have a purpose in life</td><td>3.8</td><td>0.94</td><td>1–5</td><td>3.72; 3.97</td></tr><tr><td>6. Even when I don’t care about myself, other people do</td><td>4.1</td><td>0.83</td><td>1–5</td><td>4.0; 4.21</td></tr><tr><td>7. Fear doesn’t stop me from living the way I want to</td><td>3.1</td><td>1.30</td><td>1–5</td><td>2.90; 3.25</td></tr><tr><td>8. I can handle what happens in my life</td><td>3.3</td><td>1.02</td><td>1–5</td><td>3.20; 3.47</td></tr><tr><td>9. I like myself</td><td>3.2</td><td>1.20</td><td>1–5</td><td>2.99; 3.31</td></tr><tr><td>10. If people really knew me, they would like me</td><td>3.7</td><td>0.84</td><td>1–5</td><td>3.60; 3.82</td></tr><tr><td>11. I have an idea of who I want to become</td><td>3.5</td><td>1.05</td><td>1–5</td><td>3.40; 3.67</td></tr><tr><td>12. Something good will eventually happen</td><td>4.0</td><td>0.81</td><td>1–5</td><td>3.93; 4.14</td></tr><tr><td>13. I’m hopeful about my future</td><td>3.9</td><td>0.99</td><td>1–5</td><td>3.72; 3.97</td></tr><tr><td>14. I continue to have new interests</td><td>3.7</td><td>1.09</td><td>1–5</td><td>3.57; 3.86</td></tr><tr><td>15. Coping with my mental illness is no longer the main focus of my life</td><td>3.1</td><td>1.23</td><td>1–5</td><td>2.98; 3.30</td></tr><tr><td>16. My symptoms interfere less and less with my life</td><td>3.4</td><td>1.20</td><td>1–5</td><td>3,25; 3.54</td></tr><tr><td>17. My symptoms seem to be a problem for shorter periods of time each time they occur</td><td>3.5</td><td>1.13</td><td>1–5</td><td>3.32; 3.61</td></tr><tr><td>18. I know when to ask for help</td><td>3.9</td><td>1.06</td><td>1–5</td><td>3.78; 4.05</td></tr><tr><td>19. I am willing to ask for help</td><td>4.1</td><td>0.92</td><td>1–5</td><td>4.01; 4.25</td></tr><tr><td>20. I ask for help when I need it</td><td>3.8</td><td>1.08</td><td>1–5</td><td>3.68; 3.96</td></tr><tr><td>21. I can handle stress</td><td>3.0</td><td>1.14</td><td>1–5</td><td>2.88; 3.18</td></tr><tr><td>22. I have people I can count on</td><td>4.3</td><td>0.78</td><td>1–5</td><td>4.18; 4.38</td></tr><tr><td>23. Even when I don’t believe in myself, other people do</td><td>4.0</td><td>0.87</td><td>1–5</td><td>3.88; 4.10</td></tr><tr><td>24. It is important to have a variety of friends</td><td>3.5</td><td>1.40</td><td>1–5</td><td>3.31; 3.67</td></tr><tr><td>Summary scales</td><td></td><td></td><td></td><td></td></tr><tr><td>Personal confidence and hope (mean of items 7, 8, 9, 10, 11, 12, 13, 14 & 21)</td><td>3.5</td><td>0.68</td><td>1.67–5</td><td>3.40; 3.58</td></tr><tr><td>Willingness to ask for help (mean of items 18, 19 & 20)</td><td>4.0</td><td>0.89</td><td>1–5</td><td>3.84; 4.07</td></tr><tr><td>Goal and success orientation (mean of items 1, 2, 3, 4 & 5)</td><td>4.1</td><td>0.63</td><td>1.4–5</td><td>3.99; 4.15</td></tr><tr><td>Reliance on others (mean of items 6, 22, 23 & 24)</td><td>4.0</td><td>0.68</td><td>2–5</td><td>3.88; 4.06</td></tr><tr><td>Not dominated by symptoms (mean of items 15, 16 & 17)</td><td>3.3</td><td>0.95</td><td>1–5</td><td>3.21; 3.45</td></tr><tr><td>Total scale (mean of items)</td><td>3.7</td><td>0.56</td><td>1.92–5</td><td>3.66; 3.80</td></tr><tr><td>Total scale (sum of items)</td><td>89.5</td><td>13.39</td><td>46–120</td><td>87.75; 91.24</td></tr></table> |
b5deaad4abb03646268095e9392bed62e1ff9beefb2d6987b6644e26c41128f5.png | complex | <table><tr><td>Study design</td><td>Methods & numbers</td><td>Research instruments</td><td>Respondents</td></tr><tr><td rowspan="4">Qualitative study</td><td rowspan="3">*GDs: 14 (One group from each hospital)</td><td rowspan="3">GD guideline: semi-structured open-ended questions with probes</td><td>From district hospitals: civil surgeon, obstetrics and pediatrics consultants, anesthesiologist, nursing superintendent, and two senior staff nurses</td></tr><tr><td>From MCWCs: deputy director of family planning, anesthesiologist, medical officer, one nurse, and one family welfare visitor</td></tr><tr><td>From UHCs: upazila health and family planning officer, obstetrics and gynecology specialists, pediatrician, anesthesiologist, resident medical officer, and one nurse</td></tr><tr><td>**IDIs:56 (four interviews from each hospital)</td><td>IDI guideline: semi-structured open-ended questions with probes</td><td>From district hospitals, MCWCs, and UHCs: One laboratory technician/pharmacist, one ward master/nursing supervisor, one ancillary staff from the maternal or neonatal wards, and one cleaner</td></tr><tr><td>Quantitative study</td><td>Exit interviews: 112 (eight exit interviews from each hospital)</td><td>Structured questionnaire</td><td>Patients or their attendants from maternal, labor, and neonatal wards at district hospitals, MCWCs, and UHCs</td></tr></table> |
a22a752d03b3aeb78cd08e2c8c3740523e5fd3892a34786e75a9078b1e7be886.png | complex | <table><tr><td>Colorectal cancer characteristic</td><td>Black Mississippians</td><td>White Mississippians</td><td>Difference (Black–White)</td><td><i>P</i> value</td></tr><tr><td colspan="5">Statistically-significant health disparities</td></tr><tr><td> % (Age 50+) reporting NEVER had a sigmoidoscopy or colonoscopy (average: 2006, 2008 and 2010 BRFSS)</td><td>53.2 %</td><td>41.9 %</td><td>11.3 %</td><td><.0001</td></tr><tr><td> Age-adjusted colorectal cancer incidence rate (per 100,000; 2006–2010 MCR data)</td><td>64.9</td><td>50.5</td><td>14.4</td><td><.0001</td></tr><tr><td> Age-adjusted colorectal cancer mortality rate (per 100,000; 2006–2010 MCR data)</td><td>26.2</td><td>17.5</td><td>8.8</td><td>0.0001</td></tr><tr><td> CRC mortality-to-incidence rate</td><td>0.40</td><td>0.35</td><td>0.05</td><td>0.0035</td></tr><tr><td colspan="5">No discernible differences between groups</td></tr><tr><td> % Advanced stage (regional + distant disease) at initial diagnosis</td><td>52.9 %</td><td>52.3 %</td><td>0.6 %</td><td>0.7926</td></tr></table> |
d00daff0ee42d66bca0b5dfb510d9f75c2617aaf19bd07d5ad3876e6490b41a8.png | simple | <table><tr><td>Database</td><td>Crops</td><td>Web link</td><td>Reference</td></tr><tr><td>Gramene</td><td>Grasses</td><td>http://www.gramene.org</td><td>Tello-Ruiz et al., 2016</td></tr><tr><td>International Rice Informatics Consortium</td><td>Rice (<i>Oryza sativa</i>)</td><td>http://iric.irri.org</td><td>n/a</td></tr><tr><td>Maize Genetics and Genomics Database</td><td>Maize (<i>Zea mays</i>)</td><td>http://www.maizegdb.org</td><td>Lawrence et al., 2004</td></tr><tr><td>SoyKB</td><td>Soybean (<i>Glycine max</i>)</td><td>http://soykb.org</td><td>Joshi et al., 2014</td></tr><tr><td>T3 Triticaceae toolbox</td><td>Wheat (<i>Triticum aestivum</i>), barley (<i>Hordeum vulgare</i>) and oat (<i>Avena sativa</i>)</td><td>https://triticeaetoolbox.org/</td><td>Blake et al., 2016</td></tr><tr><td>Wheat Information System</td><td>Wheat (<i>Triticum aestivum</i>)</td><td>http://wheatis.org</td><td>n/a</td></tr></table> |
09e3701deed89375299d89de42b4748e9f63d2a554870d081adda0b62d6544d2.png | simple | <table><tr><td> </td><td>One missing</td><td>Two missing</td><td>Three missing</td><td>Four missing</td><td>No missing</td><td>Total</td></tr><tr><td><i>Sex</i></td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Female</td><td>277 (18.3%)</td><td>131 (8.6%)</td><td>89 (5.9%)</td><td>77 (5.1%)</td><td>933 (61.9%)</td><td>1507 (100%)</td></tr><tr><td>Male</td><td>109 (15.5%)</td><td>97 (13.8%)</td><td>70 (10%)</td><td>34 (4.8%)</td><td>389 (55.6%)</td><td>699 (100%)</td></tr><tr><td>Total</td><td>386 (17.4%)</td><td>228 (10.3%)</td><td>159 (7.1%)</td><td>111 (4.9%)</td><td>1322 (59.9%)</td><td>2206 (100%)</td></tr><tr><td><i>Age</i></td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>7–15</td><td>29 (23.9%)</td><td>38 (31.4%)</td><td>18 (14.8%)</td><td>1 (0.8%)</td><td>35 (28.9%)</td><td>121 (100%)</td></tr><tr><td>16–30</td><td>108 (20.8%)</td><td>13 (2.5%)</td><td>0 (0%)</td><td>0 (0%)</td><td>398 (76.6%)</td><td>519 (100%)</td></tr><tr><td>31–45</td><td>115 (19.1%)</td><td>84 (13.9%)</td><td>29 (4.8%)</td><td>2 (0.3%)</td><td>371 (61.7%)</td><td>601 (100%)</td></tr><tr><td>46–60</td><td>102 (13.8%)</td><td>50 (6.7%)</td><td>72 (9.7%)</td><td>34 (4.6%)</td><td>479 (64.9%)</td><td>737 (100%)</td></tr><tr><td>>60</td><td>8 (3.4%)</td><td>32 (14%)</td><td>74 (32.4%)</td><td>74 (32.4%)</td><td>40 (17.5%)</td><td>228 (100%)</td></tr></table> |
2872f7c042f7df880e88a94ad818573c466db2e4f40434cee9ab9dbe3eb1bf5f.png | simple | <table><tr><td> </td><td>Age mean</td><td> </td><td>Visits before</td><td>Visits after</td><td>Visitors before</td><td>Visitors after</td><td>Change visits</td><td>Change visitors</td></tr><tr><td> </td><td> </td><td> </td><td>(2 years)</td><td>(2 years)</td><td> </td><td> </td><td>n (%)</td><td>n (%)</td></tr><tr><td>Men 25-44</td><td>34.7</td><td>n</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Visits to GP-all</td><td> </td><td>166365</td><td>237432</td><td>261847</td><td>91484</td><td>95276</td><td>24415 (10.3)</td><td>3792 (4.1)</td></tr><tr><td> Income below median</td><td> </td><td>85643</td><td>113878</td><td>126929</td><td>43402</td><td>45621</td><td>13051 (11.5)</td><td>2219 (5.1)</td></tr><tr><td> Income above median</td><td> </td><td>80722</td><td>123554</td><td>134918</td><td>48082</td><td>49655</td><td>11364 (9.2)</td><td>1573 (3.3)</td></tr><tr><td>Men 45-64</td><td>54.4</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Visits to GP-all</td><td> </td><td>154444</td><td>336028</td><td>378838</td><td>100717</td><td>108068</td><td>42810 (12.7)</td><td>7351 (7.3)</td></tr><tr><td> Income below median</td><td> </td><td>75384</td><td>177655</td><td>195310</td><td>49224</td><td>52150</td><td>17655 (9.9)</td><td>2926 (5.9)</td></tr><tr><td> Income above median</td><td> </td><td>79060</td><td>158373</td><td>183528</td><td>51493</td><td>55918</td><td>25155 (15.9)</td><td>4425 (8.6)</td></tr><tr><td>Men 65-84</td><td>72.6</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Visits to GP-all</td><td> </td><td>90190</td><td>309857</td><td>340047</td><td>73379</td><td>82331</td><td>30190 (9.7)</td><td>8952 (12.2)</td></tr><tr><td> Income below median</td><td> </td><td>45090</td><td>160781</td><td>171075</td><td>36641</td><td>36802</td><td>10294 (6.4)</td><td>161 (0.4)</td></tr><tr><td> Income above median</td><td> </td><td>45100</td><td>149076</td><td>168972</td><td>36738</td><td>38450</td><td>19896 (13.3)</td><td>1712 (4.7)</td></tr><tr><td>Women 25-44</td><td>34.7</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Visits to GP-all</td><td> </td><td>160983</td><td>376175</td><td>419338</td><td>110827</td><td>114475</td><td>43163 (11.5)</td><td>3648 (3.3)</td></tr><tr><td> Income below median</td><td> </td><td>78160</td><td>175822</td><td>197920</td><td>51151</td><td>53139</td><td>22098 (12.6)</td><td>1988 (3.9)</td></tr><tr><td> Income above median</td><td> </td><td>82823</td><td>200353</td><td>221418</td><td>59676</td><td>61336</td><td>21065 (10.5)</td><td>1660 (2.8)</td></tr><tr><td>Women 45-64</td><td>54.5</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Visits to GP-all</td><td> </td><td>153401</td><td>470358</td><td>517804</td><td>115657</td><td>121277</td><td>47446 (10.1)</td><td>5602 (4.9)</td></tr><tr><td> Income below median</td><td> </td><td>78558</td><td>265618</td><td>288359</td><td>60308</td><td>62654</td><td>22741 (8.6)</td><td>2346 (3.9)</td></tr><tr><td> Income above median</td><td> </td><td>74843</td><td>204740</td><td>229445</td><td>55367</td><td>58623</td><td>24705 (12.1)</td><td>3256 (5.9)</td></tr><tr><td>Women 65-84</td><td>73.3</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Visits to GP-all</td><td> </td><td>103605</td><td>432104</td><td>468395</td><td>88908</td><td>90010</td><td>36291 (8.4)</td><td>1102 (1.2)</td></tr><tr><td> Income below median</td><td> </td><td>51788</td><td>225746</td><td>238731</td><td>44685</td><td>44567</td><td>12985 (5.8)</td><td>−118 (−0.3)</td></tr><tr><td> Income above median</td><td> </td><td>51817</td><td>206358</td><td>229664</td><td>44223</td><td>45443</td><td>23306 (11.3)</td><td>1220 (2.8)</td></tr></table> |
8bb52441077fd94f2066c1bf9253147eba12b92657766112d0531817302906b7.png | simple | <table><tr><td>Family</td><td>Name</td><td>Local RDB</td><td>National RL rank</td><td>Main habitat</td><td>Life forms</td></tr><tr><td>Azollaceae</td><td><i>Azolla japonica</i></td><td>35</td><td>VU</td><td>Paddy, Ditch</td><td>perennial fern</td></tr><tr><td>Hydrocharitaceae</td><td><i>Blyxa echinosperma</i></td><td>42</td><td>VU</td><td>Paddy, Ditch</td><td>annual</td></tr><tr><td>Alismataceae</td><td><i>Caldesia parnassifolia</i></td><td>37</td><td>VU</td><td>Pond, Lake, Paddy</td><td>perennial</td></tr><tr><td>Compositae</td><td><i>Gnaphalium hypoleucum</i></td><td>40</td><td>VU</td><td>Forest edge</td><td>annual</td></tr><tr><td>Isoetaceae</td><td><i>Isoetes japonica</i></td><td>36</td><td>NT</td><td>Pond, Paddy, Ditch</td><td>perennial fern</td></tr><tr><td>Compositae</td><td><i>Ixeris chinensis subsp. strigosa</i></td><td>40</td><td>VU</td><td>Grassland, Roadside</td><td>perennial</td></tr><tr><td>Labiatae</td><td><i>Leonurus macranthus</i></td><td>39</td><td>VU</td><td>Grassland</td><td>perennial</td></tr><tr><td>Marsileaceae</td><td><i>Marsilea quadrifolia</i></td><td>46</td><td>VU</td><td>Paddy, Ditch</td><td>perennial fern</td></tr><tr><td>Pontederiaceae</td><td><i>Monochoria korsakowii</i></td><td>39</td><td>NT</td><td>Lake, River, Ditch, Paddy(fallow)</td><td>annual</td></tr><tr><td>Labiatae</td><td><i>Mosla japonica</i></td><td>36</td><td>NT</td><td>Roadside</td><td>annual</td></tr><tr><td>Najadaceae</td><td><i>Najas gracillima</i></td><td>40</td><td>NT</td><td>Pond, Paddy</td><td>annual</td></tr><tr><td>Menyanthaceae</td><td><i>Nymphoides peltata</i></td><td>40</td><td>NT</td><td>Lake, Pond, Paddy</td><td>perennial</td></tr><tr><td>Saxifragaceae</td><td><i>Penthorum chinense</i></td><td>41</td><td>NT</td><td>Swamp</td><td>perennial</td></tr><tr><td>Polygonaceae</td><td><i>Persicaria foliosa var. paludicola</i></td><td>36</td><td>VU</td><td>Swamp, Paddy(fallow), Pond</td><td>annual</td></tr><tr><td>Polygonaceae</td><td><i>Persicaria taquetii</i></td><td>36</td><td>VU</td><td>Swamp, Paddy</td><td>annual</td></tr><tr><td>Potamogetonaceae</td><td><i>Potamogeton berchtoldii</i></td><td>44</td><td>NT</td><td>Lake, Pond, River, Ditch</td><td>perennial</td></tr><tr><td>Salviniaceae</td><td><i>Salvinia natans</i></td><td>40</td><td>NT</td><td>Paddy, Ditch</td><td>annual fern</td></tr><tr><td>Compositae</td><td><i>Saussurea pulchella</i></td><td>39</td><td>VU</td><td>Grassland, Forest edge</td><td>annual</td></tr><tr><td>Sparganiaceae</td><td><i>Sparganium fallax</i></td><td>41</td><td>NT</td><td>Lake, Pond, River</td><td>perennial</td></tr><tr><td>Sparganiaceae</td><td><i>Sparganium stenophyllum</i></td><td>41</td><td>VU</td><td>Lake, Pond</td><td>perennial</td></tr><tr><td>Trapaceae</td><td><i>Trapa incisa</i></td><td>37</td><td>VU</td><td>Lake, Pond, Ditch, Paddy</td><td>annual</td></tr><tr><td>Lentibulariaceae</td><td><i>Utricularia uliginosa</i></td><td>43</td><td>NT</td><td>Swamp</td><td>perennial</td></tr><tr><td>Asclepiadaceae</td><td><i>Vincetoxicum pycnostelma</i></td><td>44</td><td>NT</td><td>Grassland</td><td>perennial</td></tr></table> |
0d6889725e571208af7b45de7387b6b64352ea6b3d40e9f674f80a1e7a993377.png | complex | <table><tr><td rowspan="2">Rat number</td><td colspan="2">Control group</td><td colspan="2">Cyanoacrylate group</td></tr><tr><td>Researcher 1</td><td>Researcher 2</td><td>Researcher 1</td><td>Researcher 2</td></tr><tr><td>1</td><td>0</td><td>0</td><td>1</td><td>1</td></tr><tr><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>3</td><td>2</td><td>2</td><td>1</td><td>2</td></tr><tr><td>4</td><td>2</td><td>2</td><td>2</td><td>2</td></tr><tr><td>5</td><td>1</td><td>1</td><td>2</td><td>2</td></tr><tr><td>6</td><td>2</td><td>2</td><td>1</td><td>1</td></tr><tr><td>7</td><td>0</td><td>0</td><td>1</td><td>2</td></tr><tr><td>8</td><td>2</td><td>2</td><td>2</td><td>1</td></tr></table> |
2ca1063a8f8d8194175e2237667975c5a24bc526ba919a15b7c614d2a85c8417.png | complex | <table><tr><td>SSP no.</td><td>Accession no.</td><td>Protein Description</td><td>Mass in kDa (experiment/predicted)</td><td>pI (experiment/predicted)</td><td>Sequence coverage (%)</td><td>Number of peptides matched</td><td>Mowse score</td><td>Error (ppm)</td></tr><tr><td colspan="9">pH 4–7</td></tr><tr><td>2120</td><td>6065880</td><td>Heterogeneous nuclear ribonucleoprotein H2</td><td>38.43/49.52</td><td>3.96/5.89</td><td>46</td><td>15</td><td>171</td><td>14</td></tr><tr><td>3609</td><td>515634</td><td>Ubiquinol-cytochrome-c reductase complex core protein I, mitochondrial precursor</td><td>54.55/52.75</td><td>5.30/5.94</td><td>46</td><td>15</td><td>170</td><td>17</td></tr><tr><td>3617</td><td>4826760</td><td>Heterogeneous nuclear ribonucleoprotein F</td><td>57.18/45.87</td><td>5.25/5.38</td><td>31</td><td>8</td><td>88</td><td>9</td></tr><tr><td>4422</td><td>57093855</td><td>Similar to heterogeneous nuclear ribonucleoprotein H (hnRNP H)</td><td>38.53/46.38</td><td>4.46/6.61</td><td>43</td><td>12</td><td>131</td><td>6</td></tr><tr><td colspan="9">pH 6–11</td></tr><tr><td>7818</td><td>8574295</td><td>Voltage-dependent anion channel 2</td><td>20.00/31.65</td><td>9.43/7.49</td><td>41</td><td>8</td><td>88</td><td>18</td></tr><tr><td>7821</td><td>21619296</td><td>Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1</td><td>20.00/34.95</td><td>9.40/8.37</td><td>23</td><td>7</td><td>72</td><td>9</td></tr></table> |
71b1b48a3eeb8698a5830fa2c0349c9b22ef21747db8267c20be25134dc69145.png | complex | <table><tr><td></td><td>Control (<i>n</i> = 20)</td><td>Imagery (<i>n</i> = 20)</td></tr><tr><td></td><td>mean ± <i>SD</i></td><td>mean ± <i>SD</i></td></tr><tr><td colspan="3">Did you ....</td></tr><tr><td>... feel your imagery improved? <i>(1: not at all, 7: considerably)</i></td><td>5.45 ± 1.10</td><td>5.80 ± 0.77</td></tr><tr><td>... image as instructed and practiced? <sup>**</sup><i>(1: not at all, 7: exactly)</i></td><td>5.65 ± 0.67</td><td>6.20 ± 0.70</td></tr><tr><td>... notice any movement in the non-dominant hand? <i>(1:not at all, 7: full grasping)</i></td><td>3.70 ± 1.08</td><td>3.32 ± 1.25</td></tr><tr><td colspan="3">How ...</td></tr><tr><td>... easy to image the feelings? <i>(1: very hard, 7: very easy)</i></td><td>5.00 ± 1.41</td><td>5.20 ± 1.01</td></tr><tr><td>... clear and vivid was the imagery? <i>(1: no image at all, 7: perfectly clear/vivid)</i></td><td>5.40 ± 0.94</td><td>5.45 ± 0.76</td></tr></table> |
3a6ed17ca0d3474d9e2a40c62fc53608bab43dbcd3f10cf810067d2172c3e621.png | simple | <table><tr><td>Parameter</td><td>Activity rate</td><td>Time (%) in novel</td><td>Crossing/min</td></tr><tr><td>VEH controls</td><td>3.79 ± 0.21</td><td>79.7 ± 1.09</td><td>2.55 ± 0.26</td></tr><tr><td>DAT-i mice</td><td>4.10 ± 0.22</td><td>78.6 ± 1.75</td><td>2.98 ± 0.33</td></tr></table> |
90ce70b4a7d6bc84d3e98f7d8609538cda8b331f4eccfc8268c2cd598502f63b.png | complex | <table><tr><td>GO ID<sup>1</sup></td><td colspan="7"><i>p</i>-values</td><td>GO group description</td></tr><tr><td></td><td>[1, 10-<sup>2</sup>)</td><td>[10<sup>-2</sup>, 10<sup>-5</sup>)</td><td>[10<sup>-5</sup>, 10<sup>-10</sup>)</td><td>[10<sup>-10</sup>, 10<sup>-20</sup>)</td><td>[10<sup>-20</sup>, 10<sup>-50</sup>)</td><td>[10<sup>-50</sup>, 10<sup>-100</sup>)</td><td>[10<sup>-100</sup>, 0]</td><td></td></tr><tr><td>* GO0005215(392)</td><td>94.13</td><td>3.68</td><td>0.66</td><td>0.42</td><td>0.52</td><td>0.26</td><td>0.33</td><td>transporter activity</td></tr><tr><td>** GO0042626(43)</td><td>85.6</td><td>2.1</td><td>2.21</td><td>4.1</td><td>2.21</td><td>1.99</td><td>1.77</td><td>ATPase activity, coupled to transmembrane movement of substances</td></tr><tr><td>*** GO0042625(30)</td><td>85.75</td><td>1.84</td><td>1.61</td><td>3.68</td><td>3.91</td><td>2.07</td><td>1.15</td><td>ATPase activity, coupled to transmembrane movement of ions</td></tr><tr><td>**** GO0019829(19)</td><td>92.4</td><td>2.92</td><td>0</td><td>1.75</td><td>1.75</td><td>0</td><td>1.17</td><td>cation-transporting ATPase activity</td></tr><tr><td>***** GO0046961(18)</td><td>92.16</td><td>2.61</td><td>0</td><td>1.96</td><td>1.96</td><td>0</td><td>1.31</td><td>hydrogen-transporting ATPase activity, rotational mechanism</td></tr><tr><td>**** GO0015662(12)</td><td>30.3</td><td>0</td><td>10.61</td><td>19.7</td><td>21.21</td><td>13.64</td><td>4.55</td><td>ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism</td></tr><tr><td>**GO0015267(11)</td><td>87.27</td><td>3.64</td><td>1.82</td><td>0</td><td>0</td><td>1.82</td><td>5.45</td><td>channel or pore class transporter activity</td></tr><tr><td>*** GO0015268(9)</td><td>88.89</td><td>5.56</td><td>2.78</td><td>0</td><td>0</td><td>2.78</td><td>0</td><td>alpha-type channel activity</td></tr><tr><td>**** GO0005216(7)</td><td>85.71</td><td>4.76</td><td>4.76</td><td>0</td><td>0</td><td>4.76</td><td>0</td><td>ion channel activity</td></tr><tr><td>** GO0015238(14)</td><td>41.76</td><td>10.99</td><td>15.38</td><td>12.09</td><td>10.99</td><td>1.1</td><td>7.69</td><td>drug transporter activity</td></tr><tr><td>*** GO0015239(11)</td><td>47.27</td><td>9.09</td><td>14.55</td><td>9.09</td><td>12.73</td><td>0</td><td>7.27</td><td>multidrug transporter activity</td></tr><tr><td>** GO0015144(27)</td><td>21.08</td><td>1.71</td><td>3.13</td><td>8.55</td><td>23.65</td><td>5.7</td><td>36.18</td><td>carbohydrate transporter activity</td></tr><tr><td>*** GO0051119(24)</td><td>0.36</td><td>1.81</td><td>3.62</td><td>10.87</td><td>30.07</td><td>7.25</td><td>46.01</td><td>sugar transporter activity</td></tr><tr><td>**** GO0015145(17)</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>11.03</td><td>88.97</td><td>monosaccharide transporter activity</td></tr><tr><td>***** GO0015149(17)</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>11.03</td><td>88.97</td><td>hexose transporter activity</td></tr><tr><td>****** GO0005354(6)</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>33.33</td><td>66.67</td><td>galactose transporter activity</td></tr><tr><td>****** GO0015578(15)</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>100</td><td>mannose transporter activity</td></tr><tr><td>****** GO0005353(15)</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>100</td><td>fructose transporter activity</td></tr><tr><td>****** GO0005355(16)</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>100</td><td>glucose transporter activity</td></tr><tr><td>** GO0015075(140)</td><td>95.6</td><td>3.02</td><td>0.16</td><td>0.29</td><td>0.37</td><td>0.2</td><td>0.36</td><td>ion transporter activity</td></tr><tr><td>*** GO0046873(38)</td><td>91.18</td><td>4.98</td><td>0.14</td><td>0.28</td><td>0.71</td><td>1.28</td><td>1.42</td><td>metal ion transporter activity</td></tr><tr><td>**** GO0046915(29)</td><td>88.67</td><td>6.9</td><td>0.25</td><td>0.25</td><td>0.49</td><td>1.48</td><td>1.97</td><td>transition metal ion transporter activity</td></tr><tr><td>***** GO0005375(8)</td><td>82.14</td><td>10.71</td><td>0</td><td>3.57</td><td>0</td><td>3.57</td><td>0</td><td>copper ion transporter activity</td></tr><tr><td>***** GO0005381(10)</td><td>75.56</td><td>6.67</td><td>0</td><td>0</td><td>0</td><td>8.89</td><td>8.89</td><td>iron ion transporter activity</td></tr><tr><td>*** GO0042625(30)</td><td>85.75</td><td>1.84</td><td>1.61</td><td>3.68</td><td>3.91</td><td>2.07</td><td>1.15</td><td>ATPase activity, coupled to transmembrane movement of ions</td></tr><tr><td>**** GO0019829(19)</td><td>92.4</td><td>2.92</td><td>0</td><td>1.75</td><td>1.75</td><td>0</td><td>1.17</td><td>cation-transporting ATPase activity</td></tr><tr><td>***** GO0046961(18)</td><td>92.16</td><td>2.61</td><td>0</td><td>1.96</td><td>1.96</td><td>0</td><td>1.31</td><td>hydrogen-transporting ATPase activity, rotational mechanism</td></tr><tr><td>**** GO0015662(12)</td><td>30.3</td><td>0</td><td>10.61</td><td>19.7</td><td>21.21</td><td>13.64</td><td>4.55</td><td>ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism</td></tr></table> |
84a3ba89559b5f95cd847b609f466f8c09cfc7aadc7a4dab8d3551a1c8264b76.png | complex | <table><tr><td>Primers</td><td>Sequence (5′-3′)</td></tr><tr><td colspan="2">Primers for gene disruption and complementation</td></tr><tr><td> LwblA-F</td><td>AAGCTTTCGGGTACGCCATCTCGTA</td></tr><tr><td> LwblA-R</td><td>TCTAGAGCTGCTCCCTGAACGAACA</td></tr><tr><td> RwblA-F</td><td>GGATCCACGACGAGGTGTACGAGAAC</td></tr><tr><td> RwblA-R</td><td>GATATCTGACGCTGCTGGAGGAGAT</td></tr><tr><td> Kan-F</td><td>TCTAGAGATCCCCTGGATACCGCTCG</td></tr><tr><td> Kan-R</td><td>GGATCCGTACCCGAACCCCAGAGTC</td></tr><tr><td> wblAJ-F</td><td>AACTGGCGGCGGTGAATA</td></tr><tr><td> wblAJ-R</td><td>ACGGACGGAGCACATATAGG</td></tr><tr><td> CwblA-F</td><td>GGATCCGCCTGAACGGACGGAGCACATA</td></tr><tr><td> CwblA-R</td><td>TCTAGAAGCACACTGACACCGAGGAACTTGGC</td></tr><tr><td colspan="2">Primers for qRT-PCR</td></tr><tr><td> RTsanG-F</td><td>GGCGTACACAGCTCAAGAGC</td></tr><tr><td> RTsanG-R</td><td>AATTCGTCGATGAGCTGATC</td></tr><tr><td> RTsanN-F</td><td>AGATCATGCGCTCGGACTGT</td></tr><tr><td> RTsanN-R</td><td>TGGCGTGCAGGATCGGTA</td></tr><tr><td> RTsanO-F</td><td>ACTGCGATCCGTGGTCAA</td></tr><tr><td> RTsanO-R</td><td>TGTACTCCAGGCACTCCC</td></tr><tr><td> RTsanF-F</td><td>CGGCGCTGGAGGAACGTAC</td></tr><tr><td> RTsanF-R</td><td>GGGTGTAGAGGCCGATGCT</td></tr><tr><td> RThrdB-F</td><td>GCTGGCCAAGGAACTCGACAT</td></tr><tr><td> RThrdB-R</td><td>CGAAGCGCATGGAGACGACG</td></tr></table> |
ea60a12b428d7e870fcb3abfcf3e5727ae7d1b12acaf3348a548bd2e88dcba33.png | complex | <table><tr><td rowspan="2">Time (weeks)</td><td colspan="5">Chemical composition</td></tr><tr><td>Ash</td><td>Crude protein</td><td>Cellulose</td><td>Hemicellulose</td><td>Lignin</td></tr><tr><td>0</td><td>54.0 d</td><td>32.8 d</td><td>470.6 c</td><td>299.4 a</td><td>79.1 ab</td></tr><tr><td>1</td><td> 56.1 cd</td><td>34.3 cd</td><td>470.7 c</td><td>293.9 ab</td><td>82.4 a</td></tr><tr><td>2</td><td>58.4 c </td><td>36.0 bc</td><td> 485.7 ab</td><td>279.7 bc</td><td>83.6 a</td></tr><tr><td>3</td><td>61.2 b</td><td>36.0 bc</td><td> 489.8 ab</td><td>268.3 cd</td><td> 81.1 ab</td></tr><tr><td>4</td><td>61.7 ab</td><td>36.1 bc</td><td>484.9 b</td><td>262.2 d </td><td>74.1 b</td></tr><tr><td>5</td><td>62.3 ab</td><td>38.4 ab</td><td> 494.5 ab</td><td>240.7 e </td><td>59.3 c</td></tr><tr><td>6</td><td>63.8 a</td><td>39.1 a</td><td> 488.9 ab</td><td>235.2 ef </td><td> 57.1 cd</td></tr><tr><td>7</td><td>63.7 a</td><td>37.9 ab</td><td>498.3 a</td><td>220.2 fg </td><td>49.2 de</td></tr><tr><td>8</td><td>64.1 a</td><td>38.9 a</td><td> 496.6 ab</td><td>215.5 g</td><td>48.6 e</td></tr><tr><td>RMSE</td><td> 0.89</td><td>0.95</td><td>4.40</td><td>5.71</td><td>2.79</td></tr><tr><td><i>P</i></td><td> < 0.0001</td><td>< 0.0001</td><td>< 0.0001</td><td>< 0.0001</td><td> < 0.0001</td></tr></table> |
14334f24c9e1f32ff9a6b918d1f28d17624949a7fea1ffb2cab37e0e344358b7.png | complex | <table><tr><td rowspan="2">Gene Locus ID</td><td rowspan="2">Gene description</td><td colspan="3">Normalized Fold (Log<sub>2</sub>)</td></tr><tr><td>P</td><td>HC</td><td>PHC</td></tr><tr><td><i>GSVIVT00016386001</i></td><td>Vitis vinifera respiratory burst oxidase homolog protein E (VvRBOHE)</td><td>0.30 ± 0.21</td><td>1.11 ± 0.18</td><td>−1.22 ± 0.06</td></tr><tr><td><i>GSVIVT00002525001</i></td><td>Vitis vinifera respiratory burst oxidase homolog protein A (VvRBOHA)</td><td>−0.64 ± 0.06</td><td>−1.53 ± 0.29</td><td>−1.96 ± 0.16</td></tr><tr><td><i>GSVIVT00031598001</i></td><td>Vitis vinifera peroxidase 72 (VvPOD72)</td><td>1.59 ± 0.77</td><td>2.09 ± 1.18</td><td>4.19 ± 0.18</td></tr><tr><td><i>GSVIVT00031723001</i></td><td>Vitis vinifera peroxidase 12 (VvPOD12)</td><td>−0.79 ± 0.05</td><td>−0.74 ± 0.25</td><td>−1.71 ± 0.13</td></tr><tr><td><i>GSVIVT00020782001</i></td><td>Vitis vinifera alpha-dioxygenase 1 (VvDOX1)</td><td>1.83 ± 1.16</td><td>2.82 ± 0.55</td><td>0.13 ± 0.25</td></tr><tr><td><i>GSVIVT00001920001</i></td><td>Vitis vinifera glutathione peroxidase 2 (VvGPX2)</td><td>0.34 ± 0.39</td><td>0.28 ± 0.45</td><td>1.10 ± 0.54</td></tr><tr><td><i>GSVIVT00004080001</i></td><td>Vitis vinifera catalase isozyme 1-like (VvCAT1)</td><td>−0.35 ± 0.17</td><td>−1.52 ± 0.02</td><td>−1.57 ± 0.15</td></tr><tr><td><i>GSVIVT00036747001</i></td><td>Vitis vinifera cytosolic ascorbate peroxidase (VvAPX3)</td><td>−0.47 ± 0.24</td><td>−1.05 ± 0.09</td><td>−1.75 ± 0.04</td></tr><tr><td><i>GSVIVT00007083001</i></td><td>Vitis vinifera superoxide dismutase [Fe] 3, chloroplastic (VvFSD3)</td><td>0.40 ± 0.17</td><td>0.17 ± 0.10</td><td>1.82 ± 0.11</td></tr><tr><td><i>GSVIVT00014163001</i></td><td>Vitis vinifera superoxide dismutase [Fe], chloroplastic (VvFSD)</td><td>0.50 ± 0.13</td><td>0.33 ± 0.22</td><td>−1.60 ± 0.17</td></tr><tr><td><i>GSVIVT00003173001</i></td><td>Vitis vinifera alternative oxidase 2, mitochondrial (VvAOX2)</td><td>0.44 ± 0.16</td><td>2.43 ± 0.37</td><td>1.07 ± 0.18</td></tr><tr><td><i>GSVIVT00036443001</i></td><td>Vitis vinifera hemoglobin-2 (VvHB2)</td><td>−0.52 ± 0.43</td><td>4.41 ± 0.34</td><td>3.08 ± 0.43</td></tr></table> |
adae28cb71a0befdaa26bb2f277ae6de01b925698165f3b191bee9c9dadd97c9.png | simple | <table><tr><td>Short Name</td><td>Designation after VDA 239-100</td><td>Thickness in mm</td></tr><tr><td>DP600</td><td>CR330Y590T-DP-GI50/50-U</td><td>1.00</td></tr><tr><td>DH600</td><td>CR330Y590T-DH-GI50/50-U</td><td>1.00</td></tr><tr><td>DP800</td><td>CR440Y780T-DP-GI50/50-U</td><td>1.00</td></tr><tr><td>DH800</td><td>CR440Y780T-DH-GI50/50-U</td><td>1.00</td></tr><tr><td>CP800</td><td>CR570Y780T-CP-GI50/50-U</td><td>1.00</td></tr><tr><td>DP1000</td><td>CR660Y980T-DP-GI50/50-U<sup>1</sup></td><td>1.00</td></tr><tr><td>DH1000</td><td>CR700Y980T-DH-GI50/50-U</td><td>1.00</td></tr><tr><td>CP1000</td><td>CR780Y980T-CP-GI70/70-U</td><td>1.00</td></tr><tr><td>CH1000</td><td>CR780Y980T-CH-EG53/53-U<sup>1</sup></td><td>1.20</td></tr><tr><td>DH1200</td><td>CR850Y1180T-DH-EG53/53-U<sup>1</sup></td><td>1.00</td></tr><tr><td>CP1200</td><td>CR900Y1180T-CP-EG53/53-U</td><td>1.20</td></tr><tr><td>CH1200</td><td>CR900Y1180T-CH-UC-U<sup>1</sup></td><td>1.00</td></tr></table> |
8a73cb5b3d72e17ea8f51819e427ccdde2862997153fb6fd944ed29484716658.png | complex | <table><tr><td>Background characteristics</td><td colspan="2">Infants starting the intervention (N = 86)</td><td colspan="2">Infants completing 3 weeks (N = 81)</td></tr><tr><td></td><td>Acupuncture group (n = 46)</td><td>Control group (n = 40)</td><td>Acupuncture group (n = 43)</td><td>Control group (n = 38)</td></tr><tr><td>Firstborn, n (%)</td><td>22 (48)</td><td>22 (55)</td><td>21 (48)</td><td>21 (55)</td></tr><tr><td>Gender, female, n (%)</td><td>22 (48)</td><td>19 (48)</td><td>21 (50)</td><td>19 (50)</td></tr><tr><td>Gestational age, weeks. Mean (SD)</td><td>39.2 (1.5)</td><td>39.5 (1.3)</td><td>39.3 (1.4)</td><td>39.5 (1.3)</td></tr><tr><td>Age when colic started, weeks. Mean (SD)</td><td>1.9 (1.3)</td><td>1.5 (1.0)</td><td>2 (1.3)</td><td>1.5 (1)</td></tr><tr><td>Age at inclusion, weeks. Mean (SD)</td><td>5.0 (1.9)</td><td>5.3 (1.7)</td><td>5.1 (1.9)</td><td>5.2 (1.6)</td></tr><tr><td>Solely breastfed, n (%)</td><td>35 (76)</td><td>26 (65)</td><td>32 (74)</td><td>25 (66)</td></tr><tr><td>Having a parent and/or sibling with food intolerance/allergy, n (%)</td><td>17 (37)</td><td>18 (45)</td><td>15 (35)</td><td>17 (45)</td></tr><tr><td>Having a parent and/or sibling who had had infantile colic, n (%)</td><td>29 (63)</td><td>23 (58)</td><td>25 (58)</td><td>20 (53)</td></tr><tr><td>Have tried simeticone, n (%)</td><td>43 (93)</td><td>37 (92)</td><td>40 (93)</td><td>35 (92)</td></tr><tr><td>With no effect, n (%)</td><td>28 (61)</td><td>25 (63)</td><td>26 (60)</td><td>23 (61)</td></tr><tr><td>With uncertain effect, n (%)</td><td>15 (33)</td><td>12 (30)</td><td>14 (33)</td><td>12 (32)</td></tr><tr><td>Have tried lactobacillus reuteri, Semper Magdroppar <sup>®</sup>, n (%)</td><td>6 (13)</td><td>7 (18)</td><td>6 (14)</td><td>6 (16)</td></tr><tr><td>With no effect, n (%)</td><td>4 (9)</td><td>7 (18)</td><td>4 (9)</td><td>6 (16)</td></tr><tr><td>With uncertain effect, n (%)</td><td>2 (4)</td><td>0 (0)</td><td>2 (5)</td><td>0 (0)</td></tr><tr><td>Have tried a diet free from cow'rotein without effect, n (%)</td><td>33 (72)</td><td>32 (80)</td><td>31 (72)</td><td>30 (79)</td></tr><tr><td>Changed to this diet during the intervention weeks, n (%)</td><td>1 (2)</td><td>1 (3)</td><td>1 (2)</td><td>1 (3)</td></tr><tr><td>Not ensured if this diet is tried, n (%)</td><td>12 (26)</td><td>7 (18)</td><td>11 (26)</td><td>7 (18)</td></tr><tr><td>Received antibiotics, either through mother's medication or by own intake, n (%)</td><td>14 (30)</td><td>10 (25)</td><td>12 (28)</td><td>9 (24)</td></tr></table> |
1b9664c4d55b199ddb4ab59a3610d8548bff929aadae80a1cc1fe5ebbf166859.png | simple | <table><tr><td></td><td>1995</td><td>2001</td><td>Change %</td></tr><tr><td>Admitted patients/doctor/year</td><td>101</td><td>87</td><td>-13.9</td></tr><tr><td>Admitted patients/nurse/year</td><td>24</td><td>22</td><td>-8.3</td></tr><tr><td>Admitted patients/office staff/year</td><td>106</td><td>83</td><td>-21.7</td></tr><tr><td>In-hospital patients at all hours</td><td>813</td><td>793</td><td>-2.5</td></tr><tr><td>In-hospital patients at all hours/doctor</td><td>2,2</td><td>1,6</td><td>-28.3</td></tr><tr><td>In-hospital patients at all hours/nurse</td><td>0.5</td><td>0,39</td><td>-20.0</td></tr><tr><td>In-hospital patients at all hours/office staff</td><td>2,3</td><td>1.5</td><td>-34.8</td></tr><tr><td>Deliveries/midwife/year</td><td>57</td><td>44</td><td>-22.8</td></tr><tr><td>Out-patients consultations/doctor/year</td><td>629</td><td>530</td><td>-15.7</td></tr><tr><td>Out-patients consultations/nurse/year</td><td>147</td><td>134</td><td>-8.8</td></tr><tr><td>Out-patients consultations/office staff/year</td><td>656</td><td>503</td><td>-23.3</td></tr><tr><td>Surgical procedures/doctor/year – total*</td><td>160</td><td>128</td><td>-20.0</td></tr><tr><td> General surgery</td><td>151</td><td>134</td><td>-11.4</td></tr><tr><td> Orthopedic surgery</td><td>189</td><td>155</td><td>-18.0</td></tr><tr><td> Neurosurgery</td><td>98</td><td>100</td><td>+2.0</td></tr><tr><td> Otorhinolaryngology</td><td>177</td><td>125</td><td>-29.4</td></tr><tr><td> Ophthalmology</td><td>135</td><td>152</td><td>+12.6</td></tr><tr><td> Gynecology</td><td>109</td><td>71</td><td>-34.9</td></tr><tr><td>Anesthetized patients/anesthesiologist/year<sup>§</sup></td><td>661</td><td>534</td><td>-19.2</td></tr><tr><td>Hours with anesthesia/anesthesiologist/year</td><td>1 322</td><td>1 148</td><td>-13.2</td></tr><tr><td>Imaging procedures/radiologist/year</td><td>7 003</td><td>5 198</td><td>-25.8</td></tr><tr><td>Imaging procedures/radiology technician/year</td><td>2 436</td><td>2 077</td><td>-14.7</td></tr><tr><td>Lab test and procedures/technologist/year#</td><td>15 981</td><td>15 256</td><td>-4.5</td></tr></table> |
750da053aa87a696d487451bfb514006e0f75063b27218bd994fd64f1b452a7f.png | complex | <table><tr><td rowspan="2">Drug</td><td rowspan="2">UDS proportion (95% CI)*</td><td colspan="3">CASI</td></tr><tr><td>Past 7 days</td><td>Past 6 months</td><td>Lifetime</td></tr><tr><td>Any drugs</td><td>53.5 (47.0-60.0)</td><td>42.0<sup>‡</sup></td><td>59.3</td><td>92.4</td></tr><tr><td>Marijuana</td><td>36.0 (29.7-42.3)</td><td>28.6<sup>‡</sup></td><td>44.1</td><td>85.0</td></tr><tr><td>Cocaine</td><td>25.8 (20.1-31.5)</td><td>18.9<sup>‡</sup></td><td>29.5</td><td>66.8</td></tr><tr><td>Opiates</td><td>7.6 (4.1-10.1)</td><td>7.5</td><td>18.5</td><td>43.8</td></tr><tr><td>Meth/amphetamine</td><td>2.2 (0.3-4.1)</td><td>1.8</td><td>6.2</td><td>25.2</td></tr><tr><td>Injection</td><td>N/A</td><td>0.4</td><td>1.8</td><td>23.7</td></tr></table> |
be6f10ce94c5f0768eb70d95a649e59076c5ba6f3f9fa962548f4654d3f81299.png | simple | <table><tr><td>Outcome</td><td><i>P</i> value</td></tr><tr><td>Arthralgia</td><td>0.390</td></tr><tr><td>Bone pain</td><td>0.608</td></tr><tr><td>Back pain</td><td>0.744</td></tr><tr><td>Pain in extremity</td><td>0.056</td></tr><tr><td>Myalgia</td><td>0.794</td></tr><tr><td>LS BMD 12 months (normal at baseline-ZOL trials)</td><td>0.0003</td></tr><tr><td>LS BMD 12 months (osteopenic at baseline-ZOL trials)</td><td>0.296</td></tr><tr><td>LS BMD 12 months (residronate and ibandronate trials)</td><td>0.345</td></tr></table> |
ce7fac0186611e4da90c589e6ce2445367b7ee2f4f97bff70df642e7c2347f00.png | complex | <table><tr><td rowspan="2">Categories</td><td colspan="2">First-line treatment (XELOX plus bevacizumab)</td><td colspan="2">Second-line treatment (FOLFIRI)</td><td colspan="2">Clinical Support</td><td colspan="2">Death</td></tr><tr><td>R$</td><td>%</td><td>R$</td><td>%</td><td>R$</td><td>%</td><td>R$</td><td>%</td></tr><tr><td>Medications</td><td>27,592.00</td><td>89.57</td><td>4327.80</td><td>33.33</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td></tr><tr><td>Preparation (Pharmacy)</td><td>120.08</td><td>0.39</td><td>270.18</td><td>2.08</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td></tr><tr><td>Administration (Nursing)</td><td>1006.40</td><td>3.27</td><td>6700.74</td><td>51.61</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td></tr><tr><td>Laboratory tests</td><td>367.00</td><td>1.19</td><td>409.08</td><td>3.15</td><td>265.48</td><td>5.28</td><td>0.00</td><td>0.00</td></tr><tr><td>Imaging tests</td><td>1720.00</td><td>5.58</td><td>1276.20</td><td>9.83</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td></tr><tr><td>Hospitalization</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.00</td><td>4767.03</td><td>94.72</td><td>0.00</td><td>0.00</td></tr><tr><td>Total</td><td>30,805.48</td><td>100.00</td><td>12,984.00</td><td>100.00</td><td>5032.51</td><td>100.00</td><td>0.00</td><td>0.00</td></tr></table> |
a13d929c9c005f9192fb5fcb71b44772fd3f0f0b92b91520d1bbd0a4751f1870.png | complex | <table><tr><td>Genotypes</td><td colspan="3">Normotensives</td><td colspan="3">Hypertensive free from current antihypertensive medication</td><td colspan="3">Current use of antihypertensive medication</td></tr><tr><td></td><td>N</td><td>SBP(mm Hg)</td><td>DBP(mm Hg)</td><td>N</td><td>SBP(mm Hg)</td><td>DBP(mm Hg)</td><td>N</td><td>SBP(mm Hg)</td><td>DBP(mm Hg)</td></tr><tr><td>G482S genotypes</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> G482G</td><td>250</td><td>119.7(0.6)</td><td>77.7(0.4)</td><td>86</td><td>150.7(1.4)</td><td>90.2(0.9)</td><td>155</td><td>151.2(1.9)</td><td>89.0(1.0)</td></tr><tr><td> G482S</td><td>428</td><td>120.1(0.5)</td><td>77.2(0.3)</td><td>155</td><td>149.6(1.1)</td><td>90.8(0.7)</td><td>209</td><td>152.6(1.6)</td><td>88.4(0.8)</td></tr><tr><td> S482S</td><td>169</td><td>121.3(0.7)</td><td>78.2(0.5)</td><td>61</td><td>148.6(1.8)</td><td>90.6(1.2)</td><td>86</td><td>144.8(2.5)</td><td>87.0(1.3)</td></tr><tr><td> p values</td><td></td><td>0.207</td><td>0.286</td><td></td><td>0.647</td><td>0.897</td><td></td><td>0.023</td><td>0.426</td></tr><tr><td>+2962A/G genotypes</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> +2962A/A</td><td>429</td><td>120.5(0.5)</td><td>77.6(0.3)</td><td>179</td><td>149.6(1.1)</td><td>90.9(0.7)</td><td>232</td><td>149.2(1.5)</td><td>87.4(0.8)</td></tr><tr><td> +2962A/G</td><td>336</td><td>120.1(0.5)</td><td>77.6(0.4)</td><td>127</td><td>150.2(1.3)</td><td>90.0(0.8)</td><td>178</td><td>151.0(1.8)</td><td>89.4(0.9)</td></tr><tr><td> +2962G/G</td><td>82</td><td>119.4(1.1)</td><td>77.2(0.7)</td><td>39</td><td>149.6(2.3)</td><td>91.0(1.5)</td><td>40</td><td>159.9(3.6)</td><td>89.4(1.9)</td></tr><tr><td> p values</td><td></td><td>0.580</td><td>0.899</td><td></td><td>0.930</td><td>0.667</td><td></td><td>0.020</td><td>0.181</td></tr></table> |
d0078c44e851be13ecc6c117adc1d12d5407888bdd169920d7008a69125228d5.png | simple | <table><tr><td>Gene</td><td>SNP<sup><i>a</i></sup></td><td>AA change<sup><i>b</i></sup></td><td>Protein domain<sup><i>c</i></sup></td><td>dbSNP ID</td></tr><tr><td><i>TLR2</i></td><td>42 C > T</td><td>Silent 14</td><td>-<sup><i>d</i></sup></td><td>rs1388116474:C > T</td></tr><tr><td></td><td>53 C > T</td><td>M18T</td><td>-</td><td>rs1388116475:C > T</td></tr><tr><td></td><td>108 C > T</td><td>Silent 36</td><td>LRR 8</td><td>rs1388116476:C > T</td></tr><tr><td></td><td>153 G > A</td><td>Silent 51</td><td>LRR_RI</td><td>rs1388116477:G > A</td></tr><tr><td></td><td>156 C > T</td><td>Silent 52</td><td>LRR_RI</td><td>rs1388116478:C > T</td></tr><tr><td></td><td>374 T > C</td><td>A125V</td><td>LRR 8</td><td>rs1388116479:T > C</td></tr><tr><td></td><td>381 A > G</td><td>Silent 127</td><td>LRR 8</td><td>rs1388116480:A > G</td></tr><tr><td></td><td>482/483 GC > CT</td><td>S161T</td><td>LRR 8</td><td>rs1388116481:GC > CT</td></tr><tr><td></td><td>519 G > C</td><td>Silent 173</td><td>LRR_RI</td><td>rs1388116482:G > C</td></tr><tr><td></td><td>1034 A > G</td><td>S345N</td><td>-</td><td>rs1388116483:A > G</td></tr><tr><td></td><td>1375 T > C</td><td>Silent 459</td><td>LRR4</td><td>rs1388116484:T > C</td></tr><tr><td></td><td>1407 C > T</td><td>Silent 469</td><td>LRR4</td><td>rs1388116485:C > T</td></tr><tr><td></td><td>1650 G > A</td><td>Silent 550</td><td>LRR_CT</td><td>rs1388116486:G > A</td></tr><tr><td></td><td>1678 A > G</td><td>A560T</td><td>LRR_CT</td><td>rs1388116487:A > G</td></tr><tr><td></td><td>1707 C > T<sup><i>e</i></sup></td><td>Silent 569</td><td>LRR_CT</td><td>rs1388116488:C > T</td></tr><tr><td></td><td>1731 C > T</td><td>Silent 577</td><td>LRR_CT</td><td>rs1388116489:C > T</td></tr><tr><td></td><td>1740 C > T</td><td>Silent 580</td><td>LRR_CT</td><td>rs1388116490:C > T</td></tr><tr><td></td><td>2064 T > C</td><td>Silent 688</td><td>TIR</td><td>rs1388116491:T > C</td></tr><tr><td><i>TLR4</i></td><td>572 A > C<sup><i>f</i></sup></td><td>Y191S</td><td>LRR8</td><td>rs1388116492:A > CG</td></tr><tr><td></td><td>572 A > G<sup><i>f</i></sup></td><td>silent</td><td>LRR8</td><td>rs1388116492:A > CG</td></tr><tr><td></td><td>574 C > T</td><td>Q192W</td><td>LRR8</td><td>rs1388116493:C > T</td></tr><tr><td></td><td>575 A > G</td><td>Q192W</td><td>LRR8</td><td>rs1388116494:A > G</td></tr><tr><td></td><td>576 T > G</td><td>Silent192</td><td>LRR8</td><td>rs1388116495:T > G</td></tr><tr><td></td><td>577 G > A</td><td>E193K</td><td>LRR8</td><td>rs1388116496:G > A</td></tr><tr><td></td><td>579 A > G</td><td>Silent193</td><td>LRR8</td><td>rs1388116497:A > G</td></tr><tr><td></td><td>647 G > A</td><td>Silent216</td><td>LRR_RI</td><td>rs1388116498:G > A</td></tr><tr><td></td><td>662 G > A</td><td>Silent221</td><td>-</td><td>rs1388116499:G > A</td></tr><tr><td></td><td>672 A > C</td><td>Silent224</td><td>-</td><td>rs1388116500:A > C</td></tr><tr><td><i>TLR9</i></td><td>2340 C > T</td><td>Silent780</td><td>-</td><td>rs1388116501:C > T</td></tr><tr><td></td><td>2475 A > G</td><td>Silent825</td><td>-</td><td>rs1388116502:A > G</td></tr></table> |
4f23349c221908ae8fb36063038e9a31250b34dba5092a864ca79ac0e500315a.png | complex | <table><tr><td>Age group</td><td colspan="2">HIV-positive children n = 123</td><td colspan="2">HIV-uninfected children n = 192</td><td>Total</td></tr><tr><td>Months</td><td>Male</td><td>Female</td><td>Male</td><td>Female</td><td></td></tr><tr><td>0–5.9</td><td>1</td><td>2</td><td>4</td><td>4</td><td>11</td></tr><tr><td>6–11.9</td><td>15</td><td>8</td><td>21</td><td>14</td><td>58</td></tr><tr><td>12–23.9</td><td>36</td><td>21</td><td>66</td><td>37</td><td>160</td></tr><tr><td>24–35.9</td><td>17</td><td>8</td><td>19</td><td>6</td><td>50</td></tr><tr><td>36–47.9</td><td>4</td><td>4</td><td>6</td><td>6</td><td>20</td></tr><tr><td>48–59.9</td><td>2</td><td>5</td><td>5</td><td>4</td><td>16</td></tr><tr><td>Total</td><td>75</td><td>48</td><td>121</td><td>71</td><td>315</td></tr></table> |
067abe9eb7b9571d016bcb4f8dabd671efd62ed0840f37a3911787ee461ec0be.png | simple | <table><tr><td>Factor</td><td>Cronbach's alpha</td><td>Number of items</td></tr><tr><td>Privacy</td><td>.756</td><td>3</td></tr><tr><td>Culture</td><td>.926</td><td>3</td></tr><tr><td>Attitude toward telemedicine </td><td>.755</td><td>3</td></tr><tr><td>Benefit</td><td>.729</td><td>5</td></tr><tr><td>Connectivity </td><td>.794</td><td>3</td></tr><tr><td>IT capability</td><td>.706</td><td>3</td></tr><tr><td>Compatibility </td><td>.763</td><td>3</td></tr><tr><td>Data warehouse</td><td>.749</td><td>3</td></tr><tr><td>Technical support</td><td>.787</td><td>3</td></tr><tr><td>Top management support</td><td>.706</td><td>3</td></tr><tr><td>Cost</td><td>.728</td><td>4</td></tr><tr><td>Policy</td><td>.815</td><td>3</td></tr><tr><td>Upper-level leadership</td><td>.818</td><td>3</td></tr></table> |
1eb5b90792141699df09568eb29e954df6aaf852bd53d0d395d009d79646bedd.png | complex | <table><tr><td rowspan="2">Variables/Group</td><td colspan="2">Control (<i>n</i> = 15)</td><td colspan="2">TKD (<i>n</i> = 15)</td><td colspan="2">Time × Group Interaction</td></tr><tr><td>Baseline</td><td>16-Week</td><td>Baseline</td><td>16-Week</td><td><i>F</i></td><td><i>p</i></td></tr><tr><td>Word test (score)</td><td>44.67 ± 10.89</td><td>45.33 ± 9.06</td><td>45.87 ± 8.62</td><td>47.60 ± 7.73</td><td>1.029</td><td>0.319</td></tr><tr><td>CV</td><td>0.24</td><td>0.20</td><td>0.19</td><td>0.16</td><td></td><td></td></tr><tr><td>Color test (score)</td><td>44.73 ± 8.73</td><td>45.27 ± 8.18</td><td>46.20 ± 7.40</td><td>47.87 ± 6.44</td><td>2.429</td><td>0.130</td></tr><tr><td>CV</td><td>0.20</td><td>0.18</td><td>0.16</td><td>0.13</td><td></td><td></td></tr><tr><td>Color-Word test (score)</td><td>49.07 ± 7.84</td><td>48.87 ± 8.07</td><td>50.33 ± 6.63</td><td>52.40 ± 6.23 <sup>#</sup></td><td>13.952</td><td>0.001 **</td></tr><tr><td>CV</td><td>0.16</td><td>0.17</td><td>0.13</td><td>0.12</td><td></td><td></td></tr></table> |
86d74620b4e9bac05ee01a60243e7151ecaba8988c090126a5d8fd718a4e7f59.png | simple | <table><tr><td> </td><td>Patients (<i>n</i> = 38)</td><td>Controls (<i>n</i> = 23)</td></tr><tr><td>Median age (range) years</td><td>37 (18 to 50)</td><td>36 (24 to 49)</td></tr><tr><td>Sex distribution</td><td>26 F/12 M</td><td>15 F/7 M</td></tr><tr><td>CIS/MS at 12 months</td><td>19/19</td><td>—</td></tr><tr><td>Median lesion volume (range) mL</td><td>0.54 (0 to 38.1)</td><td>—</td></tr><tr><td>Median number of new lesions </td><td>1 (0 to 4)</td><td>—</td></tr><tr><td>Median OR lesion volume (range) mL</td><td>0.06 (0 to 21.3)</td><td>—</td></tr></table> |
c92daa86b66e53a152a5ee1216397535b23fb0c93865cdf5b2ccce4880608a02.png | complex | <table><tr><td>Construct</td><td>Measure</td><td>Administration</td></tr><tr><td colspan="3"><i>Primary Outcome measure</i></td></tr><tr><td>Symptom Severity</td><td>Irritable Bowel Symptom Severity Scale</td><td>Pre, 2 wk, 3 mo, 6 mo, 12 mo post</td></tr><tr><td colspan="3"><i>Secondary Outcome measures</i></td></tr><tr><td>Symptom frequency</td><td>Daily Symptom Diary</td><td>Daily during the intervention and for 2 weeks post</td></tr><tr><td>IBS-related anxiety</td><td>Visceral Sensitivity Index</td><td>Pre, 2 wk, 3 mo, 6 mo, 12 mo post</td></tr><tr><td>Economic impact of IBS</td><td>The Work Productivity and Activity Impairment for IBS (WPAI: IBS)</td><td>Pre, 2 wk, 3 mo, 6 mo, 12 mo post</td></tr><tr><td>Co-Morbid Symptoms</td><td>Recent Physical Symptoms Questionnaire (RPSQ)</td><td>Pre, 2 wk, 3 mo, 6 mo, 12 mo post</td></tr><tr><td>General psychological distress</td><td>Brief Symptom Inventory (BSI)</td><td>Pre, 2 wk, 3 mo, 6 mo, 12 mo post</td></tr><tr><td>Anger and its expression</td><td>The State-trait Anger Expression Inventory (STAXI)</td><td>Pre, 2 wk, 3 mo, 6 mo, 12 mo post</td></tr><tr><td>Maladaptive coping methods</td><td>Coping Strategies Questionnaire (CSQ)</td><td>Pre, 2 wk, 3 mo, 6 mo, 12 mo post</td></tr><tr><td>Quality of life specific to IBS</td><td>IBS-QOL</td><td>Pre, 2 wk, 3 mo, 6 mo, 12 mo post</td></tr><tr><td colspan="3"><i>Effect modification measures</i></td></tr><tr><td>Expectancy of success of intervention</td><td>Borkovec and Nau credibility scales</td><td>Prior to second session</td></tr><tr><td>Catalogue of distressing prior events</td><td>Family Inventory of Life Events (FILE)</td><td>Pre intervention only</td></tr><tr><td>Demographics</td><td>Age, race, education, marital status, income</td><td>Pre intervention only</td></tr><tr><td colspan="3"><i>Process measures</i></td></tr><tr><td>Measure of mindfulness: Multiple constructs</td><td>Five Facet Mindfulness Questionnaire (FFMQ)</td><td>Pre, 2 wk, 6 mo, 12 mo post</td></tr><tr><td>Measure of mindfulness: Acceptance construct</td><td>Toronto Mindfulness Scale</td><td>Pre, 2 wk, 6 mo, 12 mo post</td></tr></table> |
edfa6611afe9e03557514a159ce2157916cb4adb13ecb9d7919f679f03bbe940.png | simple | <table><tr><td>Organizations</td><td>Carbohydrates</td><td>Fiber</td><td>Protein</td><td>Fat</td></tr><tr><td>American Diabetes Association (ADA)</td><td>50–60%</td><td>Not specified</td><td>10–15%</td><td>30–35%</td></tr><tr><td>The British Diabetic Association/Diabetes UK</td><td>45–60%</td><td><30 g/day</td><td>30–35%</td><td><35%</td></tr><tr><td>European Association for the Study of Diabetes (EASD)</td><td>45–60%</td><td>Increase fiber with low-GI food</td><td>10–20%</td><td>35%</td></tr><tr><td>The Canadian Diabetes Association (CDA)</td><td>50–60%</td><td>25–35 g/day</td><td>11%</td><td>30%</td></tr><tr><td>Japan</td><td>60%</td><td>1 fruit + 400 g vegetables</td><td>15–20%</td><td>20–25%</td></tr><tr><td>South Africa</td><td>50–60%</td><td>40 g/day</td><td>12–30%</td><td>≤30%</td></tr><tr><td>India</td><td>>65%</td><td>40 g/day</td><td>12–20%</td><td><21%</td></tr><tr><td>Mediterranean diet</td><td>40–42%</td><td>~23 g/day</td><td>~16%</td><td>40–42%</td></tr></table> |
c9858aea0d5c69da7ef0f9477e69bfb7c90c34463e6f79b35fe7a8734f2c9c93.png | simple | <table><tr><td>Gene</td><td>Reagent Sequences</td></tr><tr><td>MIP-1α</td><td>F; AGCTGACACCCCGACTGC</td></tr><tr><td></td><td>R; GTCAACGATGAATTGGCGTG</td></tr><tr><td></td><td>P; TGCTGCTTCTCCTACAGCCGGAAGAT</td></tr><tr><td>MIP-1β</td><td>F; AGCTCTGCGTGTCTGCCC T</td></tr><tr><td></td><td>R; GCTGAGAACCCTAGAGCACA</td></tr><tr><td></td><td>P; TCTCCT CTTGCTCGTGGCTGCCTT</td></tr><tr><td>TNFα</td><td>F; TCCAGGCGGTGCCTATGT</td></tr><tr><td></td><td>R; GAGCGTGGTGGCCCC</td></tr><tr><td></td><td>P; TCAGCCTCTTCTCATTCCTGCTTGTGG</td></tr><tr><td>iNOS</td><td>F; TGATGTCCGAAGCAAACATCA</td></tr><tr><td></td><td>R; TGTGGCTCCCATGTTGCAT</td></tr><tr><td></td><td>P; TTCAGATCCCGAAACGCTTCACTTCC</td></tr><tr><td>IL-1β</td><td>F; TTGGGCCTCAAAGGAAAGAAT</td></tr><tr><td></td><td>R; TCTCCAGCTGCAGGGTGG</td></tr><tr><td></td><td>P; TATACCTGTCCTGTGTAATGAAAGACGGCA CA</td></tr><tr><td>IκBα</td><td>F; CGGAGGACGGAGGACTCGTT</td></tr><tr><td></td><td>R; ACTTCCATGGTCAGCGGCT</td></tr><tr><td></td><td>P; TGCACTTGGCAATCATCCACGAAGA</td></tr><tr><td>FasL</td><td>F; TACCACCGCCATCACAACC</td></tr><tr><td></td><td>R; TTTGTGTTGTGGTCCTTCTTCTTTAG</td></tr><tr><td></td><td>P; CTCCCACTGCCGCCACTGACC</td></tr><tr><td>GFAP</td><td>F; GGAGCTCAATGACCGCTTTG</td></tr><tr><td></td><td>R; AGCGCCTTGTTTTGCTGCTC</td></tr><tr><td></td><td>P; CAGCTACATCGAGAAGGTTCG</td></tr><tr><td>RANTES</td><td>F; TCTTGCAGTCGTGTTTGTCAC</td></tr><tr><td></td><td>R; TCTTGAACCCACTTCTTCTCT</td></tr><tr><td></td><td>P; AGGAACCGCCAAGTGTGTGC</td></tr><tr><td>CCR5</td><td>F; GGAATGACACACTGCTGCCTAA</td></tr><tr><td></td><td>R; GAACACTGAGAGATAACTCCGGAAC</td></tr><tr><td></td><td>P; CCCTGTCATCTATGCCTTTGTTGGAGAGA</td></tr></table> |
2da1995d658ceb3307b1f710b49349cc55b27cbc3d08085cc03c930f155146bd.png | simple | <table><tr><td>Sexual behaviors</td><td>Number (%)</td></tr><tr><td>Diagnosed with an STI in the past 6 months</td><td>16 (10.8)</td></tr><tr><td>Sought treatment for most recent STI symptom (<i>n</i> = 16)</td><td>2 (11.1)</td></tr><tr><td>Facility where the most recent STI was treated</td><td></td></tr><tr><td> Public health center/hospital (<i>n</i> = 2)</td><td>1 (50.0)</td></tr><tr><td> Non-governmental clinic/hospital (<i>n</i> = 2)</td><td>1 (50.0)</td></tr><tr><td>Had sexual intercourse in the past 3 months</td><td>59 (41.3)</td></tr><tr><td>Used condom in last sexual intercourse (<i>n</i> = 59)</td><td>21 (35.6)</td></tr><tr><td>Had sexual intercourse when intoxicated (<i>n</i> = 59)</td><td>22 (37.3)</td></tr></table> |
1968857311b2029fe0b187b7e51414e7cbf3d2620daf87eb32e475ebab61c369.png | complex | <table><tr><td></td><td colspan="3">up to 30</td><td colspan="3">from 31 to 60</td><td colspan="3">over 61</td><td colspan="3">Male</td><td colspan="3">Female</td></tr><tr><td></td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan="2">95% C.I.</td><td>%</td><td colspan="2">95% C.I.</td></tr><tr><td>Inadequate directions</td><td>0.51</td><td>0.00</td><td>1.21</td><td>4.09</td><td>3.62</td><td>4.55</td><td>3.18</td><td>2.57</td><td>3.79</td><td>1.98</td><td>0.61</td><td>0.94</td><td>4.36</td><td>3.96</td><td>4.75</td></tr><tr><td>Inadequate cooperation of personnel working in the Institute</td><td>2.79</td><td>1.14</td><td>4.44</td><td>0.73</td><td>0.53</td><td>0.93</td><td>2.45</td><td>1.91</td><td>2.98</td><td>1.01</td><td>0.82</td><td>1.19</td><td>1.46</td><td>1.23</td><td>1.69</td></tr><tr><td>Inadequate treatment received by Doctors of the Institute</td><td>0.76</td><td>0.00</td><td>1.62</td><td>0.55</td><td>0.38</td><td>0.72</td><td>2.90</td><td>2.32</td><td>3.49</td><td>0.78</td><td>0.61</td><td>0.94</td><td>1.31</td><td>1.10</td><td>1.53</td></tr><tr><td>Short waiting time for the medical consultation after scheduling an appointment</td><td>1.78</td><td>0.46</td><td>3.09</td><td>2.04</td><td>1.71</td><td>2.37</td><td>2.17</td><td>1.67</td><td>2.68</td><td>1.38</td><td>1.16</td><td>1.60</td><td>2.44</td><td>2.15</td><td>2.74</td></tr><tr><td>Inadequate general service provided by this Institute</td><td>3.05</td><td>1.32</td><td>4.77</td><td>0.72</td><td>0.52</td><td>0.91</td><td>5.75</td><td>4.93</td><td>6.57</td><td>0.78</td><td>0.61</td><td>0.94</td><td>3.02</td><td>2.69</td><td>3.34</td></tr></table> |
a44a192764e088a9618901af0389794f351579c57e6eebe5ef8b2943f73ab91a.png | complex | <table><tr><td>Variable</td><td colspan="2">Preview</td><td colspan="2">No-Preview</td></tr><tr><td> </td><td>IB</td><td>No-IB</td><td>IB</td><td>No-IB</td></tr><tr><td>Fixation distance (in pixels) from moving coin on experimental trial</td><td>334 (122)</td><td>296 (123)</td><td>398 (122)</td><td>390 (125)</td></tr><tr><td>Fixation distance (in pixels) from moving coin on free-viewing trial</td><td>339 (224)</td><td>202 (137)</td><td>380 (156)</td><td>307 (143)</td></tr><tr><td colspan="5">PROBABILITY OF FIXATION DURING CRITICAL PERIOD</td></tr><tr><td>Starting napkin</td><td>0.06 (0.14)</td><td>0.03 (0.11)</td><td>0.03 (0.12)</td><td>0.00 (0.00)</td></tr><tr><td>End napkin</td><td>0.00 (0.00)</td><td>0.07 (0.17)</td><td>0.00 (0.00)</td><td>0.02 (0.06)</td></tr><tr><td>Space between napkins</td><td>0.06 (0.14)</td><td>0.22 (0.35)</td><td>0.00 (0.00)</td><td>0.13 (0.23)</td></tr><tr><td>Cup</td><td>0.64 (0.73)</td><td>0.36 (0.38)</td><td>0.62 (0.32)</td><td>0.35 (0.33)</td></tr><tr><td>Face</td><td>0.00 (0.00)</td><td>0.11 (0.26)</td><td>0.19 (0.27)</td><td>0.19 (0.29)</td></tr><tr><td colspan="5">PROBABILITY OF FIXATION DURING FREE-VIEWING TRIAL</td></tr><tr><td>Starting napkin</td><td>0.33 (0.29)</td><td>0.06 (0.17)</td><td>0.04 (0.10)</td><td>0.04 (0.13)</td></tr><tr><td>End napkin</td><td>0.17 (0.29)</td><td>0.16 (0.23)</td><td>0.00 (0.00)</td><td>0.06 (0.16)</td></tr><tr><td>Space between napkins</td><td>0.17 (0.29)</td><td>0.37 (0.37)</td><td>0.08 (0.13)</td><td>0.18 (0.28)</td></tr><tr><td>Cup</td><td>0.17 (0.29)</td><td>0.16 (0.29)</td><td>0.28 (0.31)</td><td>0.35 (0.42)</td></tr><tr><td>Face</td><td>0.17 (0.29)</td><td>0.05 (0.13)</td><td>0.26 (0.25)</td><td>0.07 (0.18)</td></tr><tr><td colspan="5">TIME TO FIXATE AFTER CRITICAL PERIOD (msec)</td></tr><tr><td>Starting napkin</td><td>1210 (1783)</td><td>2046 (1904)</td><td>1186 (1782)</td><td>1595 (1978)</td></tr><tr><td>End napkin</td><td>4539 (1182)</td><td>2591 (2807)</td><td>3426 (1445)</td><td>996 (1532)</td></tr><tr><td>Space between napkins</td><td>317 (242)</td><td>1180 (1405)</td><td>7687 (7148)</td><td>773 (765)</td></tr><tr><td>Face</td><td>2382 (3363)</td><td>3454 (2000)</td><td>892 (1509)</td><td>3004 (3083)</td></tr></table> |
357524fb764430aef7b868df8f7432263cfd01a971201d200d357a65b392f25a.png | simple | <table><tr><td>Condition</td><td>Stimulus type</td><td>n</td><td>Before RF (ms)</td><td>After RF (ms)</td><td>t</td><td>P</td></tr><tr><td>Genuine EMF</td><td>Rarefaction</td><td>13</td><td>1.67 ± 0.14</td><td>1.66 ± 0.15</td><td>0.34</td><td>0.737</td></tr><tr><td></td><td>Condensation</td><td>13</td><td>1.69 ± 0.18</td><td>1.65 ± 0.19</td><td>1.18</td><td>0.260</td></tr><tr><td></td><td>Alternating</td><td>13</td><td>1.79 ± 0.09</td><td>1.78 ± 0.12</td><td>1.06</td><td>0.310</td></tr><tr><td>Sham EMF</td><td>Rarefaction</td><td>15</td><td>1.61 ± 0.21</td><td>1.63 ± 0.19</td><td>-0.50</td><td>0.624</td></tr><tr><td></td><td>Condensation</td><td>14</td><td>1.66 ± 0.09</td><td>1.68 ± 0.14</td><td>-0.24</td><td>0.807</td></tr><tr><td></td><td>Alternating</td><td>14</td><td>1.74 ± 0.10</td><td>1.76 ± 0.11</td><td>-1.23</td><td>0.239</td></tr></table> |
d1ce1376e459a69408d63a94342138cfa54aa3c3457ff5649907bef7fea261ae.png | simple | <table><tr><td>Size Factor</td><td>Iterations</td><td>Nodes</td><td>Elements</td><td>Max. Elem. Vol. (mm<sup>3</sup>)</td></tr><tr><td>Initial</td><td>--</td><td>2396</td><td>7574</td><td>0.08</td></tr><tr><td>1.15</td><td>17</td><td>1332</td><td>3904</td><td>0.51</td></tr><tr><td>1.25</td><td>21</td><td>777</td><td>2200</td><td>1.49</td></tr><tr><td>1.35</td><td>20</td><td>612</td><td>1615</td><td>2.97</td></tr></table> |
7211d1bd535fb9c2062f351b71d4ec0fd1764fa68ad3add32be52b63c8d00732.png | simple | <table><tr><td>Characteristics</td><td>Number (%)</td></tr><tr><td>Age range (year)</td><td>6–88</td></tr><tr><td>Mean age (year) (SD)</td><td>42.5 ± 17.53</td></tr><tr><td>Length of stay (day) range</td><td>0–15</td></tr><tr><td>Mean length of stay (day) (SD)</td><td>8.3 ± 5.3</td></tr><tr><td>Length of stay (day)</td><td> </td></tr><tr><td> ≤1 week</td><td>67 (57.7)</td></tr><tr><td> More than one week</td><td>21 (18.1)</td></tr><tr><td>Sex</td><td> </td></tr><tr><td> Male</td><td>63 (54.4)</td></tr><tr><td> Female</td><td>53 (45.6)</td></tr><tr><td>Hospitalization</td><td> </td></tr><tr><td> Yes</td><td>87 (75)</td></tr><tr><td> No</td><td>29 (25)</td></tr><tr><td>Nosocomial infection</td><td> </td></tr><tr><td> Yes</td><td>22 (18.9)</td></tr><tr><td> No</td><td>94 (81.1)</td></tr><tr><td>MRSA</td><td>49 (42.2)</td></tr><tr><td>MSSA</td><td>67 (57.7)</td></tr><tr><td>PVL gene positive</td><td>25 (18.3)</td></tr><tr><td>MRSA carry PVL gene</td><td>14 (28.5)</td></tr><tr><td>MSSA carry PVL gene</td><td>11 (16.4)</td></tr></table> |
1800a0d8a09a99b9fa1ad266ef36d5d1ee21a6a0ca3e666e9447bec7e7a36c44.png | complex | <table><tr><td rowspan="2">Parameter</td><td rowspan="2">Unit</td><td colspan="6">Soil sample</td></tr><tr><td>WD1</td><td>WD2</td><td>WD3</td><td>ZR1</td><td>ZR2</td><td>ZR3 </td></tr><tr><td>Particle size </td><td> </td><td>SL</td><td>SL</td><td>SL</td><td>SL</td><td>SL</td><td>SL</td></tr><tr><td>pH</td><td> </td><td>8.4</td><td>8.3</td><td>8.4</td><td>8.3</td><td>8.6</td><td>8.2</td></tr><tr><td>EC</td><td>dS m<sup>−1</sup></td><td>2.1</td><td>3.2</td><td>2.2</td><td>3.7</td><td>3.0</td><td>2.2</td></tr><tr><td>CEC</td><td>cmol kg<sup>−1</sup></td><td>19.4</td><td>20.7</td><td>21.1</td><td>22.3</td><td>17.2</td><td>20.3</td></tr><tr><td>ESP</td><td>%</td><td>8.9</td><td>9.2</td><td>2.6</td><td>9.9</td><td>1.8</td><td>3.9</td></tr><tr><td>OM</td><td>%</td><td>2.0</td><td>1.1</td><td>2.1</td><td>1.6</td><td>1.0</td><td>2.1</td></tr><tr><td>CaCO<sub>3</sub></td><td>%</td><td>33.1</td><td>32.5</td><td>36.1</td><td>40.6</td><td>61.6</td><td>22.3</td></tr><tr><td>Fe</td><td>%</td><td>0.56</td><td>0.63</td><td>0.58</td><td>0.51</td><td>0.51</td><td>0.53</td></tr><tr><td>Ca</td><td>mg kg<sup>−1</sup></td><td>2759.1</td><td>2891.1</td><td>5508.8</td><td>3549.0</td><td>2421.3</td><td>5051.4</td></tr><tr><td>Mg</td><td>mg kg<sup>−1</sup></td><td>552.6</td><td>594.3</td><td>178.8</td><td>737.1</td><td>175.5</td><td>475.2</td></tr><tr><td>Na</td><td>mg kg<sup>−1</sup></td><td>398.0</td><td>439.7</td><td>125.6</td><td>509.2</td><td>70.0</td><td>181.2</td></tr><tr><td>K</td><td>mg kg<sup>−1</sup></td><td>42.3</td><td>49.9</td><td>29.4</td><td>26.9</td><td>36.8</td><td>31.9</td></tr><tr><td>Fe</td><td>mg kg<sup>−1</sup></td><td>3.6</td><td>3.6</td><td>3.5</td><td>3.7</td><td>3.9</td><td>3.5</td></tr><tr><td>NH<sub>4</sub><sup>+</sup></td><td>mg kg<sup>−1</sup></td><td>18.7</td><td>37.0</td><td>18.6</td><td>14.8</td><td>31.6</td><td>43.0</td></tr><tr><td>NO<sub>3</sub><sup>−</sup></td><td>mg kg<sup>−1</sup></td><td>35.0</td><td>37.0</td><td>43.5</td><td>87.2</td><td>39.6</td><td>94.8</td></tr></table> |
9c4b9b23334242dbcfb524df13d3e0eab8495b235f70bc56a98f508d86e47d57.png | complex | <table><tr><td rowspan="3">HIV Knowledge and Prevention Practices</td><td colspan="3">Men</td><td colspan="3">Women</td><td>Test for difference by sex<sup>c</sup></td></tr><tr><td colspan="3"><i>n</i> = 755</td><td colspan="3"><i>n</i> = 1369</td><td></td></tr><tr><td>Yes</td><td>No</td><td>Don’t know/not sure</td><td>Yes</td><td>No</td><td>Don’t know/not sure</td><td></td></tr><tr><td>Have you heard of HIV or AIDS?</td><td>739 (97.9)</td><td>16 (2.1)</td><td></td><td>1361 (99.4)</td><td>8 (0.6)</td><td></td><td>0.003</td></tr><tr><td colspan="8">Ways of transmitting HIV/AIDS<sup>a</sup></td></tr><tr><td> Can be transmitted by sex with someone who looks healthy</td><td>628 (83.3)</td><td>63 (8.4)</td><td>63 (8.4)</td><td>1084 (79.2)</td><td>122 (8.9)</td><td>162 (11.8)</td><td>0.03</td></tr><tr><td> Can’t be transmitted by mosquito or other insect bites</td><td>480 (63.8)</td><td>173 (23.0)</td><td>100 (13.3)</td><td>638 (46.6)</td><td>435 (31.8)</td><td>295 (21.6)</td><td><0.001</td></tr><tr><td> Can’t be transmitted by bewitchment/curses or supernatural means</td><td>652 (86.6)</td><td>34 (4.5)</td><td>67 (8.9)</td><td>1159 (84.9)</td><td>56 (4.1)</td><td>151 (11.1)</td><td>0.28</td></tr><tr><td> Can’t be transmitted by sharing food with HIV infected person</td><td>656 (87.1)</td><td>36 (4.8)</td><td>61 (8.1)</td><td>1141 (83.4)</td><td>82 (6.0)</td><td>145 (10.6)</td><td>0.03</td></tr><tr><td> Can be transmitted by having sex without condom</td><td>726 (96.6)</td><td>4 (0.5)</td><td>21 (2.8)</td><td>1338 (98.0)</td><td>11 (0.8)</td><td>17 (1.2)</td><td>0.08</td></tr><tr><td colspan="8">Knowledge about PMTCT<sup>a</sup></td></tr><tr><td> HIV can be transmitted to child during pregnancy</td><td>330 (43.7)</td><td>298 (39.5)</td><td>127 (16.8)</td><td>544 (39.7)</td><td>537 (39.2)</td><td>288 (21.0)</td><td>0.08</td></tr><tr><td> HIV can be transmitted to child during delivery</td><td>670 (88.7)</td><td>22 (2.9)</td><td>63 (8.3)</td><td>1265 (92.4)</td><td>34 (2.5)</td><td>70 (5.1)</td><td>0.005</td></tr><tr><td> HIV can be transmitted to child during breastfeeding</td><td>653 (86.5)</td><td>23 (3.1)</td><td>79 (10.5)</td><td>1248 (91.2)</td><td>30 (2.2)</td><td>91 (6.7)</td><td>0.001</td></tr><tr><td>Do you practise any HIV prevention methods?<sup>b</sup></td><td>723 (97.8)</td><td>16 (2.1)</td><td></td><td>1347 (99.0)</td><td>14 (1.0)</td><td></td><td>0.04</td></tr><tr><td colspan="8">HIV prevention practices used<sup>b</sup></td></tr><tr><td> Abstinence</td><td>260 (35.2)</td><td>477 (64.6)</td><td>1 (0.1)</td><td>478 (35.2)</td><td>880 (64.7)</td><td>2 (0.2)</td><td>0.99</td></tr><tr><td> Faithfulness</td><td>510 (69.0)</td><td>226 (30.6)</td><td>3 (0.4)</td><td>1044 (76.7)</td><td>316 (23.2)</td><td>1 (0.1)</td><td><0.001</td></tr><tr><td> Condom use</td><td>368 (49.8)</td><td>371 (50.2)</td><td>0 (0.0)</td><td>262 (19.3)</td><td>1097 (80.7)</td><td>1 (0.1)</td><td><0.001</td></tr><tr><td> Circumcision</td><td>21 (2.9)</td><td>685 (92.8)</td><td>32 (4.3)</td><td>5 (0.4)</td><td>1073 (78.8)</td><td>283 (20.8)</td><td><0.001</td></tr><tr><td> Others</td><td>123 (18.5)</td><td>451 (67.9)</td><td>90 (13.6)</td><td>180 (14.3)</td><td>828 (66.8)</td><td>231 (18.6)</td><td>0.02</td></tr></table> |
f9d0e53fc1c3697b77fdb89b795439470bee437287c96cdc3b0f953257fbd60c.png | simple | <table><tr><td>Doctors</td><td>Organisations/ Designated body</td><td>GMC</td></tr><tr><td>Licensed doctors who are not trainees must:- Have a connection to one organisation (known as a designated body).- Take part in regular appraisal- Collect supporting information for appraisal: 6 types • CPD (annually) • significant events (annually) • review of complaints and complements (as occur) • quality improvement activity • feedback from colleagues • feedback from patients- Reflect on supporting informationAll trainees must:- Have a connection to either a Local Education Training Board or Deanery- Supporting information and discussion of progress and learning needs as generated for curriculum and training programme.</td><td>Organisations are required by the GMC to provide:- a RO new role, responsible for the revalidation recommendation)- an up to date appraisal system and ensure every licensed doctor has a regular appraisal- a sufficient number of trained appraisers- clinical governance systems that can provide supporting information- policies and systems for identifying and responding to concerns about doctors- link with other organisations where doctors work, so information about their practice can be sharedRO makes one of three possible revalidation recommendation to the GMC:- Revalidation- Deferral (request for GMC to provide more time for revalidation decision). Does not affect licence to practise.- Non-engagement (can lose licence)</td><td>As the regulator the GMC is responsible for:- setting guidelines- Making the final revalidation decision based on RO’s recommendation (to revalidate; how much time to provide for deferral and whether to refer to a Fitness to Practise Panel)- Provide an Employer Liaison Service to help responsible officers with revalidation and the management of concerns about doctors</td></tr></table> |
002bfeebe20be2e97fab46b99ce68321afb8972f6d8f131f0c1f5392819d3a23.png | simple | <table><tr><td> </td><td>Small-for-gestational age group (<i>n</i> = 10)</td><td>Appropriate-for-gestational age group (<i>n</i> = 7)</td></tr><tr><td>Age at delivery (years)</td><td>27.3 ± 5.2</td><td>26.4 ± 6.5</td></tr><tr><td>Gestational age at delivery (weeks)</td><td>38.4 ± 1.0</td><td>39.7 ± 0.7</td></tr><tr><td>Birth weight (grams)</td><td>2159 ± 506</td><td>3156 ± 301*</td></tr><tr><td>TGF-<i>β</i>1 levels at 34 weeks (ng/mL)</td><td>32.5 ± 3.2</td><td>39.2 ± 9.8*</td></tr><tr><td>TGF-<i>β</i>1 levels at 38 weeks (ng/mL)</td><td>36.04 ± 4.3</td><td>36.7 ± 7.0</td></tr></table> |
e1e6a11104f08cb81cb18b3b61f25a688630347486a03f83f9b878686752239b.png | simple | <table><tr><td>Indicators</td><td>2006</td><td>2007</td><td>2008</td><td>2009</td><td>2010</td><td>2011</td><td>2012</td></tr><tr><td>Interviewed</td><td>54,369</td><td>54,251</td><td>54,353</td><td>54,367</td><td>54,339</td><td>54,144</td><td>45,448</td></tr><tr><td>Females (%)</td><td>53.9</td><td>53.9</td><td>53.9</td><td>53.9</td><td>53.9</td><td>53.9</td><td>53.9</td></tr><tr><td>Mean age (SD)</td><td>40.1 (16.2)</td><td>40.3 (16.2)</td><td>40.5 (16.2)</td><td>40.8 (16.1)</td><td>40.9 (16.3)</td><td>41.1 (16.3)</td><td>41.3 (16.4)</td></tr><tr><td>0-4 years of schooling (%)</td><td>21.6</td><td>20.4</td><td>19.4</td><td>18.0</td><td>16.8</td><td>17.2</td><td>16.1</td></tr><tr><td>Response rate (%)</td><td>90.9</td><td>92.3</td><td>94.2</td><td>97.0</td><td>97.7</td><td>97.8</td><td>94.1</td></tr></table> |
f0f4582a95cef84b07f442570adc4ebb35829ea87628723507e737496176bf25.png | complex | <table><tr><td>Output variable</td><td>Predictive variables</td><td>R<sup>2</sup></td><td>B(Coef)</td><td>p</td><td>95%CI</td><td>HL<sup>*</sup></td></tr><tr><td rowspan="2">Cardiovascular risk (PDAY)</td><td>Sex</td><td rowspan="2">0.271</td><td>0.090</td><td>< 0.01</td><td>0.044-0.183</td><td rowspan="2">0,939</td></tr><tr><td>Waist circumference</td><td>0.043</td><td>< 0.01</td><td>0.014-0.136</td></tr></table> |
76f67c1340d24d24eee4dfb79ea3284bc6083e819ca6873b75c8188828b09480.png | simple | <table><tr><td>NH<sub>4</sub>NO<sub>3</sub> (g/L)</td><td>Residual sugar (g/L)</td><td>Cell biomass (g/L)</td><td>PMA (g/L)</td><td>Productivity (g/L h)</td><td>Yield (Y<sub>P/X</sub>, g/g)</td><td>Yield (Y<sub>P/S</sub>, g/g)</td></tr><tr><td>0.1</td><td>56.67 ± 0.50</td><td>6.23 ± 0.71</td><td>6.17 ± 0.29</td><td>0.06 ± 0.003</td><td>1.00 ± 0.137</td><td>0.18 ± 0.011</td></tr><tr><td>0.5</td><td>40.77 ± 0.12</td><td>13.09 ± 1.09</td><td>10.86 ± 1.91</td><td>0.09 ± 0.042</td><td>0.85 ± 0.246</td><td>0.25 ± 0.081</td></tr><tr><td>1.0</td><td>24.57 ± 0.31</td><td>17.17 ± 0.77</td><td>14.01 ± 0.04</td><td>0.15 ± 0.000</td><td>0.82 ± 0.037</td><td>0.21 ± 0.000</td></tr><tr><td>2.0</td><td>16.95 ± 1.91</td><td>21.31 ± 3.81</td><td>20.02 ± 2.81</td><td>0.21 ± 0.029</td><td>0.96 ± 0.242</td><td>0.24 ± 0.032</td></tr><tr><td>4.0</td><td>16.70 ± 0.35</td><td>23.55 ± 0.85</td><td>17.31 ± 0.24</td><td>0.18 ± 0.003</td><td>0.74 ± 0.024</td><td>0.24 ± 0.002</td></tr><tr><td>10.0</td><td>14.52 ± 0.58</td><td>24.20 ± 1.96</td><td>16.57 ± 0.90</td><td>0.17 ± 0.009</td><td>0.69 ± 0.081</td><td>0.22 ± 0.013</td></tr></table> |
590c198428ddc9f6b180abebae8488ab3281e9295d50be77ef6ca04af200b07c.png | simple | <table><tr><td>Score cutoff</td><td>Sensitivity</td><td>Specificity</td><td>PPV <sup>b</sup></td><td>NPV <sup>b</sup></td><td>LR+</td><td>LR-</td></tr><tr><td>≧1</td><td>0.96</td><td>0.13</td><td>0.37</td><td>0.86</td><td>1.10</td><td>0.31</td></tr><tr><td>≧2</td><td>0.96</td><td>0.18</td><td>0.38</td><td>0.89</td><td>1.16</td><td>0.23</td></tr><tr><td>≧3</td><td>0.75</td><td>0.69</td><td>0.56</td><td>0.84</td><td>2.41</td><td>0.36</td></tr><tr><td>≧4</td><td>0.63</td><td>0.78</td><td>0.60</td><td>0.80</td><td>2.81</td><td>0.48</td></tr><tr><td>5</td><td>0.21</td><td>1.00</td><td>1.00</td><td>0.70</td><td><sup>a</sup></td><td>0.79</td></tr></table> |
5a868c1005f03ca9954934b629f91947975c8174df2b65fe92f835129f063d44.png | simple | <table><tr><td> </td><td>Before 14 days</td><td>At/later 14 days</td><td>p-value</td></tr><tr><td>N</td><td>150</td><td>26</td><td> </td></tr><tr><td>Mean age, years (SD)</td><td>51.8 (12.7)</td><td>52.6 (15.5)</td><td>NS</td></tr><tr><td>First transplantation</td><td>138/150 (92.0%)</td><td>24/26 (92.3%)</td><td>NS</td></tr><tr><td>Mode of dialysis, hemodialysis</td><td>95 (22.9%)</td><td>19 (73.1%)</td><td>NS</td></tr><tr><td>Mean time on dialysis, days (SD)</td><td>842 (614.1)</td><td>899 (410.2)</td><td>NS</td></tr><tr><td>Donor age, years (SD)</td><td>51.0 (14.3)</td><td>56.3 (SD 10.9)</td><td>NS</td></tr><tr><td>CIT, hours (SD)</td><td>21.7 (3.7)</td><td>23.2 (3.4)</td><td>NS</td></tr><tr><td>ECD donor status</td><td>53 (35.3%)</td><td>16 (61.5%)</td><td>0.008</td></tr><tr><td>Day 1 creatinine, μmol/L (SD)</td><td>508 (219.4)</td><td>676 (224.6)</td><td>0.002</td></tr><tr><td>Day 1 urine output, mL (SD)</td><td>1983 (1594.0)</td><td>392 (446.6)</td><td><0.0001</td></tr><tr><td>1-year graft survival</td><td>148 (98.7%)</td><td>19/26 (73.1%)</td><td><0.0001</td></tr><tr><td>1-year patient survival</td><td>149 (99.3%)</td><td>25 (96.2%)</td><td>NS</td></tr></table> |
51fb75399d91236187dbbeacbe49c1cbb629716bb8ce2c2ac189dad02c13ed9f.png | complex | <table><tr><td rowspan="2"> </td><td>Without CKD<sup>a</sup></td><td> </td><td> </td><td>With CKD</td><td> </td><td> </td></tr><tr><td>Variables</td><td>BMI 18.5-24.9 (N = 1398)</td><td>BMI 25–29.9 (N = 2314)</td><td>BMI ≥ 30 (N = 1548)</td><td>BMI 18.5-24.9 (N = 379)</td><td>BMI 25–29.9 (N = 418)</td><td>BMI ≥ 30 (N = 152)</td></tr><tr><td>No. of person-years</td><td>12329</td><td>17274</td><td>9936</td><td>2094</td><td>4748</td><td>3834</td></tr><tr><td>No. of incidence CVD</td><td>64</td><td>135</td><td>82</td><td>30</td><td>78</td><td>50</td></tr><tr><td>Incidence rate</td><td>52</td><td>78</td><td>82</td><td>143</td><td>164</td><td>130</td></tr><tr><td colspan="7">(per 10,000 person-years)</td></tr><tr><td>Unadjusted HRs</td><td>1</td><td>1.52 (1.13-2.06)*</td><td>1.60 (1.15-2.23)*</td><td>2.94 (1.90-4.55)*</td><td>3.36 (2.41-4.67)*</td><td>2.64 (1.82-3.83)*</td></tr><tr><td colspan="7">Adjusted HRs</td></tr><tr><td>Model 1†</td><td>1</td><td>1.65 (1.22-2.22)*</td><td>2.03 (1.45-2.83)*</td><td>1.45(0.92-2.27)</td><td>2.02 (1.42-2.85)*</td><td>2.11 (1.42-3.12)*</td></tr><tr><td>Model 2‡</td><td>1</td><td>1.24 (0.86-1.79)</td><td>1.12 (0.62-1.99)</td><td>1.41(0.90-2.22)</td><td>1.43 (0.95-2.15)</td><td>1.08 (0.59-1.99)</td></tr></table> |
07d16546d641b79c1f44b8f65420e54ada9f9ec52d1b131a716db94538650428.png | complex | <table><tr><td></td><td colspan="2">Skin Prick</td><td colspan="2">sIgE</td><td colspan="2">APT</td><td colspan="2">History</td></tr><tr><td></td><td>A</td><td>B</td><td>A</td><td>B</td><td>A</td><td>B</td><td>A</td><td>B</td></tr><tr><td><i>D. pteronyssinus </i></td><td>59</td><td>56</td><td>56</td><td>56</td><td>34</td><td>39</td><td>52</td><td>34</td></tr><tr><td>Cat dander</td><td>54</td><td>44</td><td>49</td><td>46</td><td>12</td><td>10</td><td>23</td><td>30</td></tr><tr><td>Grass pollen</td><td>65</td><td>57</td><td>75</td><td>59</td><td>18</td><td>15</td><td>33</td><td>31</td></tr><tr><td>Birch pollen</td><td>65</td><td>49</td><td>65</td><td>53</td><td>11</td><td>17</td><td>13</td><td>20</td></tr></table> |
f990f2636d05661b59ca1ad4621da0a6b172f5225f71e35d1fe789e218d572d1.png | simple | <table><tr><td></td><td>ZA group (<i>n</i> = 27)</td><td>Control group (<i>n</i> = 27)</td></tr><tr><td>Age (years), mean (SD)</td><td>60.1 (11.7)</td><td>59.4 (13.3)</td></tr><tr><td>Sex, female:male</td><td>15:12</td><td>14:13</td></tr><tr><td>BMI (kg/m<sup>2</sup>), mean (SD)</td><td>26 (4)</td><td>25 (5)</td></tr><tr><td>Operation time (minutes), mean (SD)<sup>a</sup></td><td>118 (27)</td><td>103 (17)</td></tr><tr><td>Blood loss (mL), mean (SD)</td><td>502 (312)</td><td>387 (162)</td></tr><tr><td>Diagnosis (OA/AVN)</td><td>16/11</td><td>17/10</td></tr></table> |
c3537b0d19e3710915f303adf519ae4b7d99d1d990175791d644654a17c8b249.png | simple | <table><tr><td>S. No</td><td>Water soluble</td><td>Exchangeable</td><td>Carbonate & sulfide</td><td>Reducible fraction</td><td>Oxidisable fraction</td><td>Residual fraction</td><td>Total Cr</td></tr><tr><td>1a</td><td>51.85 ± 0.34</td><td>29.62 ± 0.20</td><td>17.28 ± 0.30</td><td>98.76 ± 0.92</td><td>55.55 ± 0.32</td><td>64.81 ± 0.67</td><td>317.9 ± 2.1</td></tr><tr><td>1b</td><td>83.29 ± 0.61</td><td>36.74 ± 0.60</td><td>14.69 ± 0.40</td><td>102.8 ± 1.20</td><td>52.05 ± 0.43</td><td>42.87 ± 0.41</td><td>332.5 ± 2.8</td></tr><tr><td>1c</td><td>44.48 ± 0.21</td><td>23.47 ± 0.05</td><td>13.59 ± 0.06</td><td>98.86 ± 0.58</td><td>49.43 ± 0.17</td><td>24.70 ± 0.04</td><td>254.6 ± 1.9</td></tr><tr><td>2a</td><td>80.29 ± 0.42</td><td>29.29 ± 0.15</td><td>13.38 ± 0.22</td><td>105.8 ± 0.73</td><td>42.57 ± 0.21</td><td>36.49 ± 0.35</td><td>307.8 ± 2.7</td></tr><tr><td>2b</td><td>49.11 ± 0.33</td><td>36.83 ± 0.30</td><td>19.64 ± 0.33</td><td>115.4 ± 0.72</td><td>30.69 ± 0.41</td><td>39.90 ± 0.06</td><td>291.6 ± 0.9</td></tr><tr><td>2c</td><td>81.04 ± 0.61</td><td>12.27 ± 0.60</td><td>18.41 ± 0.16</td><td>103.1 ± 0.80</td><td>36.83 ± 0.33</td><td>61.39 ± 0.61</td><td>313.1 ± 2.1</td></tr><tr><td>3a</td><td>57.09 ± 0.23</td><td>35.98 ± 0.45</td><td>17.36 ± 0.23</td><td>107.9 ± 0.90</td><td>34.11 ± 0.31</td><td>68.23 ± 0.63</td><td>327.7 ± 1.7</td></tr><tr><td>3b</td><td>34.58 ± 0.21</td><td>44.33 ± 0.21</td><td>16.00 ± 0.31</td><td>108.3 ± 0.32</td><td>36.94 ± 0.42</td><td>36.94 ± 0.32</td><td>277.1 ± 1.1</td></tr><tr><td>3c</td><td>22.55 ± 0.09</td><td>45.11 ± 0.38</td><td>42.60 ± 0.62</td><td>112.7 ± 0.56</td><td>43.85 ± 0.26</td><td>25.06 ± 0.12</td><td>291.9 ± 0.7</td></tr><tr><td>4a</td><td>38.58 ± 0.08</td><td>13.78 ± 0.30</td><td>16.50 ± 0.24</td><td>26.18 ± 0.32</td><td>44.78 ± 0.51</td><td>31.00 ± 0.05</td><td>170.9 ± 0.8</td></tr><tr><td>4b</td><td>47.52 ± 0.11</td><td>32.51 ± 0.80</td><td>27.59 ± 0.14</td><td>12.50 ± 0.04</td><td>28.13 ± 0.44</td><td>56.29 ± 0.22</td><td>204.5 ± 1.3</td></tr><tr><td>4c</td><td>33.46 ± 0.05</td><td>11.15 ± 0.10</td><td>26.77 ± 0.72</td><td>94.82 ± 0.71</td><td>25.93 ± 0.07</td><td>25.10 ± 0.80</td><td>217.3 ± 1.4</td></tr><tr><td>5a</td><td>44.24 ± 0.53</td><td>34.41 ± 0.70</td><td>57.76 ± 0.43</td><td>110.7 ± 0.48</td><td>30.72 ± 0.62</td><td>18.43 ± 0.22</td><td>296.2 ± 1.5</td></tr><tr><td>5b</td><td>32.08 ± 0.33</td><td>34.55 ± 0.32</td><td>25.91 ± 0.41</td><td>103.7 ± 0.83</td><td>49.35 ± 0.70</td><td> 2.77 ± 0.01</td><td>240.3 ± 2.0</td></tr><tr><td>5c</td><td>44.05 ± 0.42</td><td>31.81 ± 0.27</td><td>14.68 ± 0.32</td><td>99.11 ± 0.37</td><td>30.59 ± 0.17</td><td>48.94 ± 0.42</td><td>269.2 ± 0.7</td></tr><tr><td>6a</td><td>37.34 ± 0.06</td><td> 9.03 ± 0.20</td><td>25.20 ± 0.13</td><td>17.01 ± 0.03</td><td>42.00 ± 0.51</td><td>35.00 ± 0.04</td><td>218.9 ± 1.4</td></tr><tr><td>6b</td><td>76.20 ± 0.23</td><td>29.49 ± 0.61</td><td>40.56 ± 0.73</td><td>307.2 ± 1.31</td><td>67.60 ± 0.48</td><td>30.70 ± 0.18</td><td>551.9 ± 2.3</td></tr><tr><td>6c</td><td>116.7 ± 0.92</td><td>26.20 ± 0.39</td><td>17.86 ± 0.44</td><td>78.60 ± 0.43</td><td>29.71 ± 0.32</td><td>29.77 ± 0.27</td><td>298.9 ± 1.7</td></tr><tr><td>7a</td><td>36.63 ± 0.07</td><td>29.37 ± 0.26</td><td>40.30 ± 0.72</td><td>102.5 ± 0.72</td><td>30.53 ± 0.05</td><td>39.69 ± 0.62</td><td>279.1 ± 1.5</td></tr><tr><td>7b</td><td>32.40 ± 0.05</td><td>44.86 ± 0.32</td><td>29.91 ± 0.51</td><td>112.1 ± 0.61</td><td>37.38 ± 0.44</td><td>24.90 ± 0.20</td><td>281.6 ± 1.2</td></tr><tr><td>7c</td><td>50.69 ± 0.61</td><td>34.61 ± 0.27</td><td>17.30 ± 0.04</td><td>92.72 ± 0.47</td><td>28.43 ± 0.37</td><td>40.18 ± 0.51</td><td>264.0 ± 1.7</td></tr><tr><td>8a</td><td>62.98 ± 0.45</td><td>53.29 ± 0.42</td><td>25.43 ± 0.64</td><td>17.25 ± 0.04</td><td>33.30 ± 0.41</td><td>27.25 ± 0.31</td><td>272.3 ± 1.1</td></tr><tr><td>8b</td><td>36.37 ± 0.34</td><td>12.12 ± 0.33</td><td>13.33 ± 0.06</td><td>12.12 ± 0.03</td><td>48.49 ± 0.60</td><td>16.62 ± 0.05</td><td>183.1 ± 0.6</td></tr><tr><td>8c</td><td>29.62 ± 0.21</td><td>24.69 ± 0.50</td><td>59.25 ± 0.76</td><td>29.62 ± 0.12</td><td>37.03 ± 0.42</td><td>21.60 ± 0.03</td><td>201.8 ± 0.9</td></tr><tr><td>9a</td><td>27.03 ± 0.13</td><td>49.23 ± 0.52</td><td>35.15 ± 0.04</td><td>81.24 ± 0.64</td><td>55.39 ± 0.42</td><td>52.31 ± 0.71</td><td>303.4 ± 1.0</td></tr><tr><td>9b</td><td>42.22 ± 0.37</td><td>37.25 ± 0.24</td><td>24.83 ± 0.11</td><td>99.35 ± 0.83</td><td>31.04 ± 0.53</td><td>27.94 ± 0.50</td><td>262.7 ± 0.5</td></tr><tr><td>9c</td><td>287.2 ± 2.10</td><td>12.04 ± 0.10</td><td>66.26 ± 0.63</td><td>93.97 ± 0.53</td><td>33.13 ± 0.04</td><td>21.08 ± 0.07</td><td>515.7 ± 1.7</td></tr><tr><td>10a</td><td>46.29 ± 0.70</td><td>37.03 ± 0.70</td><td>27.77 ± 0.32</td><td>115.7 ± 0.74</td><td>57.89 ± 0.08</td><td>57.87 ± 0.53</td><td>342.6 ± 1.4</td></tr><tr><td>10b</td><td>33.80 ± 0.40</td><td>31.38 ± 0.30</td><td>26.55 ± 0.06</td><td>96.75 ± 0.44</td><td>36.21 ± 0.33</td><td>51.30 ± 0.42</td><td>275.8 ± 1.3</td></tr><tr><td>10c</td><td>27.39 ± 0.53</td><td>48.99 ± 0.44</td><td>34.29 ± 0.16</td><td>17.54 ± 0.34</td><td>42.87 ± 0.51</td><td>51.31 ± 0.87</td><td>180.0 ± 0.7</td></tr></table> |
8a1fd4708ffcbe346aa51679a8839c28ff93bb8d53add240323403e25f8d8dbe.png | complex | <table><tr><td>Genus</td><td>Individuals</td><td>Assemblages</td><td>Mean vector (μ)</td><td>Length of mean vector (r)</td><td>Concentration</td><td>Circular variance</td><td>Circular standard deviation</td><td>Rayleigh's Z (<i>P</i>)</td><td>Rao's spacing test (<i>P</i>)</td></tr><tr><td colspan="10">Astroblepidae</td></tr><tr><td> <i>Astroblepus*</i></td><td>6</td><td>3</td><td>52°</td><td>0.74</td><td>1.27</td><td>0.26</td><td>45°</td><td>0.031</td><td>< 0.05</td></tr><tr><td colspan="10">Loricariidae</td></tr><tr><td colspan="10">Hypoptopomatinae</td></tr><tr><td> <i>Hypoptopoma</i></td><td>7</td><td>2</td><td>274°</td><td>0.22</td><td>0.00</td><td>0.78</td><td>99°</td><td>0.722</td><td>0.90 > <i>P</i> > 0.50</td></tr><tr><td colspan="10">Hypostominae</td></tr><tr><td colspan="10">Ancistrini</td></tr><tr><td> <i>Ancistrus*</i></td><td>44</td><td>9</td><td>192°</td><td>0.45</td><td>0.99</td><td>0.56</td><td>73°</td><td>0.000</td><td>< 0.01</td></tr><tr><td> <i>Baryancistrus</i>†</td><td>23</td><td>4</td><td>14°</td><td>0.32</td><td>0.67</td><td>0.68</td><td>87°</td><td>0.098</td><td>< 0.01</td></tr><tr><td> <i>Chaetostoma*</i></td><td>44</td><td>5</td><td>179°</td><td>0.68</td><td>1.88</td><td>0.32</td><td>51°</td><td>0.000</td><td>< 0.01</td></tr><tr><td> <i>Dekeyseria</i></td><td>2</td><td>1</td><td>271°</td><td>1.00</td><td>20.46</td><td>0.00</td><td>4°</td><td>0.139</td><td>–</td></tr><tr><td> <i>Etsaputu</i>*</td><td>12</td><td>2</td><td>120°</td><td>0.59</td><td>1.36</td><td>0.41</td><td>59°</td><td>0.012</td><td>< 0.01</td></tr><tr><td> <i>Hemiancistrus*</i></td><td>51</td><td>5</td><td>60°</td><td>0.46</td><td>1.03</td><td>0.54</td><td>72°</td><td>0.000</td><td>< 0.01</td></tr><tr><td> <i>Hopliancistrus</i></td><td>5</td><td>1</td><td>86°</td><td>0.31</td><td>0.02</td><td>0.69</td><td>88°</td><td>0.650</td><td>0.50 > <i>P</i> > 0.10</td></tr><tr><td> <i>Hypancistrus*</i></td><td>25</td><td>4</td><td>157°</td><td>0.88</td><td>4.62</td><td>0.12</td><td>28°</td><td>0.000</td><td>< 0.01</td></tr><tr><td> <i>Lasiancistrus*</i></td><td>17</td><td>4</td><td>174°</td><td>0.57</td><td>1.38</td><td>0.43</td><td>61°</td><td>0.003</td><td>< 0.05</td></tr><tr><td> <i>Leporacanthicus*</i></td><td>12</td><td>2</td><td>136°</td><td>0.68</td><td>1.82</td><td>0.32</td><td>50°</td><td>0.002</td><td>< 0.01</td></tr><tr><td> <i>Lithoxus</i></td><td>2</td><td>1</td><td>69°</td><td>0.97</td><td>1.90</td><td>0.03</td><td>13°</td><td>0.158</td><td>–</td></tr><tr><td> <i>Panaque*</i></td><td>41</td><td>5</td><td>343°</td><td>0.34</td><td>0.72</td><td>0.66</td><td>84°</td><td>0.008</td><td>< 0.01</td></tr><tr><td> <i>Peckoltia*</i></td><td>15</td><td>5</td><td>113°</td><td>0.64</td><td>1.59</td><td>0.36</td><td>55°</td><td>0.001</td><td>< 0.01</td></tr><tr><td> <i>Pseudacanthicus</i></td><td>1</td><td>1</td><td>110°</td><td>1.00</td><td>–</td><td>–</td><td>–</td><td>0.512</td><td>–</td></tr><tr><td> <i>Pseudancistrus*</i></td><td>32</td><td>4</td><td>53°</td><td>0.75</td><td>2.34</td><td>0.25</td><td>44°</td><td>0.000</td><td>< 0.01</td></tr><tr><td> <i>Pseudolithoxus*</i></td><td>24</td><td>3</td><td>108°</td><td>0.50</td><td>1.16</td><td>0.50</td><td>67°</td><td>0.002</td><td>0.10 > <i>P</i> > 0.05</td></tr><tr><td> <i>Scobinancistrus</i></td><td>2</td><td>1</td><td>149°</td><td>0.99</td><td>6.29</td><td>0.01</td><td>7°</td><td>0.143</td><td>–</td></tr><tr><td> <i>Spectracanthicus</i></td><td>4</td><td>1</td><td>86°</td><td>0.69</td><td>1.72</td><td>0.31</td><td>49°</td><td>0.148</td><td>0.50 > <i>P</i> > 0.10</td></tr><tr><td colspan="10">Hypostomini</td></tr><tr><td> <i>H. cochliodon</i> grp.†</td><td>30</td><td>7</td><td>329°</td><td>0.30</td><td>0.63</td><td>0.70</td><td>89°</td><td>0.063</td><td>< 0.05</td></tr><tr><td> <i>H. plecostomus</i> grp.*</td><td>97</td><td>14</td><td>302°</td><td>0.19</td><td>0.39</td><td>0.81</td><td>104°</td><td>0.028</td><td>< 0.05</td></tr><tr><td colspan="10">Pterygoplichthyini</td></tr><tr><td> <i>Pterygoplichthys</i></td><td>2</td><td>2</td><td>254°</td><td>0.73</td><td>0.22</td><td>0.27</td><td>45°</td><td>0.396</td><td>–</td></tr><tr><td colspan="10">Loricariinae</td></tr><tr><td colspan="10">Farlowellini</td></tr><tr><td> <i>Farlowella</i></td><td>4</td><td>3</td><td>251°</td><td>0.51</td><td>0.77</td><td>0.49</td><td>66°</td><td>0.376</td><td>0.50 > <i>P</i> > 0.10</td></tr><tr><td colspan="10">Harttiini</td></tr><tr><td> <i>Harttia*</i></td><td>14</td><td>2</td><td>1°</td><td>0.98</td><td>18.40</td><td>0.02</td><td>12°</td><td>0.000</td><td>< 0.01</td></tr><tr><td> <i>Lamontichthys*</i></td><td>10</td><td>1</td><td>174°</td><td>0.97</td><td>12.64</td><td>0.03</td><td>14°</td><td>0.000</td><td>< 0.01</td></tr><tr><td> <i>Sturisoma*</i></td><td>16</td><td>2</td><td>187°</td><td>0.65</td><td>1.74</td><td>0.35</td><td>53°</td><td>0.001</td><td>< 0.01</td></tr><tr><td colspan="10">Loricariini</td></tr><tr><td> <i>Limatulichthys</i></td><td>20</td><td>3</td><td>304°</td><td>0.25</td><td>0.51</td><td>0.75</td><td>96°</td><td>0.299</td><td>< 0.01</td></tr><tr><td> <i>Loricaria</i></td><td>10</td><td>5</td><td>339°</td><td>0.36</td><td>0.50</td><td>0.64</td><td>82°</td><td>0.289</td><td>0.90 > <i>P</i> > 0.50</td></tr><tr><td> <i>Loricariichthys</i></td><td>5</td><td>2</td><td>6°</td><td>0.55</td><td>1.01</td><td>0.45</td><td>63°</td><td>0.231</td><td>0.50 > <i>P</i> > 0.10</td></tr><tr><td> <i>Pseudoloricaria</i>†</td><td>3</td><td>1</td><td>331°</td><td>0.93</td><td>2.01</td><td>0.07</td><td>22°</td><td>0.062</td><td>–</td></tr><tr><td> <i>Rineloricaria*</i></td><td>52</td><td>5</td><td>313°</td><td>0.26</td><td>0.54</td><td>0.74</td><td>94°</td><td>0.030</td><td>< 0.01</td></tr><tr><td> <i>Spatuloricaria</i></td><td>17</td><td>6</td><td>90°</td><td>0.21</td><td>0.42</td><td>0.80</td><td>102°</td><td>0.497</td><td>< 0.01</td></tr></table> |
a2073fdd9536f481d0e742116295417d8794a567d82b5454fecab901fb761342.png | simple | <table><tr><td></td><td>Sodium ibuprofen(geometric means)</td><td>Ibuprofen/ poloxamer(geometric means)</td><td>Standard ibuprofen(geometric means)</td><td>Ratio (%)sodium ibuprofen/ standard ibuprofen</td><td>90% confidence interval</td><td>Ratio (%)ibuprofen/ poloxamer/ standard ibuprofen</td><td>90% confidence interval</td></tr><tr><td>AUC 0-0.08 (μg/h/mL)</td><td>Not estimated</td><td>Not estimated</td><td>Not estimated</td><td>Not estimated</td><td>Not estimated</td><td>Not estimated</td><td>Not estimated</td></tr><tr><td>AUC 0-0.17 (μg/h/mL)</td><td>0.06</td><td>0.03</td><td>0.03</td><td>217.32</td><td>95.29-495.60</td><td>118.65</td><td>49.21-286.08</td></tr><tr><td>AUC 0-0.25 (μg/h/mL)</td><td>0.49</td><td>0.13</td><td>0.09</td><td>529.77</td><td>262.01-1071.16</td><td>138.56</td><td>68.53-280.17</td></tr><tr><td>AUC 0-0.33 (μg/h/mL)</td><td>1.61</td><td>0.50</td><td>0.18</td><td>905.93</td><td>462.33-1775.19</td><td>278.80</td><td>142.28-546.31</td></tr><tr><td>AUC 0-0.42 (μg/h/mL)</td><td>3.57</td><td>1.24</td><td>0.55</td><td>644.02</td><td>362.66-1143.69</td><td>224.33</td><td>126.32-398.37</td></tr><tr><td>AUC 0-0.50 (μg/h/mL)</td><td>6.09</td><td>2.34</td><td>1.31</td><td>466.40</td><td>287.78-755.90</td><td>179.01</td><td>110.45-290.13</td></tr><tr><td>AUC 0-0.58 (μg/h/mL)</td><td>8.99</td><td>3.72</td><td>2.30</td><td>390.44</td><td>251.21-606.85</td><td>161.71</td><td>104.04-251.34</td></tr><tr><td>AUC 0-0.67 (μg/h/mL)</td><td>12.08</td><td>5.39</td><td>3.52</td><td>343.55</td><td>227.18-519.53</td><td>153.34</td><td>101.40-231.89</td></tr><tr><td>AUC 0-0.83 (μg/h/mL)</td><td>18.03</td><td>9.24</td><td>6.36</td><td>283.49</td><td>195.09-411.95</td><td>145.21</td><td>99.93-211.00</td></tr><tr><td>AUC 0-1.00 (μg/h/mL)</td><td>23.71</td><td>13.65</td><td>9.54</td><td>248.48</td><td>176.57-349.68</td><td>143.08</td><td>101.67-201.35</td></tr></table> |
b0615727e9559f8873551394ca4eecba28cb8828e365043294075b9f77a39913.png | simple | <table><tr><td>Activity</td><td>A1</td><td>A2</td><td>A3</td><td>A4</td><td>A5</td><td>A6</td><td>A7</td></tr><tr><td>A1</td><td>30</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>A2</td><td>1</td><td>29</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>A3</td><td>0</td><td>0</td><td>30</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>A4</td><td>0</td><td>0</td><td>0</td><td>30</td><td>0</td><td>0</td><td>0</td></tr><tr><td>A5</td><td>0</td><td>0</td><td>0</td><td>0</td><td>19</td><td>7</td><td>4</td></tr><tr><td>A6</td><td>0</td><td>0</td><td>0</td><td>0</td><td>7</td><td>15</td><td>8</td></tr><tr><td>A7</td><td>0</td><td>0</td><td>0</td><td>0</td><td>4</td><td>6</td><td>20</td></tr></table> |
39a0877f2546bfef74b380db9c01f0332fb67e3875204bc78fbe4e4bfaf71adc.png | simple | <table><tr><td>Diagnosis</td><td>anti-MAP1Abs+</td><td>anti-MAP1Abs−</td><td>anti-MAP2Abs+</td><td>anti-MAP2Abs−</td><td>IS900+</td><td>IS900−</td></tr><tr><td>CD</td><td>13 (46%)</td><td>15 (54%)</td><td>11 (39%)</td><td>17 (61%)</td><td>18 (64%)</td><td>10 (36%)</td></tr><tr><td>UC</td><td>1 (3%)</td><td>29 (97%)</td><td>5 (16.7%)</td><td>25 (83.3%)</td><td>10 (33%)</td><td>20 (67%)</td></tr><tr><td>nIBD</td><td>3 (5%)</td><td>59 (95%)</td><td>4 (6%)</td><td>58 (94%)</td><td>7 (9.7%)</td><td>55 (90.3%)</td></tr></table> |
c242ac653653a214e05a7e9f820b84091520536388803879aaaba4d691570ed4.png | simple | <table><tr><td>RBM, um<sup>b</sup></td><td>RBM, um<sup>c</sup></td><td>ASM% large AW</td><td>ASM% small AW</td><td>T-cell<sup>a</sup></td><td>B- cell</td><td>MF</td><td>Mast</td><td>Eos</td><td>CD15</td><td>PDC</td><td>Mucus large AW (0–3)</td><td>Mucus small AW (0–3)</td></tr><tr><td>Cases</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>2,8</td><td>4,4</td><td>13</td><td>11</td><td>121</td><td>118</td><td>431</td><td>129</td><td>27</td><td>23</td><td>0</td><td>2,5</td><td>1</td></tr><tr><td>5,6</td><td>5,6</td><td>29</td><td>17</td><td>309</td><td>30</td><td>345</td><td>353</td><td>65</td><td>140</td><td>4</td><td>2</td><td>1</td></tr><tr><td>2,3</td><td>3,4</td><td>7</td><td>9</td><td>1097</td><td>560</td><td>875</td><td>154</td><td>1240</td><td>659</td><td>100</td><td>3</td><td>1</td></tr><tr><td>4,0</td><td>3,9</td><td>9</td><td>17</td><td>297</td><td>64</td><td>342</td><td>149</td><td>77</td><td>80</td><td>4</td><td>2</td><td>1</td></tr><tr><td>6,9</td><td>6,3</td><td>15</td><td>20</td><td>191</td><td>49</td><td>455</td><td>92</td><td>240</td><td>140</td><td>20</td><td>3</td><td>2</td></tr><tr><td>5,8</td><td>6,2</td><td>20</td><td>14</td><td>393</td><td>87</td><td>300</td><td>113</td><td>653</td><td>73</td><td>80</td><td>2</td><td>1</td></tr><tr><td>6,4</td><td>5,7</td><td>28</td><td>14</td><td>521</td><td>19</td><td>239</td><td>106</td><td>360</td><td>87</td><td>20</td><td>3</td><td>0</td></tr><tr><td>3,4</td><td>4,6</td><td>12</td><td>8</td><td>508</td><td>225</td><td>500</td><td>149</td><td>20</td><td>813</td><td>24</td><td>2</td><td>1</td></tr><tr><td>6,4</td><td>4,7</td><td>14</td><td>18</td><td>421</td><td>443</td><td>1133</td><td>153</td><td>320</td><td>107</td><td>20</td><td>3</td><td>1</td></tr><tr><td>4,8</td><td>5</td><td>10</td><td>NA</td><td>166</td><td>51</td><td>320</td><td>151</td><td>700</td><td>140</td><td>14</td><td>3</td><td>1</td></tr><tr><td>6,6</td><td>6,4</td><td>17</td><td>13</td><td>150</td><td>35</td><td>161</td><td>79</td><td>1</td><td>9</td><td>20</td><td>3</td><td>2,5</td></tr><tr><td>6,2</td><td>5,6</td><td>35</td><td>19</td><td>427</td><td>194</td><td>520</td><td>146</td><td>467</td><td>447</td><td>40</td><td>2</td><td>1</td></tr><tr><td>Controls</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>2,3</td><td>3,8</td><td>6</td><td>6</td><td>NA</td><td>22</td><td>158</td><td>140</td><td>0</td><td>640</td><td>0</td><td>0</td><td>0</td></tr><tr><td>3,1</td><td>4,9</td><td>16</td><td>14</td><td>454</td><td>29</td><td>184</td><td>248</td><td>0</td><td>147</td><td>0</td><td>1</td><td>0</td></tr><tr><td>1,7</td><td>3,3</td><td>16</td><td>22</td><td>257</td><td>25</td><td>219</td><td>169</td><td>0</td><td>73</td><td>12</td><td>0</td><td>0</td></tr><tr><td>3,2</td><td>3,6</td><td>18</td><td>17</td><td>487</td><td>51</td><td>204</td><td>95</td><td>6</td><td>47</td><td>4</td><td>1</td><td>0</td></tr><tr><td>1,7</td><td>2,6</td><td>14</td><td>9</td><td>400</td><td>81</td><td>167</td><td>131</td><td>12</td><td>320</td><td>8</td><td>1</td><td>0</td></tr><tr><td>2,8</td><td>3,4</td><td>14</td><td>11</td><td>450</td><td>48</td><td>188</td><td>187</td><td>0</td><td>347</td><td>4</td><td>0</td><td>0</td></tr><tr><td>1,8</td><td>2,4</td><td>11</td><td>14</td><td>68</td><td>12</td><td>157</td><td>65</td><td>0</td><td>113</td><td>12</td><td>1</td><td>0</td></tr><tr><td>2,4</td><td>3,3</td><td>NA</td><td>NA</td><td>325</td><td>NA</td><td>144</td><td>NA</td><td>0</td><td>120</td><td>4</td><td>0</td><td>0</td></tr></table> |
459c55c9ee23139c3f65bf8d3855b1d36d215523cdac479f191173d0b897806f.png | simple | <table><tr><td>Mouse</td><td>Number</td><td>Rate</td><td>Theoretical rate</td><td>Theoretical value</td><td>χ<sup>2</sup> test</td></tr><tr><td>Total</td><td>657</td><td>—</td><td>—</td><td>—</td><td>—</td></tr><tr><td>WT</td><td>153</td><td>1</td><td>1</td><td>164.25</td><td></td></tr><tr><td>Heterozygous</td><td>330</td><td>2.06</td><td>2</td><td>328.5</td><td></td></tr><tr><td>KO</td><td>174</td><td>0.98</td><td>1</td><td>164.25</td><td>0.50759</td></tr></table> |
fd48ae850a9daa8e2fb71f51c466addc6ba954b32064e8f6aeace63beaa04451.png | simple | <table><tr><td>Density Measure</td><td>Confirmed Spn Cases<sup>a</sup></td><td>RSV+ Cases<sup>b</sup></td><td>Controls Targeted for CRP Testing<sup>c</sup></td><td>Confirmed Non- Spn Bacterial Cases<sup>d</sup></td></tr><tr><td>NP/OP PCR Spn density</td><td>(n = 36)</td><td>(n = 858)</td><td>(n = 597)</td><td>(n = 79)</td></tr><tr><td> NP/OP PCR density > 10<sup>6.9</sup> copies/mL<sup>e</sup> alone</td><td>21 (58.3)</td><td>109 (12.7)</td><td>73 (12.2)</td><td>20 (25.3)</td></tr><tr><td> + CRP ≥40 mg/L</td><td>17 (47.2)</td><td>33 (3.9)</td><td>3 (0.5)</td><td>17 (21.5)</td></tr><tr><td> + CRP ≥100 mg/L</td><td>15 (41.7)</td><td>8 (0.9)</td><td>0 (0.0)</td><td>14 (17.7)</td></tr><tr><td>Whole-blood PCR Spn density</td><td>(n = 35)</td><td>(n = 847)</td><td>(n = 597)</td><td>(n = 78)</td></tr><tr><td> Density >10<sup>2.2</sup> copies/mL<sup>e</sup> alone</td><td>18 (51.4)</td><td>19 (2.2)</td><td>119 (19.9)</td><td>4 (5.1)</td></tr><tr><td> + CRP ≥40 mg/L</td><td>17 (48.6)</td><td>3 (0.4)</td><td>5 (0.8)</td><td>3 (3.9)</td></tr><tr><td> + CRP ≥100 mg/L</td><td>16 (45.7)</td><td>1 (0.1)</td><td>1 (0.2)</td><td>1 (1.3)</td></tr><tr><td>NP/OP PCR Spn density <i>or</i> whole-blood PCR Spn density</td><td>(n = 34)</td><td>(n = 835)</td><td>(n = 593)</td><td>(n = 77)</td></tr><tr><td> (NP/OP density >10<sup>6.9</sup> copies/mL <i>or</i> whole-blood density >10<sup>2.2</sup> copies/mL)<sup>e</sup> alone</td><td>27 (79.4)</td><td>126 (15.1)</td><td>179 (30.2)</td><td>23 (29.9)</td></tr><tr><td> + CRP ≥40 mg/L</td><td>23 (67.7)</td><td>35 (4.2)</td><td>8 (1.4)</td><td>19 (24.7)</td></tr><tr><td> + CRP ≥100 mg/L</td><td>21 (61.8)</td><td>9 (1.1)</td><td>1 (0.2)</td><td>15 (19.5)</td></tr><tr><td>NP/OP PCR Spn density <i>and</i> whole-blood PCR Spn density</td><td>(n = 37)</td><td>(n = 870)</td><td>(n = 601)</td><td>(n = 80)</td></tr><tr><td> (NP/OP density >10<sup>6.9</sup> copies/mL <i>and</i> whole-blood density >10<sup>2.2</sup> copies/mL)<sup>e</sup> alone</td><td>12 (32.4)</td><td>2 (0.2)</td><td>13 (2.2)</td><td>1 (1.3)</td></tr><tr><td> + CRP ≥40 mg/L</td><td>11 (29.7)</td><td>1 (0.1)</td><td>0 (0.0)</td><td>1 (1.3)</td></tr><tr><td> + CRP ≥100 mg/L</td><td>10 (27.0)</td><td>0 (0.0)</td><td>0 (0.0)</td><td>0 (0.0)</td></tr></table> |
06f4f7409a158308b1e5fa287ad57743b97ad87fe3d6cf4c4f3dbc6f63800d46.png | simple | <table><tr><td></td><td>Number of patients with positive test result(<i>n</i> = 30)</td></tr><tr><td>Spices</td><td>27</td></tr><tr><td>Seeds and nuts</td><td>24</td></tr><tr><td>Seafood</td><td>24</td></tr><tr><td>Starch</td><td>22</td></tr><tr><td>Food additives</td><td>21</td></tr><tr><td>Vegetables</td><td>21</td></tr><tr><td>Cheese</td><td>20</td></tr><tr><td>Fruits</td><td>20</td></tr><tr><td>Sugar products</td><td>20</td></tr><tr><td>Other additives</td><td>14</td></tr><tr><td>Eggs</td><td>14</td></tr><tr><td>Milk and milk products</td><td>14</td></tr><tr><td>Infusions</td><td>13</td></tr><tr><td>Salads</td><td>10</td></tr><tr><td>Mushrooms</td><td>9</td></tr><tr><td>Yeast</td><td>5</td></tr><tr><td>Meat</td><td>5</td></tr></table> |
1743476203e554fb14dd9f869eba123f005cab2c9da0479c4a50ae4f58373f81.png | simple | <table><tr><td></td><td>n = 88</td></tr><tr><td>Patient age (years)Mean ± SD</td><td>36 ± 9.3</td></tr><tr><td>Sex (female/male)n (%)</td><td>60/28 (68.19/31.81 %)</td></tr><tr><td>BMI (kg/m<sup>2</sup>)Mean ± SD</td><td>48.65 ± 7.71</td></tr></table> |
55a84988e855aed8c052e983318eb0fca24e43f1512e12202e5a41f9fa24a4b7.png | simple | <table><tr><td></td><td>Non-interacting</td><td>Interacting</td></tr><tr><td>unconstrained</td><td>Z-score = 8.17, AUC = 93.48%</td><td>Z-score = 7.09, AUC = 91.06%</td></tr><tr><td>constrained</td><td>Z-score = 4.32, AUC = 87.01%</td><td>Z-score = 6.94, AUC = 90.07%</td></tr></table> |
04385580fe5a9b33fb7e9d37bd7ae8599ff1ac83ac639ecdcbeb20a7ec629a51.png | simple | <table><tr><td></td><td>Endocan (pg/ml)</td><td>Osteoprotegerin (pmol/l)</td></tr><tr><td>Baseline</td><td>146 ± 110</td><td>4,4 ± 2,4</td></tr><tr><td>2 months</td><td>168 ± 133</td><td>4,5 ± 2,7</td></tr><tr><td>4 months</td><td>168 ± 134</td><td>4,6 ± 2,3</td></tr><tr><td>6 months</td><td>179 ± 224</td><td>4,4 ± 2,0</td></tr><tr><td>8 months</td><td>196 ± 238</td><td>4,3 ± 2,1</td></tr><tr><td>Paired sample <i>t</i>-test</td><td><i>p</i>-value = 0,036</td><td><i>p</i>-value = 0,668</td></tr><tr><td>Friedman test</td><td>Chi-Square: 12,696Asymp. Significance: 0,013</td><td>Chi-Square: 8,309Asymp. Significance: 0,081</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.